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Abstract 
Nematode parasites of the gastro-intestinal (GI) tract, including species of the 
genus Trichostrongylus, are a major cause of pathology and loss of production in 
sheep and goat farming world wide. Such infections are currently controlled by 
prophylactic drenching with several classes of anthelmintic drugs. Spreading drug 
resistance and public concern over drug residues in food have led to research into 
vaccination as an alternative means of controlling these parasite species. 
Nippostrongylus brasiliensis is a GI nematode parasite of rodents and is an 
extensively applied laboratory model for defining the immune mechanisms that 
mediate worm expulsion. N. brasiliensis infection in the rat shares many similarities 
with Trichostrongylus infection in ruminants including, importantly, the functional 
proteins excreted or secreted by the nematode (ES proteins). Several of these ES 
proteins are potential candidates for vaccines. The aim of this project was to use the 
rat / Nippostrongylus parasite system as a model for vaccination with recombinant 
ES proteins. 
Prior to vaccination trials N. brasiliensis infections of varying levels were 
investigated and immunological assays were developed to allow the assessment of 
immune responses to infection and vaccination. The assays measured specific 
antibody and Mast Cell Protease (RMCP II) by ELISA. The utility of measuring 
immune cytokines by RT PCR was also investigated. 
Two proteins of interest, a superoxide dismutase (SOD) and 
acetylcholinesterase (AChE), were selected as vaccine candidates. Recombinant 
AChE was kindly provided for study by Prof Murray Selkirk. A cDNA encoding the 
SOD was amplified by PCR with a functional enzyme being obtained after 
expression in Escherichia coli. Sequence analysis of the predicted recombinant 
protein sequence is described along with activity and stage specificity of expression 
of the native protein 
Vaccination with these two recombinant enzymes was investigated to 
ascertain their protective capacity and thus their suitability as vaccine candidates. In 
a preliminary trial with AChE, vaccinated animals showed a 48% reduction in egg 
output compared to controls, this being associated with changes in antibody and 
RMCP II levels. The SOD did not induce any protection or a significant immune 
response. Further trials investigated how the route of administration and adjuvant 
might affect the protective capacity of these proteins, with protection varying 
between 0 and 38%. The relevance of these results to future vaccine trials in 
ruminants is discussed. 
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Chapter 1 - Introduction 
1.1 Introduction 
Gastro-intestinal (GI) nematode parasite species are a major problem for 
livestock production, both in the UK and the rest of the world. They cause gastro-
intestinal disease referred to as parasitic gastro-enteritis. The common symptoms in 
ruminants are of inflammation, inappetance and scouring (diarrhoea). These 
symptoms lead to malabsorption of nutrients from the gut with resultant poor weight 
gain and growth in infected animals and malnutrition that may ultimately lead to 
death in heavily infected animals. 
Substantial economic losses result directly from the reduced productivity 
effects on livestock and a cost is also incurred from the measures needed to control 
infection. This latter cost alone was estimated at £1000 million world-wide in 1994 
based on anthhelmintic sales figures (Newton and Munn, 1999). 
The currently used control methods for ruminant GI nematodes are chemical 
control and pasture management. Frequent dosing with anthelmintic drugs is the 
primary means of control. The development of resistance to anthelmintic drugs in GI 
nematode populations has led to an increased interest in the development of vaccines 
against the parasites. 
Intestinal nematode species of importance in sheep in the UK are two species 
of the genus Trichostrongylus inhabiting the small intestine, Trichostrongylus 
vitrinus and Trichostrongylus colubriformis (Reid and Armour, 1975; Coop et al., 
1979). A laboratory model of nematode infection of the small intestine may be useful 
in the development of vaccines against Trichostrongylus sp. allowing antigen 
candidates, delivery systems, adjuvants and challenge regimes to be tested in small 
scale trials. 
Nippostrongylus brasiliensis is a rodent intestinal nematode that has 
commonly been used as a laboratory model of GI nematode infection (reviewed; 
Ogilvie and Jones, 1971). Although the third larval (L3) stage follows a tissue 
migratory phase of infection, the L4 and adult stages inhabit the small intestine and 
induce similar pathology and immune responses to Trichostrongylus sp. These 
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similarities in the niche of the adult worms and in the pathology and immune 
responses to both species are the basis of the infection model. 
1.2 Phyloqeny of nematode parasites 
Nematode worms form the distinct phylum Nematoda. Trichostrongylus sp. 
and N. brasiliensis belong to the order Strongylida, which contains 4 sub-orders and 
seven superfamilies of animal parasitic nematodes (Blaxter et al., 1998; Durette-
Desset et al., 1994) 
Trichostrongylus sp. are members of the superfamily Trichostrongyloidea and 
the family Trichostrongylidae (Chilton et al., 2001; Durette-Desset et al., 1999). This 
group contains several other important parasites of animals and in particular of 
ruminants, including Haemonchus contortus, Ostertagia ostertagi, and Teladorsagia 
circumcincta. 
N. brasiliensis belongs to the closely related superfamily 
Heligmosomatoidea. This taxum is grouped with the superfamily 
Tnchostrongyloidea of ruminant parasites in the sub-order Tnchostrongylina 
(Durette-Desset et al., 1994). 
The molecular phylogenetic tree of the Nematoda constructed using small 
subunit ribosomal DNA sequences groups N. brasiliensis very closely with 
H. contortus and other Tnchostrongylid nematodes in the order Strongylida (Blaxter 
et al., 1998). This indicates a high degree of similarity between the species at a 
molecular genetic level. 
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1.3 Life cycle of nematode parasites 
1.3.1 Trichostronciytidae 
Trichostrongylus sp. have a direct lifecycle, typical of the Trichostrongylidae 
and illustrated in Figure 1.1. Eggs deposited on pasture in the faeces and hatch and 
develop to L3 stage larvae in around 1-2 weeks in optimal environmental conditions. 
The L3 larvae are ingested directly by the grazing host animal from the pasture and 
pass through the digestive tract exsheathing in the abomasum. On entering the small 
intestine the L3 penetrate and burrow into the mucosa. Here the worms go through 
their remaining moults to immature adult (L5) at around 12 days and to mature adult 
at around 16 days after infection. Eggs are passed in the faeces by around 2-3 weeks 
following infection (Urquhart et al., 1987). 
1.3.2 Nippostronqylus brasiliensis 
N. brasiliensis life cycle, shown in Figure 1.2, is also direct although the 
larvae infect the host through the skin and migrate to the intestine via the lungs. Eggs 
are passed in the faeces and hatch with the larvae developing to infective L3 stage in 
around a week. When the larvae contact the skin of the host they rapidly penetrate 
the dermal tissues (Lee, 1972). They then migrate through the venous circulation, 
penetrating the alveolar spaces of the lungs around 24-72 h following infection 
where they moult to L4 stage (Croll, 1977; Tindall and Wilson, 1990). The L4 are 
passed up the trachea and swallowed. Larvae migrate to a site in the anterior small 
intestine and go through the remaining moults to emerge as sexually mature adults on 
the surface of the mucosa after around 5 days (Alphey, 1970). 
16 
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L3 ingested by feedir 
host 
L4 and adult stages in 
predilection site in gut of host 
(Trichostrongylus: small intestine) 
Eggs passed in 
faeces 
I 
Infective L3 larvae 
	
Larval moults 	 Li 
on herbage (Free-living stages) 
S. 
L2 
Figure 1.1. The life cycle of Trichostrongyloid nematodes parasitic in the 
sheep gastro-intestinal tract. Eggs passed in the faeces of the host sheep 
hatch to free living larval stages. The infective L3 stage is ingested by the 
feeding sheep and the L4 and adult stages mature in the predilection site, in 
the case of the illustrated example, Trichostrongylus vitrinus, the small 





L4 and adult d and Y worms 
establish in small intestine 
L4 passed up the 
trachea and swallowed 
L3 penetrate into 
alveolar spaces 
and moult to L4 
l L 
L3 migrates through 
venous system to lungs 
L3 penetrates 
host dermis 
Larval moults / 
Infective L3 larvae L2 
Figure 1.2. The life cycle of Nippostrongylus brasiliensis in the rat host Eggs 
passed in the faeces hatch and larvae moult through Li and L2 free-living 
forms. The L3 infective larvae enter the host by skin penetration and go 
through a tissue migratory phase passing through the veinous system and 
entering the lung alveoli. Larvae are then passed up the airways and 
swallowed. L4 and adult worms then enter the small intestinal phase of the 
life cycle. (Photograph, Moredun Research Institute, G Ball). 
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1.4 Epidemiology of GI nematode infection 
1.4.1 Trichostrongylus infection in sheep 
Sheep acquire nematode infections from infected pasture as they graze. 
Infections usually occur as mixed infections of several species with T. vitrinus in the 
small intestine and T. circumcincta in the abomasum as the species of most 
prevalence in the UK. T. colubrformis is the more common intestinal species in 
other temperate regions such as Australia (Reid and Armour, 1975; Coop et al., 
1979). 
Infection rate is linked to the rate of ingestion of infective larvae, which is 
dependent on how heavily the pasture is infected, and on the susceptibility of host 
animals. Infection rate in the UK is typically high during summer and autumn, 
dropping to lower levels over the winter as exposed ewes and lambs acquire 
immunity to infection and pasture contamination decreases (Urquhart et al., 1987). 
Larvae of Trichostrongylus sp. have a high capacity to survive cold or dry 
conditions and many larvae will over winter and remain viable to infect animals in 
the spring. In some areas climatic conditions can allow Trichostrongylus sp. larvae to 
survive in sufficient numbers to produce severe problems in the spring (Urquhart et 
al., 1987). In the UK, however, numbers of over wintering T. vitrinus larvae are 
lower and mortality among the larval population is high during the winter. Warmer 
spring and summer temperatures decrease the development time and mortality rate of 
larvae on pasture if there is adequate humidity. Such conditions allow increased rates 
of infection during this time (Rose and Small, 1984). 
Numbers of Trichostrongylus spp in grazing lambs in the UK, are usually low 
during spring and early summer indicating a low infection rate from over wintering 
larvae (Cornwell, 1975). The phenomenon of periparturient relaxation of acquired 
immunity, whereby previously exposed and immune ewes lose their immunity 
around the time of parturition, leads to an increase in egg output in summer, 
exposing new-born lambs to high infection rates. Worm numbers in lambs 
accumulate in late summer and early autumn, at which time Trichostrongylus spp 
(predominantly T. vitrinus) along with T. circumcincta become the most common 
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nematode parasites (Cornwell, 1975). Clinical effects of parasitic gastro-enteritis 
associated with these species tend to occur at this time. 
1.4.2 Laboratory infection regimes with Nippostrongylus brasiliensis 
Single challenge infections on naïve rats with between two to three thousand, 
N. brasiliensis L3 larvae have a characteristic 10-14 day infection cycle. The faecal 
egg count (FEC), and also worm numbers, peak at around seven days post infection. 
From day 7 onwards worm numbers decrease, with the infection clearing completely 
by day 10-14. This has been the most commonly used and described laboratory 
infection regime with N. brasiliensis (Ogilvie and Jones, 1971; Rothwell, 1989). 
An infection regime using a trickle infection, whereby the rats are 
continually infected with a low numbers of larvae (five per day for five days a week) 
has been shown to have a different profile of infection (Jenkins and Phillipson, 
1971). In this case the worm burden can increase steadily through the infection 
period and a sustained chronic infection can occur with worm numbers being 
maintained even after infection stops as seen in Figure 1.3 (Jenkins and Phillipson, 
1971). This situation is much closer to naturally occurring nematode infections and is 
similar to the pattern in ruminant, parasitic nematode infections acquired from 
contaminated pasture. 
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Figure 1 .3. The accumulating mean faecal egg counts and adult worm 
numbers of a group of 36 rats infected via a trickle challenge regime with 5 
Nippostrongylus brasiliensis L3 per day over the course of 12 weeks. The 
dashed line indicates the number of worms persisting in a group of animals 
which were removed from the infection regime after 8 weeks of the 
experiment (adapted from Jenkins and Phillipson, 1971). 
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1.5 Parasitic GastrO Enteritis and the pathology of infection 
Parasitic gastro-enteritis is the generic term used to describe the clinical 
symptoms produced by infection with parasitic GI nematodes. Most field infections 
comprise concomitant infections with more than one species of nematode (Reid and 
Armour, 1975; Bartley et al., 2003). General symptoms include inappettance, weight 
loss, poor fleece and carcass quality at slaughter and scouring. These symptoms 
result from the damage induced by the infection and even in sub-clinical infections 
pathology can be significant and result in economic losses (Urquhart et al., 1987). 
1.5.1 Pathology during Trichostrongylus infections 
Pathology is similar in both T. vitrinus (Taylor and Pearson, 1979) and 
T. colubriformis (Barker, 1975a) infections, although it may be more marked in the 
latter. The major harmful effect is damage to the mucosa of the small intestine with 
resultant intestinal inflammation and reduced nutrient uptake. Heavy infections may 
also induce scouring, leading to further serious effects on the health of the animal 
(Sykes and Coop, 1976). 
Effects are most evident in the proximal 3-4 m of the small intestine where 
the worms are present in sub-epithelial tunnels (Barker, 1975a; 1975b). In this region 
there is marked villous atrophy, or flattening of the intestinal villi, the crypts are 
elongated and the epithelial cells are flattened with unusual morphology (Coop et al., 
1979). Some breaks in the epithelial surface occur that may be due to rupture of the 
worm tunnels. Inflammation of the mucosa is associated with the eroded epithelium 
(Taylor and Pearson, 1979). Barker (1975b) also demonstrated an increase in the 
vascular permeability of the infected region, which may lead to loss of plasma and 
protein into the gut. 
More distal regions show reduced villous atrophy and after around 5-7 
months after infection show normal morphology and histology. In one study on 
T. colubriformis an increase in villous length in the distal portion of the small 
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intestine was seen after day 15. This was suggested to be an adaptive response to the 
reduced surface area and nutrient uptake of the damaged region (Roy et al., 1996). 
The severity of pathology also decreases with lower infection dose or rate and 
pathology becomes less severe as the infection develops (Taylor and Pearson, 1979; 
Coop et al., 1979). Villous atrophy becomes subtotal regressing proximally and 
becomes focal, forming characteristic "fingerprint" lesions in areas occupied by the 
worms. This coincides with the onset of host resistance to incoming larvae, and may 
occur earlier in T. vitrinus than T. colubriformis (Jackson et al., 1983). 
Changes in activity of brush border associated and other mucosal enzymes 
has been reported during infection (Jones, 1982). Reduction in the serum level of one 
of these enzymes, alkaline phosphatase, similar to the change in mucosal level, has 
been associated with reduction in bone density and size during a mixed T. vitrinus / 
T. circumcincta infection (Thamsborg and Hauge, 2001). 
As a result of pathological changes in the gut, protein deposition and skeletal 
mineral deposition are reduced in infected lambs compared to uninfected controls 
leading to the reduced growth and weight gain effects seen in the former (Sykes et 
al., 1979). These effects probably result from the reduced uptake of nutrients across 
the damaged mucosa. Loss of plasma proteins leaking into the gut may further 
reduce the protein deposition along with the increased protein turnover required to 
repair the worm induced damage to the intestinal mucosa (Sykes and Coop, 1976; 
Sykes et al., 1979). 
1.5.2 Pathology during Nippostronqylus infection 
N. brasiliensis infection results in similar pathological changes in the rat 
intestine. Here pathology is also confined largely to the proximal end of the small 
intestine or jejunum. Thickening of the mucosa and inflammation of the villi and 
crypts of the jejunum result from the infection (Simaren and Ogunyoye, 1973). The 
villi of Nippostrongylus infected rats become shortened and irregular compared to 
those in uninfected rats or in distal, uninfected areas of the same host. The microvilli 
on the cell surfaces also become shortened and irregular (Symons, 1976). Levels of 
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activity of brush border enzymes are reduced in a manner similar to those seen in 
Trichostrongylus infections (Symons and Fairbairn, 1963). 
The villous atrophy during N. brasiliensis infection has been associated with 
increased apoptosis of epithelial cells on the villous surface (Hyoh et al., 1999). This 
increased epithelial cell turnover may lead to undifferentiated crypt cells being 
present on the villi surface explaining some of the altered morphology seen (Symons, 
1965). 
The villous atrophy produced during Nippostrongylus infection, although 
often described by authors as very similar, is generally somewhat less severe than in 
Trichostrongylus infections of sheep. One possible reason is that the adult worms do 
not burrow through the mucosal epithelium, but are present coiled around or between 
villi (Symons, 1976). 
Intestinal malabsorption of nutrients including glucose and amino acids also 
occurs during Nippostrongylus infection in rats. This has been explained by the 
changes to the morphology of villi and cells in the jejunum and to the reduction in 
the levels of activity of mucosal enzymes such as maltase aminopeptidase and 
alkaline phosphatase in this area (Symons et al., 1971). Reductions in serum protein 
and glucose levels and reduced weight gain in heavy infections are likely to result 
from this malabsorption and inappetance induced by worm damage (Simaren and 
Ogunyoye, 1973). 
Significant pathology in N. brasiliensis infection also results from the 
migrating larvae penetrating the alveolar walls of the lungs. This is characterised by 
focal haemorrhage accompanied by accumulation of inflammatory cells at the site of 
larval penetration (Ramaswamy et al., 1991). Infected lungs may be spotted or 
mottled with haemorrhages for several days after infection. Pathological changes in 
the lung are more marked during repeat infections when cell accumulation and 
granuloma formation around incoming larvae are enhanced and persist for much 
longer (Salman and Brown, 1980; Ramaswamy et al., 1991). 
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1.6 Resistance and expulsion of gastro-intestinal nematode 
infection 
Adult sheep exposed to repeated nematode challenges acquire an effective 
immunity to infection over time and will eventually expel a primary worm burden. 
Following this, they have immunity to further repeated challenges (Balic et al., 
2000). A similar immunity develops in repeatedly challenged laboratory rodent 
models (reviewed; Miller, 1984; Rothwell, 1989). This response vanes with the 
infection level and there are also marked differences in the ability of animals to 
respond to challenge. This varies between individuals, with age and with 
reproductive status. 
The development of resistance and expulsion of both ruminant and rodent 
nematodes follow similar patterns, and similar effector processes may be involved. 
The events surrounding expulsion and the development of resistance are outlined 
below and a more detailed outline of the immune responses that underlie these events 
is discussed in the next section (1.7 Immune Responses to Infection). 
1.6.1 Resistance and expulsion in Trichostrongylus infection of sheep 
Adult animals exposed to repeated Trichostrongylus infection acquire an 
effective immunity to infection over time. Continuous natural or experimental trickle 
infections with differing levels of infective Trichostrongylus larvae give cumulative 
worm burdens up to a threshold level of infection. Once this level has been exceeded 
establishment of incoming worms is prevented and the established worms are 
expelled by the immune response. The time taken to reach this threshold level is 
dependent on the rate of infection. Total worm burden can peak at 20-30,000 prior to 
expulsion at a high rate of infection whereas a cumulative worm burden at a low 
infection rate can reach 1,500 without eliciting expulsion (Waller and Thomas, 
1981). Following expulsion of a primary infection, animals have immunity to 
reinfection with further challenges. 
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Experimental challenges and studies of natural infections have shown that the 
development of an immune response and the onset of expulsion during a natural or 
continuous trickle infection follow a distinct pattern. This is characterised first by the 
resistance to establishment of incoming infective larvae followed by expulsion of 
established L4 and adult worms (Waller and Thomas, 1981). The exclusion of 
incoming larvae in this manner followed by expulsion of adults is similar to the 
sequence of events observed during infection with various nematode species in 
rodent hosts (Rothwell, 1989). Immune exclusion of incoming larvae may be 
associated with trapping in mucus while the expulsion of established adult worms is 
associated with a range of developing humoral and cellular responses (Miller, 1984). 
Young animals are susceptible to infection and are not protected or able to 
expel worms until they reach a critical age. Lambs are unable to mount a protective 
immune response up to 36 weeks of age (Gibson and Parfitt, 1972; Dobson et al., 
1990). The reasons behind this lack of response have not been defined but are 
believed to involve the immaturity of the immune response. In one study the authors 
reported that the lack of protection may be related to a reduced globule leukocyte 
response seen in young lambs (<6 months of age) compared with older counterparts 
(Gregg et al., 1978). 
Protective immunity is relaxed in periparturient and lactating ewes previously 
immune to infection, leading to an increase in infection rate and a rise in egg output 
onto pasture during spring (O'Sullivan and Donald, 1973). The mechanism behind 
this effect is not fully understood but may involve protein resource needs at this time 
(Coop and Kyriazakis, 1999). This feature of ruminant nematode infections is very 
important in their epidemiology, being a major source of infection for weaning lambs 
(Cornwell, 1975; Urquhart et al., 1987). 
1.6.2 Resistance and expulsion of Nippostrongylus infection in rodents 
Following a single challenge with several thousand N. brasiliensis larvae, rats 
develop an immune response that expels the adult worms from the initial infection 
and prevents re-infection with subsequent challenges. During such a primary 
infection with N. brasiliensis in rats, three phases are observed corresponding to the 
initial loss of infective larvae, the establishment and survival of adult worms and the 
expulsion of the established adult population. The initial loss of larvae is due to 
failure of between 40 to 60% of larvae to migrate or establish, while expulsion of 
adults is the result of a developing immune response (Jarrett et al., 1968). Similar 
infection kinetics are demonstrated by other rodent models of nematode infection 
such as Trichinella spiralis infection of mice and rats (reviewed; Miller, 1984; 
Rothwell, 1989). 
In N. brasiliensis infected rats, this developing immune response and 
expulsion of the challenge may be dose dependent, in a similar manner to that 
observed in ruminant nematode infections, as a trickle infection regime has been 
shown to be both cumulative and persistent (Jenkins and Phillipson, 1971). 
Threshold levels of infection may be tolerated before a response is initiated, as a low 
number of worms may remain in the gut of "immune" animals following rejection of 
the bulk of infection. However this population might represent "adapted" worms that 
avoid the developing host immune response (Jarrett et al., 1968; Rothwell, 1989). 
This threshold level of infection required prior to an immune response being 
generated has also been demonstrated in the mouse parasitic nematode Trichuris 
muris (Bancroft et al., 2001). 
In a repeat N. brasiliensis challenge, loss of larvae is enhanced to over 80%. 
This is probably due to a specific immune response and represents an "immune 
exclusion" of incoming larvae from their niche in the small intestine (Miller, 1984). 
Around 50% of infecting larvae may be lost prior to the lung stages with only 1% of 
the remaining L4 larvae becoming established as adults. This indicates that 
components of the immune response operate against both the pre-lung and the gut-
establishing larval stages (Love et al., 1974). Expulsion of adult worms also occurs 
earlier and at a faster rate (Jarrett et al., 1968). 
The prevention of establishment of Nippostrongylus larvae in immune rats 
and the expulsion of established adults show similarities with events observed during 
the development of resistance to Trichostrongylus infection in sheep described 
earlier (Section 1.6.1 Resistance and expulsion in Trichostrongylus infection of 
sheep). The protective immune response against N. brasiliensis infection in rats also 
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shows the same deficiencies with regard to age and reproductive status as does the 
infection of sheep with Trichostrongylus. 
Neonatal rat pups infected following birth showed a reduced ability to expel 
N. brasiliensis infection compared to adult rats such that they may harbour 
significant worm burdens for up to 40 days after infection (Ogilvie and Jones, 1967). 
The young rats were also unable to mount a protective response to repeated 
infections until the age of 6 weeks and even at this age the response was not as strong 
as that expressed in adult rats (Ogilvie and Jones, 1967). In this respect these rats are 
similar to young lambs, which are unable to mount a protective immune response to 
nematode infection until around 36 weeks of age (Gibson and Parfitt, 1972). In both 
infections the lack of response is thought to lie in the lack of development of the 
immune system. 
The phenomena of periparturient relaxation of immunity, similar to that seen 
in ruminant infection, is also exhibited by lactating female rats infected with 
Nippostrongylus (Houdijk et al.,, 2003). Lactating rats that had previously been 
infected and were therefore immune, harboured higher worm burdens and had higher 
FEC than non-reproducing counterparts. This observation was also suggested to have 
its basis in reduced allocation of protein resources as suggested in the ruminant 
infection (Houdijk et al., 2003). 
1.6.3 The immune basis of nematode expulsion 
The exclusion of incoming larvae in repeatedly infected animals and the 
expulsion of adult worms from a single challenge infection result from developing 
immune responses in both rodents and sheep (Jarrett et al., 1968; Dobson et al., 
1990). These are generally characterised as T-helper (Th) 2 responses due to the 
involvement of specific T-cell subsets and associated cytokines (Finkelman et al., 
1997). The specific immune effector responses expressed during GI nematode 
infection are described in detail in the next section. Presented here is an overview of 
expulsion events with reference to the underlying immune responses discussed later 
(Section 1.7 Immune Responses to Infection). 
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The response of "immune exclusion" expressed against larval stages before 
they establish in their niche is seen in rodent and in ruminant nematode infections. 
"Rapid expulsion," was first described in T. spiralis infections of rats (reveiwed; 
Rothwell, 1989) and the term has been used to describe rejection of larvae in other 
rodent infections including N. brasiliensis transplanted adult worms (Miller et al., 
1981). It has also been described in experimental H. contortus infection (Miller et al., 
1983a), and is suggested to occur in field infection of ruminants (Chiejina and 
Sewell, 1974). 
Rapid expulsion is an extremely rapid process by which incoming larvae are 
removed from the gut within hours of infection. In both T. spiralis and N. brasiliensis 
infections, rapid expulsion involves mucus trapping (Miller et al., 1981). In this 
respect the events in rodent models are similar to the immune exclusion of incoming 
larvae described in ruminant Trichostrongylus infections, that may be the result of 
antibody / mucus trapping (Harrison et al., 2003). 
The expulsion of established adult worms, from primary infected and immune 
animals, is considered a specific immune-mediated response both in rodent and in 
ruminant GI nematode infections (Jarrett et al., 1968; Dobson et al., 1990). Similar 
humoral and cellular responses may be observed in each case (reviewed; Miller, 
1984; Balic et al., 2000). 
Serum levels of Immunoglobulin (Ig) G, IgA and IgE antibody isotypes may 
increase during the response, both in rodents and in ruminant infection (Miller, 1984; 
Balic et al., 2000). During N. brasiliensis infection IgE production is particularly 
strongly stimulated (Jarrett and Haig, 1976) and serum IgGi is associated with the 
transfer of passive protection (Jones et al., 1970). Mucosal antibody has been 
observed in this and other models and may be more important in the resolution of 
infection (Miller, 1984). 
Cellular responses are also stimulated and are implicated in the resolution of 
infection. Mast cells increase in numbers and tend to aggregate in the infected 
intestinal tissue areas, correlating with expulsion (Miller, 1984). In some infections, 
for example during Strongyloides ratti and T. spiralis infection of mice, mast cells 
are required for expulsion (Nawa et al., 1994). In others, such as Nippostrongylus, 
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they are strongly stimulated but do not appear to be the effector of expulsion (Miller 
et al., 1983b; Nawa et al., 1994). 
Eosinophilia increases in the blood and eosinophils aggregate at the sites of 
infection. In addition eosinophils may attach to and damage parasites in vitro 
(McLaren et al., 1977; Shin et al., 2001). Goblet cells may also be involved in the 
response with an increase in numbers and activation leading to an increased output of 
mucus into the gut lumen (Karlsson et al., 2000). In Nippostrongylus it is this 
response that is considered to effect worm expulsion (Nawa et al., 1994). 
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12 Immune responses to infection 
Expulsion of nematodes from the gastro-intestinal tract and resistance to 
further infection is mediated by host immune responses. Similar responses are seen 
in different nematode infections in terms of the cell types, immunoglobulin subtypes 
and cytokine responses that are expressed. This suggests that there may be common 
expulsion mechanisms expressed against different nematode species by various host 
species. However, differences are also evident between different infections indicating 
that multiple separate immune mechanisms may act on different parasites, life stages 
and in different host / parasite systems. Termination of an infection might also 
therefore be brought about by different effector responses in each situation despite 
general similarities in the responses observed (reviewed Rothwell, 1989; Balic et al., 
2000). The similarities and differences of rat and ruminant immune responses to GI 
nematode infection are summarised in Table 1.2. 
1.7.1 T-cells and the immune resøonse 
The T-helper cell (CD4+ T-cell) response that develops in response to a 
pathogen infection is very important in the type of immune response that develops 
and the subsequent outcome of the infection. T-helper cells are polarised towards T-
helper subset 1 (Th-1) or 2 (Th-2) mediated responses (Mosmann et al., 1986). Th-1 
responses are described as cell mediated immune responses that are involved with 
the killing of intra-cellular pathogens (Kaufmann et al., 1992). Th-2 response is 
described as antibody mediated immune response and involves antibody and 
different cell types in the resolution of infections with extra-cellular pathogens and 
epecially helminth parasites (Urban et al., 1992; Finkelman et al., 1997; Liu et al., 
2004). That CD4+ T-cell involvement is required for the resolution of GI nematode 
infection has been demonstrated in rodent and ruminant models by T-cell transfer or 
depletion experiments (Grencis et al., 1985; Katona et al., 1988; Gill et al., 1993). 
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In rodent infections with gastro intestinal nematodes, such as N. brasiliensis, 
T. spiralis, T. muris and Nematospiroides dubius (formerly Heligmosomoides 
polygyrus), Th-2 polarisation is especially marked and as such these models have 
been used extensively to study T-cell polarisation (reviewed; Finkelman et al., 1997; 
Else and Finkelman , 1998). In these models Th-2 reponses are responsible for 
expulsion while induction of a Th-1 response usually impairs this protection. The 
idea that all infections are as completely polarised in their T-cell response is now 
seen as inaccurate with components of Th- 1 and -2 possibly involved in a complex 
regulatory interaction (Allen and Maizels, 1998). However, it has been broadly 
accepted that immune reactions involving Th-2 like responses are protective during 
gastro-intestinal nematode infection. 
T-cell polarisation is initiated when antigens of the invading pathogen are 
taken up by antigen presenting cells such as dendritic cells. The antigen molecule is 
digested into smaller fragments and these fragments are then presented at the cell 
surface associated with the MHC class 2 protein. A T-cell clone with a specific T-
cell receptor then binds the MHC/antigen complex and is activated. Signalling 
molecules such as cytokines and cell surface molecules are important in this 
activation and in the subsequent polarisation of response (Else and Finkelman, 1998; 
Liu et al., 2004). Following activation the T-cell then enters a pathway leading to the 
production of either a Th- 1 or a Th-2 response. The events and interactions of T-cell 
activation are illustrated in Figure 1.4. Table 1.1 summarises the characteristics of 
the cell types and the cytokines involved in the T-cell response. 
Nematode infections in both rodent and ruminant infection are considered to 
provoke Th-2 immune responses (Urban et al., 1992; Balic et al., 2000; Schallig, 
2000). In this pathway the activated T-helper cells secrete IL-4 and IL-13 generating 
Th-2 cellular responses (Finkelman et al., 2004) and interact with B-cells presenting 
the same antigen. This interaction leads to the development of plasma cells and 
antibody responses, particularly IgE (Figure 1.4). 
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B7 " 	Antibody secretion 
Figure 1.4. The stimulation of 1-helper (Th) cell differentiation and the 
resultant immune responses. Antigen from incoming pathogens is first taken 
up by antigen presenting cells (APC) and partially degraded. Epitopes are then 
presented on the cell surface bound to MHC class 2 molecules. Naïve T-cells 
with T-cell receptor specificity for this MHC 2 / antigen complex are then 
stimulated by this contact, with CD28 / B7 ligand interaction and cytokine 
involvement. IL-2 autocrine stimulation leads to 1-cell proliferation. The APC 
contact and cytokine milieu influence the development towards IFN-y secreting 
Th-1 like cells or IL-4 secreting Th-2 like cells. Different cytokines are released 
by each subset leading to the differing cellular immune responses and 
production of different antibodies through B-cell contact. Negative feedback 
effects on the development of the opposing subset are displayed by IFN-y and 
IL-4. Adapted from Else and Finkelman (1998). 
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eg. dendntic cells, macrophages. 
Take up antigen from pathogens 
and present epitopes bound to 
MIHC-2. 
Th-1/2 development may depend 
on type of APC stimulus. 
Resting 	T-cell. 	Following 
activation by APC, proliferation 
and polarisation of T-cell bearing 
antigen specific receptor occurs. 
Release cytokines involved in cell 
mediated immune responses and 
induce B-cells to produce Th-1 
charateristic antibodies eg. IgG2a 
in mice. Stimulate macrophages. 
Releases cytokines 	involved in 
antibody mediated immune 
responses. Stimulate 	B-cells 	to 
produce Th-2 	characteristic 
antibodies eg. IgE. 
Antigen specific up-take and 
presentation on MHC-2. On 
stimulation by activated T-cell 
proliferate and differentiate into 
memory and plasma cells. Plasma 
cells secrete specific antibody. 
IL-12 (Th- 1 development) 
IL-6? (Th-2 development) 
Following activation: 
IL-2 (autocnne stimulation) 
IFN-y (Th-1 development; Th-
2 inhibition) 
IL-4 (Th-2 development; Th-1 
inhibition) 
IFN-y (macrophages and 13-
cells) 
IL-2 (B-cells) 
IL-4 (B-cells, eosinophils, mast 
cells, basophils, goblet cells 
and epithelia) 
IIL-10 (B-cells, mast cells and 
basophils) 
IL-9 (mast cells and basophils) 
IL-13 (similar to IL-4) 
IL-5 (eosinophils) 
Table 1.1. Some characteristics of the cell types involved in the T-cell 
response and the cytokines released. Through cytokines release (and other 
signalling molecules) T-cells influence the immune effector response against 
other infections. During gastro-intestinal nematode infection dominant Th-2 
responses are considered protective, whilst dominant Th-1 responses may 
impede expulsion (Else and Finkelman, 1998; Finkelman etal., 2004). 
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1.7.2 Cytokine involvement in the immune response 
Cytokines are signalling molecules or immune mediators that have many 
functions in immune reactions including effects on cell recruitment, proliferation and 
activation. Critically cytokines are involved with the early development of either Th-
1 or Th-2 responses and therefore the bias of the immune T-helper cell response. In 
particular IL-4 and IL- 13 are considered cytokines that drive Th-2 development 
(Finkelman et al., 2004), acting through an IL-4 receptor and the signal tranducer 
and activation of transcription (STAT) -6 pathway (Hou et al., 1994; Schindler et al., 
1994). In contrast Th-1 development is driven by I1L-12, acting through the STAT-4 
pathway (Bacon et al., 1995; Jacobson et al., 1995) and Interferon (IFN)-y release 
(Heinzel et al., 1989). In this regard the production of specific cytokines may be used 
as markers of Th- 1 or -2 response. 
The specifc role of individual cytokines in the immune response has been 
dissected, in part using the previously mentioned rodent / nematode infection models, 
in which pronounced Th-2 responses occur. Using these models relationships such as 
the dependance of IgE production and mast cell response on IL-4 and the stimulation 
of eosinophilia by IL-S were derived (Coffman et al., 1989; Madden et al., 1991). 
Some cytokines, their function and target cells in the immune response are 
summarised in Figure 1.4 and Table 1.1. 
The development of many of the responses observed during nematode 
infection such as the cell types involved and the generation of antibody (and 
especially IgE) responses are characteristic of Th-2 response. Many of the cytokines 
observed in rodent nematode infections are also considered Th-2 promoting or 
characteristic cytokines, as illustrated in figure 1.4 and Table I.I. These include 
Interleukins (IL) -4, -5, -6, -10 and —13 (Else and Finkelman, 1998; Behm and 
Ovington, 2000; Finkelman et al., 2004). Studies in rodent / nematode infection 
models have shown that the Th-2 promoting cytokine 11L-4 is associated with 
protection whereas the Th- 1 promoting cytokine IFN-y may inhibit rejection 
(reviewed; Finkelman etal., 1997). 
Th-2 cytokine responses have been correlated with immune expulsion of 
Nippostrongylus infection from mouse (Coffman et al., 1989) and rat (Matsuda et al., 
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1995) hosts. Increases in Th-2 cytokine transcription were measured from the 
mesenteric lymph nodes during N. brasiliensis infection of rats and indicated that IL-
3, -4, —5 and —13 mRNA production was elevated, correlating with the time of 
expulsion (Matsuda et al., 1995; Matsuda et al., 1999). IL-2, -10 and IFN-y mRNA 
levels were either unchanged or slightly decreased from controls suggesting an 
overall Th-2 bias to response. The change in the cytokine levels varied with strain of 
rat tested (Matsuda et al., 1995). These strains are known to have differing ability to 
expel worms, such that expulsion is delayed in the strain expressing lower levels of 
Th-2 cytokines (Uchikawa et al., 1996). 
More recently, studies have been conducted into the role of cytokines in 
ruminant nematode infections (Pernthaner et al., 1997; Gill et al., 2000). These 
studies indicate changes in cytokine levels being generated during response to 
ruminant infections with some similarity to those seen in rodents. 
Th-2 cytokine production may be upregulated during ruminant nematode 
infection. IL-4 production increased following immunisation of immune lambs with 
T. colubriformis (Pernthaner et al., 1997). Elevated production of IL-S mRNA 
occurred during H. contortus infection of lambs, and correlated with a Th-2 immune 
cell response (Gill et al., 2000). The IL-S and infiltrating cell responses in this study 
were greatest from a line of lambs selected for parasite resistance. Further, the level 
of Th- 1 cytokines may be reduced during ruminant nematode infection. The level of 
Th-1 cytokines 11L-2 and IFN-y was reduced following immunisation of immune 
lambs with T. colubriformis (Pernthaner et al., 1997). IFN-y production was also 
reduced during infection with H. contortus and was lowest in resistant lambs (Gill et 
al., 2000). This suggests that the response in ruminants may be Th-2 type with 
elevated Th-2 cytokines such as IL-4 and -5 and reduced Th- 1 such as IFN-y (Gill et 
al., 2000). 
IL-S mRNA production by cells from the lamina propria, mesenteric lymph 
nodes and Peyer' s patches in the gut of sheep immune to T. colubriformis was 
associated with eosinophils and y/ö T cells. The authors ascribe a regulatory role in 
the activation of effector cells such as eosinophils to this cytokine (Bao et al., 1996). 
11L-6 mRNA producing cells in the intestine of sheep also increased in number during 
infection with T. colubriformis (Shen et al., 2000). This increase was correlated with 
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increases in immunoglobulin containing cells and specifically IgG containing cells. 
The authors suggest a role in the increase of IgG production to this cytokine response 
(Shen et al., 2000). 
1.7.3 Mast cells, basophils and globule leukocytes 
Mast cells are an immune effector cell commonly associated with nematode 
infections. They release mediators from cytoplasmic granules including histamine, 
proteoglycans, cytokines and proteases that have effects on the local tissues. Mast 
cells fall into two main types, connective tissue and mucosal, and derive from the 
same stem cell line as basophils, containing similar products and activation factors 
including high affinity IgE receptors. Basophils circulate in the blood stream whereas 
mast cells are localised to tissue sites and their differentiation is under the control of 
different cytokines (Balic et al., 2000). Globule leukocytes (GLs), which are often 
referred to in literature, are now believed to be intra-epithelial mast cells with 
enlarged granules. These may be the effector stage ready to release the granule 
components (Rothwell, 1989; Balic et al., 2000). 
During nematode infections, mast cells proliferate and infiltrate the site of 
infection (mastocytosis). They then degranulate releasing the contents into the 
surrounding tissue environment or intestinal lumen. Consequent effects may include 
increased vascular permeability, mucus secretion and smooth muscle contraction as 
well as recruitment of other immune cells and effector mechanisms (Balic et al., 
2000). 
The level of one mast cell product, mast cell protease (MCP), rises 
systemically and in mucosal tissue during both rodent and sheep nematode 
infections, in both cases an event correlating with expulsion (Miller et al., 1983b; 
Huntley et al., 1993; Douch et al., 1996). MCP level is therefore a useful marker of 
mast cell activation during nematode infection. It is thought that MCP may act on 
epithelial cell tight junctions to increase the epithelial permeability (Miller, 1984; 
McDermott et al., 2003). 
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Numbers of mast cells and GL increase in the small intestine mucosa during 
infection and expulsion of Trichostrongylus infections in sheep (O'Sullivan and 
Donald, 1973), and guinea pigs (Huxtable and Rothwell, 1975). Lumenal and tissue 
GL numbers also increase with resistance status following repeated and abrogated 
larval challenge with T. colubriformis (Stankiewicz et al., 1993). Mast cell and, in 
particular, GL numbers correlate negatively with numbers of adult worms in the 
intestine during Trichostrongylus infection of sheep, suggesting a correlation with 
protection (Douch et al., 1986). The increase in numbers of GL during infection also 
correlated positively with increased larval migratory inhibitory action of mucus in 
infected sheep (Stankiewicz et al., 1995) 
Treatment with dexamethasone, a corticosteroid, abrogated the rejection of 
GI nematodes in the sheep. There was a corresponding reduction in serum MCP level 
and tissue GL number. Both effects ended when the drug treatment was removed 
(Douch et al., 1996). 
The rise in effector cell number varies with the reproductive status of infected 
ewes, a factor that influences ability to resist infection. This may suggest that 
reduction in effector cell accumulation, including mast cells, is a factor in the loss of 
immunity of periparturient ewes (O'Sullivan and Donald, 1973). 
Mastocytosis is very pronounced during Nippostrongylus infection of the rat 
(Kelly and Ogilvie, 1972; Miller et al., 1983b). Mast cells and GL accumulate in 
infected areas in correlation with the time of expulsion, (Kelly and Ogilvie, 1972). 
Degranulation of activated mast cells, as determined by increase in systemic level of 
MCP, occurs at around the time of worm expulsion (Miller et al., 1983b). These 
observations might suggest that the mast cell response is a component of the 
expulsion in the N. brasiliensis infection, by a mechanism such as the increase in 
mucosal permeability (Miller, 1984). 
In several other parasite models, including S. ratti (Nawa et al., 1985) and T. 
spiralis (Ha et al., 1983; McDermott et al., 2003) in mice, mast cell activation has 
been linked to the expulsion of the worms. In Nippostrongylus infection of mice 
however the expulsion of worms occurs even in the absence of a mast cell response, 
or a mast cell component (Uber et al., 1980). It has also been suggested that 
N. brasiliensis expulsion is a consequence of goblet cell activation following 
observations by some workers (Ishsikawa et al., 1994; Nawa et al., 1994). This 
would suggest that while strong stimulation of mast cell accumulation and activation 
occurs during N. brasiliensis infection, this is the result of a generalised response 
against nematode infection and not the specific effector (Nawa et al., 1994). MCP is 
however a good indictor of mast cell activation and therefore of a cellular component 
in the response during N. brasiliensis infection (Miller et al., 1983b). 
1.7.4 Eosinophils 
Eosinophils are a cytotoxic immune cell type commonly associated with 
parasitic infections. They are produced in bone marrow and circulate in the blood 
with numbers increasing and accumulation occurring at sites of infection. 
Eosinophils have granules containing strongly cationic proteins including peroxidase 
(eosinophil peroxidase) and lyosomal proteins, which are released onto pathogens by 
activated eosinophils, and which are capable of a respiratory burst that produces 
reactive oxygen species (Babior et al., 1973). During nematode infection, eosinophils 
accumulate in infected tissue and eosinophil association with dead or damaged 
worms in some systems has suggested they may be involved in worm killing 
(Rothwell, 1989; Balic et al., 2000). 
Studies with nematode larvae in vitro in several species including 
Nippostrongylus (Shin et al., 2001) and the ruminant nematode H. contortus 
(Rainbird et al., 1998) have demonstrated that eosinophils are capable of attaching 
to, degranulating and damaging or killing nematode larvae. These studies also 
showed that larval killing by eosinophils in vitro is enhanced by the addition of 
antibody, complement and IL-5, which is indicative of an in vivo relationship 
(Rainbird et al., 1998; Shin et al., 2001). 
In the guinea pig T. colubriformis infection system, eosinophilia and 
increased mast cell counts coincide with worm expulsion (Huxtable and Rothwell, 
1975; Rothwell, 1975). Increased tissue eosinophil numbers have also been 
correlated with resistance in ruminant nematode infection suggesting a role in 
protection (Bao et al., 1996). In a mixed T. colubriformis / H. contortus infection 
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eosinophil numbers, along with mast cells and GL were increased in the gut mucosa 
of animals with reduced faecal egg outputs (O'Sullivan and Donald, 1973). 
Circulatory eosinophil counts were also correlated with increased protection 
in a line of sheep that had been bred for resistance to T. colubriformis (Dawkins et 
al., 1989) and in goats with increased resistance to T. circumcincta and T. vitrinus 
(Patterson et al., 1996). The eosinophilia was more pronounced and the FEC were 
lower in resistant groups than in controls with low resistance to infection in both 
studies. Another study, however, showed that circulatory eosinophilia was not 
always more pronounced in H. contortus or T. colubriformis resistant animals, 
possibly due to differences in infection regimes, and therefore might not be useful as 
an indicator of increased resistance (Woolaston et al., 1996). 
1.7.5 Goblet cells and mucus 
Goblet cells are specialised mucus producing cells present in the epithelium 
of the intestine and also the respiratory tract. The cells are largely filled with 
mucinogen the precursor of mucus, which gives the cells a characteristic goblet 
shape. Mucus secretion from crypt goblet cells may be rapidly and dramatically 
increased under the influence of parasympathetic nerves in the intestine (Specian, 
1980). Goblet cell hyperplasia occurs during nematode infection (reviewed; 
Rothwell, 1989). 
During N. brasiliensis infections goblet cell hyperplasia occurs and both the 
amount of mucus increases and its glycosylation changes (Karisson et al., 2000). 
This mechanism has been strongly linked to the expulsion of N. brasiliensis adult 
worms and has been suggested as the effector mechanism of expulsion in this 
infection (Nawa et al., 1994). 
Ishikawa et al., (1994) suggested that adult N. brasiliensis induce mucus 
secretion and are expelled only after they have become damaged by the host immune 
response. "Normal" or undamaged worms do not induce mucus secretion and 
actively inhibit it by means of excreted or secreted (ES) products. Mucus secretion 
may be increased by acetylcholine from parasympathetic nerves in the intestine 
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(Specian, 1980). N. brasiliensis secretes copious amounts of acetyicholinesterase 
(AChE) which might act as a defence against immune response mechanisms 
(Sanderson and Ogilvie, 1971). This secreted AChE is recognised by the host 
antibody response against N. brasiliensis and the AChE isoform profile changes 
during infection as the worms become "damaged" (Jones and Ogilvie, 1972). This 
suggested mechanism of expulsion might then fit the observed data. 
Goblet cell numbers also increase during T. colubrfomiis infection in guinea 
pigs and sheep (Manjili et al., 1998). In guinea pig strains bred for resistance, earlier 
hyperplasia and changes in mucin suiphation, similar to those seen during 
Nippostrongylus infection in the rat, were associated with resistant strains (Karlsson 
et al., 2000). Goblet cell accumulation did not however correlate with protection 
during infection in sheep (Douch et al., 1986). 
While goblet cell accumulation has not been linked to resistance in 
Trichostrongylus infections of sheep, mucus itself is thought to have a protective 
role. Trapping of nematode larvae in mucus from sheep immune to T. colubriformis 
has been demonstrated in vitro (Douch et al., 1986; Stankiewicz et al., 1995) and in 
vivo (Harrison et al., 1999). This activity was correlated to the number of GL and the 
aryl sulphatase content of the mucus in the lumen (Stankiewicz et al., 1995). Specific 
antibody in mucus may also aid in binding antigen and complexing with mediators in 
the mucus (McClure et al., 1992; Harrison et al., 2003). 
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1.7.6 Antibody responses 
Antibody responses are generated against parasite antigens by the host 
following nematode infection. Parasite specific IgG, IgE and IgA isotypes have been 
demonstrated in responses against GI nematodes in various species, both to primary 
and secondary infections (reviewed; Miller, 1984; Balic et al, 2000). Specific IgG 
levels can increase in the serum and also in GI mucus. IgGi isotype tends to 
predominate over IgG2 in nematode infections, indicative of the Th-2 immune bias 
(Balic et al., 2000). IgE production is stimulated by infection and may be induced by 
worm secreted allergens (Jarrett and Miller, 1982). IgE increases are associated with 
allergic and hypersensitivity type responses and may be involved in mast cell 
activation by cross-linking with antigen (Shaw et al., 1998). IgA is associated with 
antibody responses at mucosal surfaces. Specific IgA responses may be generated at 
the site of infection in the GI mucosa during nematode infections (Miller, 1984). 
Responses to secondary infections tend to occur earlier and peak sooner than those 
elicited by primary infections due to anamnestic responses primed by the primary 
infection and triggered on secondary challenge (Shaw et al., 1998). 
T. colubrformis-specific antibody is produced both locally and systemically 
on challenge of immune animals (Adams et al., 1980). Sheep vaccinated with 
repeated T. colubrformis larval infections subsequently rejected a challenge 
infection and showed raised serum titres of IgGi, IgG2 and IgA compared to 
unvaccinated controls (McClure et al., 1992). Early rejection of incoming larvae was 
associated with increases in worm-specific IgGi and IgG2 in intestinal mucus. 
Rejection of the remaining worms was associated with increased IgG2 and IgA 
isotypes in the mucus (McClure et al., 1992). 
The IgGi and 1gM responses to both adult and L3 antigens were greater in a 
line of sheep selected for reduced FEC than in an unselected line (Bisset et al., 
1996). Animals with higher antibody titres had higher levels of protection, 
suggesting a correlation of immunoglobulin level with protection, and implicating 
antibody as an effector of this protection. 
The IgE response during T. colubrzformis challenge has been examined using 
enzyme linked immunosorbent assay (ELISA; Shaw et al., 1998). Serum levels 
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conformed to the general pattern, rising slowly during primary infection and more 
sharply during secondary. The IgE response in this study was also correlated with the 
mast cell response and the onset of immunity to infection during both primary and 
secondary challenges. IgE has been linked to mast cell activation and mast cells 
express high affinity IgE receptors on their cell surface (Ishizaka et al., 1975). The 
correlation with IgE and mast cells may indicate a role for IgE in direct or mast cell-
mediated termination of T. colubrfonnis infection (Shaw et al., 1998). 
Antibody responses have been demonstrated during infection with 
N. brasiliensis (reviewed; Ogilvie and Jones, 1971). In particular, N. brasiliensis is 
known to induce large specific and non-specific IgE responses (Jarrett and Haig, 
1976; Yamada et al., 1993a). The IgE response is associated with and may be 
induced by secreted or excreted allergens (Yamada et al., 1991; Uchikawa et al., 
1993). Specific IgE responses are linked to amine release from mast cells in vitro and 
in vivo although this has been shown on some occasions not to correlate with 
protective immune responses (Ogilvie and Jones, 1971). 
Increased levels of IgGi and IgG2, IgA and 1gM have also been reported 
during infection, although the increases were modest compared to those seen in IgE 
(Jarrett and Bazin, 1977). IgGi responses occur to some similar antigens to those 
responsible for stimulating IgE upregulation in Nippostrongylus ES (Yamada et al., 
1993b; Kamata et al., 1995; Nakazawa et al., 1995). IgG2a responses, however, were 
stimulated by a different group of antigens present on the adult worm (Yamada et al., 
1993b). Experiments have implicated IgGi as the antibody responsible for the 
passive transfer of protection in this system (Jones et al., 1970). 
In their review of Nippostrongylus expulsion, Ogilvie and Jones (1971) 
considered worm expulsion to be a two-stage phenomenum. The worms first being 
damaged by antibody, mainly of the IgG isotype with a further mechanism, at that 
time unexplained, leading to the expulsion of damaged worms. This mechanism of 
expulsion has been backed up by a later investigation, which suggested that changes 
in mucus secretion removed the worms, following damage by an immune-mediated 
response (Ishsikawa et al., 1994). 
Antibody / mucin interaction has been implicated in the trapping of worms 
during T. spiralis infection of rats (Carlisle et al., 1990). This is an interesting 
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observation given the implicated role of mucus in the mechanism which has been 
suggested to remove Nippostrongylus from immune rats and the larval inhibitory 
action of mucus in sheep Trichostrongylus infections (Miller, 1987; Ishsikawa et al., 
1994). 
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Rodent / Nippostrongylus Ruminant / nematode 
T-cell requirement for expulsion in rats T-cell 	requirement 	for 	expulsion 	of 
(Keller 	and 	Keist, 	1972) 	and 	mice infection (Gill etaL, 1993) 
(Katona etal., 1988). 
Th-2 cytokines are up-regulated and Th- Th-2 	cytokine 	increases 	and 	Th-1 
1 cytokines are down-regulated during reductions may correlate with protection 
expulsion in rats (Matsuda et al, 1995). but results are equivocal (Pernthaner et 
Th-2 	cytokines 	(IL-4, 	IL-13) 	lead 	to al., 1997; McClure et al., 1995; Ba/ic et 
expulsion while Th-1 cytokines (IL-12, al., 2000) 
IFN-'y) lead to persistence in mice (Else 
and Finkelman, 1998; Finkelman et al., 
2004). 
Response 	seen 	against 	early tissue No tissue migratory phase, however 
migratory phases in lung (Matsuda et response observed to tissue associating 
al., 2001). L3/L4 in gut (Emery et al., 1992) 
Mast 	cell 	accumulation 	and Mast 	cell 	accumulation 	and 
degranulation correlated 	to protection degranulation correlated 	to protection 
(Kelly 	and 	Ogilvie, 	1972; Miller 	et (Douch etal., 1986; Douch etal., 1996). 
al.,1 983b). 
Eosinophil 	response 	correlated 	to Eosinophil 	response 	correlated 	to 
protection and kill infective larvae (Kelly resistance and kill infective larvae (Bao 
and Ogilvie, 1972; Shin etal., 2001) etal., 1996; Rainbird etaL, 1998). 
Goblet cell activation I mucus trapping Goblet cell hyperp!asia not correlated to 
responsible for expulsion (Nawa et aL, protection, but mucus trapping of larvae 
1994). reported (Douch etal., 1986). 
IgE, IgA, lgG responses correlated to IgE, IgA, lgG responses correlated to 
protection 	(Jarrett 	and 	Haig, 	1976; protection (McClure et al., 1992; Shaw 
Jarrett and Bazin, 1977). etal., 1998). 
IgGi responsible for passive transfer of !gGl predominates over !gG2 during 
protection (Jones et al., 1970). nematode infections (Ba/ic et al., 2000). 
lgG subtypes IgGi and lgG2a linked to !gGl 	associated, 	but not definitively 
Th-2 response. lgG2b and c linked with shown to be Th-2 linked, while !gG2 
Th-1 response (Cetre etal., 1999). considered Th- 1 (Gi!l et al., 2000). 
Table 1.2. Some similarities and differences between the immune response 
of the proposed model and that of nematode infected ruminants. Similarities 
include the nature of the cell types and antibody involved. There is less 
evidence in ruminant infections of the marked Th-1 / Th-2 dichotomy 
observed in rodent models and the proposed mechanism of expulsion may 
differ. The tissue migratory phase of Nippostrongy!us infection also 
represents a difference in the life cycle leading to differences in the observed 
immune responses 
1.8 Methods for the control of nematode parasites 
Due to the substantial production and economic losses that can be caused 
even by sub-clinical infections, the control of nematode GI infections in livestock is 
both important and necessary (Kyriazakis et al., 1996). The current methods used for 
control of ruminant GI nematodes are based mainly on the use of chemical agents 
with some use of pasture management. Frequent treatment and prophylactic dosing 
of animals with anthelmintic drugs has been the most effective and primary means of 
control. 
1.8.1 Anthelmintic Drugs 
Livestock, both sheep and cattle, are routinely dosed, or drenched, with 
anthelmintic drugs in regimes designed to suppress nematode infection and limit 
production loss and clinical infections. Dosing at around 4 weeks before parturition 
and 4-6 weeks after lambing is recommended for ewes and 2-3 times following 
weaning for lambs depending on how intensive the stocking rate is (Urquhart et al., 
1987). Three classes of anthelmintic are currently in common use, namely the 
benzimidazoles, levamisoles and macrocyclic lactones (avermectins). These are 
routinely administered orally using a drenching gun in a liquid formulation although 
some development of slow release bolus formulations has been carried out (Donald, 
1985). 
Mechanisms of drug action 
The molecular and biochemical modes of anthelmintic action of several of the 
different classes have not, as yet, been absolutely defined. Different cell processes 
are thought to be affected by the different drugs. 
Benzimithzoles have been shown to interfere with parasite microtubule 
formation (Lacey and Prichard, 1986; Lacey and Gill, 1994; Kwa et al., 1994). The 
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drug binds to the -tubulin subunit and prevents aggregation thereby preventing 
formation of the microtubules. Interference with this major cell structure protein 
causes the death of the parasite (Prichard, 1990). 
Avermectins are considered to act through a high affinity receptor that leads 
to an increase in membrane Cl- permeability. They have been shown to act as ligands 
on a glutamate gated chloride channel (Yates et al., 2003). This activation causes 
hyper-polarisation of the membrane and thus interferes with nerve and muscle cell 
polarisation. In Caenhorrabditis elegans, H. contortus and T. colubrformis the drug 
causes interference with pharyngeal pumping and feeding while fecundity effects and 
paralysis of the worms also result (Sheriff et al., 2002; Yates et al., 2003). 
Levamisoles act as cholinergic agonists on nicotinic acetylcholine receptors, 
which activate cation channels in somatic muscle (Martin et al., 1998). 
Depolarisation and contraction of the muscles leads to a spastic paralysis of the 
nematodes facilitating their removal (Atchison et al., 1992). 
Problems with control of nematode parasites using anthelmintic drugs 
Although they are the primary choice and currently the most effective means 
of control, there are problems with the use of anthelmintic chemicals. Resistance of 
nematodes to the drugs threatens the long-term sustainability of this means of 
control. Concerns over drug residues in food products and the growth of the organic 
sector has increased consumer pressure to reduce their use. 
Due to widespread use and long term application, resistance of the parasites 
to all classes of drugs currently available has been identified. The use of 
benzimidazole anthelmintics selects for worms already present in the population and 
carrying a mutation in the -tubulin gene conferring drug resistance (Kwa et al., 
1994). Molecular mechanisms of resistance to the other classes of drug have not as 
yet been defined with certainty, but may involve changes in the gama-aminobutyric 
acid (GABA) receptor (Blackhall et al., 2003) and P-glycoproteins (Kerboeuf et al., 
2003). 
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In some areas drug resistance is widespread and parasites resistant to several 
drug classes are present. This problem is so severe that it has major effects on the 
sustainability of livestock production in some areas of the world (Wailer et al., 1996; 
van Wyk et al., 1997). 
In the UK parasites resistant to benzimidazoles, levamisoles and ivermectin 
have been identified, with benzimidazoie resistance being particularly widespread. 
Resistance to these drugs is thought to be spreading in parasite populations (Mitchell 
et al., 1991; Bartley et al., 2003). 
1.8.2 Pasture management 
Pasture management techniques may be employed as a control measure to 
prevent or minimise infection (Barger, 1997). Eggs and larvae of most nematode 
species have a life span on pasture limited to around one year (apart from 
Nematodirus sp.) and moving animals onto fresh pasture with a suitable gap or 
fallow period will reduce the larval challenge. 
Systems involving moving animals onto fresh pastures at strategic times can 
maintain exposure at sub-clinical levels during critical periods such as the weaning 
of lambs. Management of grazing in this way may be used in conjunction with 
anthelmintic treatment to limit the infection of the "clean" pasture with nematode 
eggs (Lindqvist et al., 2001). Alternatively, rotating sheep with cattle on pasture may 
be an effective method of controlling parasite infection by preventing the build up of 
host-specific species on mixed herd farms (Barger, 1997). Moving animals to clean 
pasture in this way may be used as part of a strategy to reduce anthelmintic use. 
Alternatively, a pasture moving strategy may be effective enough at controlling 
parasite infection to be used without drugs as a means of limiting clinical infection 
(Githigia et al., 2001). 
There are several problems with this approach. Climatic variables play a great 
role in the suitability of such a strategy. Temperature and rainfall influence the 
longevity of eggs and larvae on pasture as well as determining which nematode 
species will be present. While wet tropical climates might be more suited (Barger et 
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al., 1994), temperate climates may be unsuitable for such a strategy due to the long 
survival time of the larvae (Gibson, 1973). 
The frequency of moving animals may be limited by the amount of pasture 
available. Animals must be moved at an interval such that nematode numbers do not 
increase while at the same time pasture has had sufficient time to be decontaminated. 
Limited pasture and high stocking densities may be limiting factors in such a system 
and as such these strategies do not always lend themselves to intensive farming 
practices (Uriarte and Valderrabano, 1990). 
Pasture management is often not effective enough to limit parasite infection 
on its own. Some grazing systems only limit the infection to a degree necessary to 
reduce anthelmintic use and not completely stop its use (Barger, 1997). Pasture 
management strategies may also increase the selection pressure towards parasite 
genotypes or species that are least affected by this strategy (Barger, 1997). This 
would therefore ultimately reduce the effectiveness of such a strategy in the long 
term. Such issues would need to be considered in the design of control programs 
based on pasture management (Barger, 1997). 
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1.9 Novel control strategies 
The problems with current control strategies have led to an interest in the 
development of novel, non-chemical methods of parasite control. Several approaches 
including biological control with fungi, genetic selection of nematode resistant sheep 
and vaccination are being researched. 
1.9.1 Larval trapping fungi 
Several studies have investigated the use of nematophagous fungi for the 
control of nematode parasites on pasture (Larsen, 1999). Species of fungi, including 
genera Duddingtonia and Arthrobotrys, actively trap and feed on nematode larvae in 
faecal pats deposited on pasture. Some of these species can survive passage through 
the gut of ruminants (Larsen et al., 1992). By using fungi as a food additive it has 
therefore been possible to reduce larval counts in faecal cultures collected during 
sheep trials (Faedo et al., 1997). Pasture larval contamination has also been 
demonstrably reduced in both sheep (Faedo et al., 1998) and cattle trials (Woistrup et 
al., 1994), indicating the potential of this approach in nematode control. 
In these trials animals were dosed with set numbers of fungal 
chiamydospores. During trials in which individual animals were allowed free access 
to fungi as a food additive, differences in uptake rates occurred (Jackson et al., 
2003). Differences in larval survival in differing climates might also reduce the 
effectiveness of the treatment (Gibson, 1973). Therefore optimisation of conditions 
and delivery systems must be carried out before biological control with fungi 
becomes viable. 
1.9.2 Selective breeding 
Differences in susceptibility to nematode infection or clinical disease caused 
by infection exist both between and within sheep breeds (Burke and Miller, 2002; 
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Gauly and Erhardt, 2001). Some of this difference is accounted for by genetic 
difference between animals. Farming more resistant breeds in areas of high incidence 
of nematodiasis is one method of exploiting this genetic resistance to infection. 
However breeds that are more resistant to nematode infection might be less suitable 
in other essential traits such as wool production, carcass quality and weight gain. 
Selectively breeding from animals more resistant to infection within 
established breeds can increase the disease resistance status of the offspring (Gauly 
and Erhardt, 2001). Selective breeding for nematode resistance in this way has been 
predicted to have the potential to reduce production loss (Windon, 1990). 
Selective breeding schemes within breeds of sheep (Bisset et al., 1996; Kahn 
et al., 2003) and goats (Patterson et al., 1996) have been carried out with some 
success in generating lines resistant and susceptible to parasite infection. By using 
FEC and other markers of response, it has been possible to select rams and dams 
with a resistant phenotype as breeding stock and thus generate more resistant 
offspring down several generations (Bisset et al., 1996; Kahn et al., 2003). This 
approach has been successful to the point of being commercially applicable in 
Australia and New Zealand (Gray, 1997). 
Breeding for increased resistance however may not be the most suitable 
strategy, if resistance is not accompanied by a production gain. In a selective 
program, production traits would need to be maintained, or improved, along with 
improved resistance. This may not always be the case, due to complex genetic 
heritability and linkage of traits. Unsuitable traits, such as breech soiling, may also 
be increased in selected lines (Bisset et al., 1997). The assessment of production 
parameters is therefore an important part of a selective breeding program. Breeding 
for tolerance of infection, whereby lambs have improved weight gain under 
infectious conditions, rather than focussing on reducing FEC may be a more suitable 
strategy (Bisset and Morris, 1996). Given the central role of Th2 responses in worm 
expulsion, selection for nematode resistance may have the effect of increasing 




1.9.3 Improved nutrition and dietary supplementation 
Improved nutrition of animals can enhance the immune response to infection 
and has a direct effect on the clinical expression of disease and productivity during 
infection (Kahn et al., 2003). Increasing the quality of the diet can severely reduce 
the weight loss effects and reduce FEC and worm burden during infection with 
T. colubriforinis, H. contortus and other nematodes. In particular, the protein content 
of the diet as opposed to the total energy appears to be of importance (Kahn et al., 
2000; Strain and Stear, 2001). 
Limited resources for feeding sheep and increased production costs may limit 
this approach for commercial or extensive farming. Nutritional supplementation 
could have utility for organic / pedigree animal production where increased cost is 
more acceptable for an improvement in animal quality or in intensive systems where 
animal are fed on pelleted diets. 
Addition of substances to the diet that adversely affect the worms has also 
been investigated. Dietary supplementation with plant foods rich in tannins can 
decrease adult worm burden and FEC (Athanasiadou et al., 2001). Tannins may have 
an effect on the worms directly or enhance the uptake of nutrients in the ruminant 
digestive tract (Niezen et al., 1998). 
Copper wire particles, when given as a feed supplement, have been shown to 
reduce H. contortus infection (Knox, 2002). Molybdenum has also been administered 
experimentally as a dietary supplement that reduces worm burden, probably through 
a mechanism involving free radical generation (Suttle et al., 1992a; 1992b). Either of 
these supplements may be toxic at increased levels and so may not be useful 
practically or require careful dose limitation. 
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1.10 Vaccination 
Host immunity to re-infection develops in ruminant GI nematode infections 
including Trichostrongylus and also to N. brasiliensis in rats. This suggests that, the 
host expresses protective immune responses and that protection could be elicited by 
vaccination with parasite material. Several different strategies of vaccination have 
been attempted or are being investigated. 
1.10.1 Attenuated larval vaccines 
Early attempts at nematode control by vaccination were by the use of live 
attenuated larvae. Larvae can be attenuated by gamma irradiation and will then 
produce self-limiting infections that give significant levels of protection to 
re-infection. The main success of this approach was the development of a live 
attenuated vaccine against Diclyocaulus viviparus, the bovine lungworm, which 
remains the only effective and commercially available nematode vaccine (Jarret et 
al., 1958). 
Protection levels of 97-99% were also generated against T. colubrformis 
infection in sheep, by vaccination with 20,000 irradiated L3 larvae (Gregg and 
Dineen, 1978). The number of larvae required was however prohibitive, as several 
donors would be required to provide a single protective dose. The treatment also 
failed to protect young lambs, the most important target group for a control strategy 
(Emery et al., 1993). 
1.10.2 Native and recombinant antigens 
The advent of recombinant protein technology has provided a potential new 
source for parasite antigens (Knox, 2000; Knox et al., 2001). Research has 
concentrated on the isolation of parasite proteins, which protect the host against 
infection, with the aim of producing them in vitro as recombinant antigens. A 
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"fractionate and vaccinate" approach has been taken in order to isolate protective 
fractions, and protective proteins from several sources of parasite material such as 
parasite tissues or parasite ES proteins (Smith, 1999). Separating and identifying 
individual proteins from such complex mixtures is difficult and time consuming, 
although some success has been achieved. Examples of helminth vaccines using this 
approach are the cestode recombinant protein vaccines derived from onchosphere 
surface tissues and the "hidden" nematode antigens discussed below (Smith, 1999). 
Genomic tools such as eDNA libraries and expressed sequence tags (ESTs) 
are also used as a source from which to select vaccine targets. Selecting immuno-
reactive, highly or differentially expressed proteins from such datasets is one method 
that may be used to select potential vaccine targets for recombinant expression 
(Knox et al., 2001). 
1.10.3 Hidden antigens 
One approach that has been particularly successful is the targeting of gut 
expressed, or hidden, antigens in blood-feeding nematodes such as H. contortus. 
These antigens are mostly integral membrane proteins, often enzymes thought to be 
associated with the digestion of the blood meal. The vaccination strategy depends on 
the parasite ingesting significant quantities of immunoglobulin as they feed, the 
ingested specific antibodies bind to the proteins in the worm's gut and inactivate 
them, thus preventing normal function and killing the worms (Newton and Munn, 
1999; Knox and Smith, 2001). A recombinant vaccine against the cattle tick 
Boophilus microplus based on this principle has already been developed 
commercially in Australia (Willadsen et al., 1995). 
Vaccination studies against H. contortus are well advanced with several 
candidate, hidden antigens having been identified including Hi 1 and H-gal-GP. 
These enzyme complexes were identified using a "fractionate and vaccinate" 
approach from gut tissue dissected from adult worms (reviewed Newton and Munn, 
1999; Knox and Smith, 2001). 
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Other species of nematode including Trichostrongylus sp. and T.circumcincta 
are, however only partially susceptible to this approach, as they do not feed primarily 
on blood. They do not, therefore, ingest sufficient quantities of immunoglobulin to 
inhibit digestion (Knox and Smith, 2001). 
1.10.4 Excreted / secreted antigens 
Many proteins are excreted or secreted into their environment by nematode 
parasites at different life stages (Pritchard, 1986). Some of these proteins are 
functional and have been ascribed roles in parasite feeding, tissue penetration or 
immune evasion. Some ES proteins are also immunogenic. Therefore ES proteins are 
rational vaccination targets and studies have examined ES as a source of protective 
antigens. 
Protective nematode ES antigens have been identified, including 15 and 24 
kDa proteins from the nematode H. contortus (Schallig et al., 1997a; 1997b). These 
proteins shared homology with two ES proteins of T. colubriformis, already 
identified, which induced protective responses in Guinea pigs (Savin et al., 1990; 
Dopheide et al., 1991). The larger protein also shared homology with an 
Ancylostoma caninum secreted protein of interest (Schallig et al., 1997b). 
Immunisation with Cathepsin L proteases from the ES of the ruminant 
trematode parasite Fasciola hepatica also gave protection in a trial in cattle (Dalton 
et al., 1996). This was associated with the generation of specific antibody responses 
(Mulcahy and Dalton, 2001). 
ES proteins have been implicated in the persistence of some intestinal 
nematodes in their host and have functional homologues in other species occupying 
the same niche. These proteins may protect the parasite from host immune responses 
and hence are suitable targets for immunisation. Two such proteins of particular 
interest in the present study are superoxide dismutase (SOD) and AChE, which are 
both released in vivo by nematode GI parasites of interest. 
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1.10.5 Superoxide dismutase 
Superoxide radicals generated by host leukocytes are part of the immune 
response and can damage nucleic acids, proteins and membranes. Superoxide 
radicals such as 02 and OH as well as oxidative responses, have been implicated in 
resolution of infections with N. brasiliensis, T. vitrinus and H. contortus and other 
nematodes (Henkle-Duhrsen and Kampkotter, 2001). 
Oxidative responses occur during a N. brasiliensis infection and adult worms 
are damaged by oxygen radicals in vitro (Smith and Bryant, 1986). Administration of 
antioxidants that are active in the gut of rats will delay expulsion of N. brasiliensis in 
vivo (Smith and Bryant, 1989a). Similarly in sheep and lambs dietary 
supplementation with molybdenum, a chemical involved in free radical generation, 
reduced the total worm burdens during H. contortus and T vitrinus infections (Suttle 
et al., 1992a; 1992b). 
Eosinophils are implicated in the host response to Nippostrongylus (Shin et 
al., 2001) and Trichostrongylus (Dawkins et al., 1989). Eosinophils contain 
peroxidase in their granule proteins and are capable of a prolonged respiratory burst 
generating oxidative radicals (Babior et al., 1973). Eosinophils have also been 
demonstrated to attach to and release their granule proteins on the surface of 
nematode larvae in vitro (Rainbird et al., 1998; Shin et al., 2001). It is possible that 
the generation of oxidative responses by eosinophils in vivo is one mechanism by 
which they could damage nematode parasites. 
SOD and several other enzymes including catalase, glutathione peroxidase 
and a novel family of peroxiredoxins are involved in pathways that protect the 
parasite from free radical damage, as shown in Figure 1.4 (Henkle-Duhrsen and 
Kampkotter, 2001). SOD converts the superoxide radical, 02,  to H202, one step in 
this enzymatic process. Some evidence suggests that SOD is released by nematode 
parasites including N. brasiliensis, T. vitrinus, H. contortus and T. circumcincta 
(Knox and Jones, 1992; Hadas and Stankiewicz, 1998). This has received further 
support by the demonstration that nematodes, for example H. contortus, express 
mRNA transcripts encoding both cytosolic and extracellular forms of the enzyme 
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(Liddell and Knox, 1998). Increased levels of SOD have been correlated with 
persistence of N. brasiliensis in the rodent host (Smith and Bryant, 1989b). 
As noted above, H. contortus expresses two distinct SODs, a cytosolic and a 
putative extra-cellular form. A vaccination trial with H. contortus SOD showed a 
17% reduction in parasite burden, a low but significant level of protection. This was 
achieved using a systemic vaccination with single challenge infection (Liddell and 
Knox, 1998). Further investigation of immunisation with SOD is an aim of this 
project, specifically investigating the efficacy of SOD vaccination against a low-level 
parasite challenge and comparing the outcome of systemic and mucosal vaccination. 
Figure 1.5. Antioxidant pathways (blue) and antioxidant enzymes (red) of 
parasitic nematodes (adapted from Henkle-Duhrsen and Kampkotter, 2001). 
Oxygen radicals are converted to harmless products under the influence of 
these enzymes. Such reactions may be important in the protection of the 
nematodes from host mediated oxidative immune responses. SOD = 




The enzyme AChE is secreted in large amounts by N. brasiliensis, and by 
Trichostrongylus spp. and is considered to act in a way that protects the parasite 
(Sanderson and Ogilvie, 1971; Rothwell et al., 1973). AChE has several in vivo 
effects that might aid in the worm's survival, for example it has been thought that it 
may act as a biochemical holdfast by reducing acetylcholine stimulated muscle 
contraction (Foster et al., 1994). However, acetylcholine, the enzyme substrate also 
has many effects in immune response mechanisms such as the induction of rapid 
mucus secretion from goblet cells (Specian, 1980) and the induction of cellular 
immune responses (Strom et al., 1974). A more plausible explanation for the high 
level of secreted AChE therefore is that it interferes with acetylcholine induced 
immune effector mechanisms directed against the parasite. 
The amount of AChE secreted by N. brasiliensis increases through the course 
of an infection (Sanderson and Ogilvie, 1971). The isoform profile of the enzyme 
also changes with the amount of isotype "A" decreasing and being replaced by 
upregulation of isotypes "B" and "C" (Edwards et al., 1971; Blackburn and Selkirk, 
1992). These changes in AChE expression pattern correlate with parasite survival, 
suggesting that an immune response is generated against the enzyme and the worms 
are damaged and expelled by this developing immune response (Ogilvie and Jones, 
1971). Any remaining "adapted" worms show high levels of the "A" isoform as well 
as "B" and "C" isoforms (Edwards et al., 1971). This suggests that the "A" isoform 
is important in worm protection and that adapted worms have an increased capacity 
for its production in the face of immune pressure. 
The changes in enzyme output are certainly influenced by the host immune 
status, such that an immune host will generate such changes more rapidly (Sanderson 
et al., 1972; 1976). Infection with N. brasiliensis or Trichostrongylus sp. leads to the 
production of anti-AChE antibodies by the host (Rothwell et al., 1973; Jones and 
Ogilvie, 1972). This response appears to account for the change in enzyme profile 
and consequent effects on survival of the worms described above (Edwards et al., 
1971; Jones and Ogilvie, 1972). These antibodies also indicate that the parasite 
protein is immunogenic. 
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A mechanism by which N. brasiliensis infection was resolved by the worms 
first being damaged by antibody and then removed by a second immune process was 
suggested by Ogilvie and Jones (1971). The observed immune response against 
AChE and the consequent changes in the AChE expression profile by N. brasiliensis 
might provide support for this hypothesis, and suggest that AChE is at least one 
target of the primary antibody response. The proposed removal of damaged worms 
by changes in mucus secretion (Ishsikawa et al., 1994) would also fit this hypothesis. 
Mucus secretion from goblet cells may be stimulated by acetylcholine (Specian, 
1980), worm expression of AChE may interfere with this process, hence protecting 
the worms from expulsion. An antibody response against AChE would therefore 
remove the interference and allow worm expulsion by the mucus secretion effector 
mechanism. Such a response would be the aim of vaccinating with recombinant 
AChE. 
Previous attempts have been made at vaccination against Trichostrongylus sp. 
with AChE. In the Guinea pig / T. colubrformis model no significant level of 
protection was achieved (Rothwell and Merritt, 1975). Protection using ES protein 
extracts enriched for AChE was achieved in a Guinea pig model of D. viviparus 
infection but protection did not extend to challenged calves, this study being 
conducted with recombinant enzyme protein (McKeand et al., 1995a; Matthews et 
al., 2001). In a mixed nematode infection in sheep of T. colubriformis, H. contortus 
and Cooperia oncophora however, vaccination with T. colubrformis AChE led to a 
31% reduction in total worm burden (Griffiths and Pritchard, 1994). The authors 
described these results as promising. This project will further investigate the use of 
recombinant AChE as a candidate vaccine. 
N. brasiliensis AChE has previously been characterised, cloned and 
expressed as a recombinant protein (Blackburn and Selkirk, 1992; Hussein et al., 
1999). Recombinant AChE has been kindly made available for the planned 
vaccination trials by Dr M Selkirk of Imperial College, London. 
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1. 10.7 Vaccine delivery 
Previous vaccination trials have relied mainly on the use of systemic 
vaccination with recombinant or native parasite antigens (Gregg and Dineen, 1978; 
Emery et al., 1993). The immune response to systemic vaccination is characterised 
by increases in serum immunoglobulin levels and specifically in IgG. It is likely that 
the immune responses generated in this way are not the most appropriate in 
protection against GI nematode infection, which may be modulated by local humoral 
and cellular responses. 
Mucosal tissues are believed to share a common immune response. 
Stimulation of immune responses in the mucosal tissues of the gut may, therefore, be 
achievable through vaccination of other mucosal surfaces such as the nasal mucosa 
(Davis, 2001). In recent years interest has grown in the use of such alternative routes 
of vaccination. Methods for nasal vaccination have been developed for rodents and 
have been demonstrated against the trematode parasite Schistosoma mansoni 
(Akhiani, 1997) and also against GI nematode infection with Ascaris suum (Tsuji et 
al., 2001) and T. spiralis (McGuire et al., 2002). In these trials, in which the adjuvant 
cholera toxin was co-administered with the antigen, a significant immune response, 
polarised towards a Th-2 response, was generated. The nematode trials also achieved 
significant levels of protection associated with the local expression of IgGi and IgA 
antibody responses both systemically and in the gut mucosa (Tsuji et al., 2001); 
(McGuire et al., 2002). Responses characterised as Th-2 and involving IgG 1 and IgA 
also correlate with protection in the N. brasiliensis infection (Jarrett and Bazin, 
1977). As the stimulation of local antibody responses demonstrated a protective 
effect in the above vaccination systems, it might, therefore, also be appropriate to 
stimulate such responses to achieve protection against N. brasiliensis. A further 
evaluation of nasal vaccination and its efficacy with recombinant antigens against 
intestinal nematodes is a main aim of the project. 
1.11 Nippostronqylus brasiliensis as a model infection 
N. brasiliensis has been used extensively as a model for GI nematode 
infection and immunity. There are a number of factors, besides its suitability for 
laboratory maintenance and abundance of reagents and techniques for use with the 
rat that suggest it might be a suitable model for Trichostrongylus infection. 
Vaccination against helminth parasites has been investigated using a number 
of rodent model systems. These include S.mansoni (reviewed; McLaren, 1989), A. 
suum (Tsuji et al., 2001) and T. spiralis (Goyal and Wakelin, 1993) in mice, 
D. viviparus (McKeand et al., 1995a; McKeand et al., 1995b) and T. colubrformis 
(Rothwell and Love, 1974; Rothwell and Merritt, 1975) in Guinea pigs and N. 
brasiliensis in both mice (Rhalem et al., 1988a; Rhalem et al., 1988b) and rats 
(Poulain et al., 1976a; Murray et al., 1979). In most of these studies parasite 
homogenates or purified parasite proteins have been delivered as antigens using a 
variety of formulations and routes of immunisation. Only more recently have studies 
conducted in these rodent vaccination models begun to utilise recombinant peptides 
and proteins (Tsuji et al., 2001; McGuire et al., 2002; Tsuji et al., 2003). 
Studies into vaccination against N. brasiliensis infection in both rats 
and mice have indicated that a high degree of protection can be generated by 
vaccinating with worm homogenate (Murray et al., 1979) or ES material (Poulain et 
al., 1976a; Rhalem et al., 1988a; 1988b). Two of the ES components conferring 
protection in mice were partially purified and determined as 14 and 43 kDa proteins 
(Rhalem et al., 1988b). In the rat host the highest degree of protection was afforded 
by immunisation with worm homogenates via the intra-peritoneal route using a 
Bordetella pertussis adjuvant (Murray et al., 1979). An ES antigen was demonstrated 
to be more effective than homogenate when delivery was via the oral route (Poulain 
et al., 1976a). The present study, however, is the first to propose the use of single 
recombinant antigen vaccines in this system, as a model for recombinant protein 
vaccination against GI nematode infection in ruminants. 
The trickle infection regime with N. brasiliensis yields a stable, chronic 
infection, more similar to the natural infection and similar to the acquisition of 
ruminant nematodes on pasture (Jenkins and Phillipson, 1972). This chronic 
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infection is the basis of the suggested model system, with the modulation of this 
infection the aim of vaccination. A chronic infection in a rodent model is likely to be 
more informative than the more usually studied single challenge situation where the 
immune response is already rapidly excluding the worms, such as in the Guinea pig / 
T. colubriformis model. The trickle infection with N. brasiliensis has not to date been 
tested as a vaccination model. An evaluation of its potential by comparing the 
kinetics of single and trickle challenges following immunisation is one aim of the 
project. 
The lifecycle and infective niche of Trichostrongylus sp. and the L4 and adult 
stages of N. brasiliensis, as well as pathology of infection and the immune responses 
invoked are very similar. Both infections may also provoke spontaneous expulsion 
and immunity to re-infection. Similar mechanisms of immunity may therefore exist 
between or be effectively provoked against these two nematode infections 
(summarised Table 1.2). 
As far as has been established to date similar antigens, including SOD and 
AChE, which are of particular interest, are released by gut dwelling stages of both 
Trichostrongylus sp. and N. brasiliensis. Both of these enzymes are implicated as 
having a role in the ability of the parasite to evade the immune response of the host 
and therefore are obvious and rational targets for vaccination. 
To examine the different systems of immunisation, systemic versus mucosal, 
a mucosal vaccination scheme is required. Nasal vaccination systems have been used 
effectively in a S. mansoni model (Akhiani, 1997) and GI nematode infections in 
mice (Tsuji et al., 2001; McGuire et al., 2002). A similar system may be an 
applicable to a model of a small intestinal species in rats. 
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1.12 Aims and objectives: 
1.12.1 The aim of the project 
To evaluate the N. brasiliensis I rat system as a vaccination model for intestinal 
nematodes, primarily small intestinal species of genus Trichostrongylus, by testing 
putative protective antigens and comparing delivery systems. 
1.12.2 The objectives of the project 
Establishing an appropriate infection regime for the challenge of vaccinated 
animals 
Development of methods with which to monitor the immune response to infection 
and immunisation. 
Production and characterisation of recombinant antigens. Enzymically active 
recombinant AChE is available through a collaboration with Prof M Selkirk, 
Imperial College, London. The cloning and expression of SOD is an early objective 
of this project. 
An evaluation of AChE and SOD as vaccine candidates. 
A comparison of the immunogenicity of systemic verses mucosal delivery 
systems. 
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Chapter 2— Materials and Methods 
21 General parasitoloqical techniques 
2.1 .1 Nippostronqylus brasiliensis infections 
Infections were carried out as described previously (Ogilvie and Jones, 1971). 
Unless otherwise indicated all donor or trial animals used were groups of male or 
female Wistar rats 2-3 months old. Rats were either anaesthetised with 
02INO2IhaIothane or suitably restrained and inoculated with N. brasiliensis L3 larvae 
prepared as described below. Immunisation with L3 was carried out in 0.2 - 0.5 ml 
phosphate buffered saline (PBS, Appendix 1), subcutaneously above the hind leg. 
Donor animals, immunised with approximately 2000 L3, were culled at 7 
days post infection (dpi) near the anticipated peak of egg output and worm burden. 
Faeces were collected for larval cultures from 6 dpi and adult worms were collected 
from the small intestine at 7 dpi. 
2.1.2 Recovery of Nippostronpylus brasiiensis larvae 
Infective stage (L3) larvae were obtained by faecal culture from infected 
donor animals. Faecal pellets from donor rats at 6 - 7 dpi were moistened, broken up 
and mixed with activated charcoal granules (Sigma, C-2889). This mixture was 
cultured at 20°C, on a Petri dish lined with damp filter paper (Whatman No. 1, 70 
mm, 1001 070). L3 larvae were present on the plates from four days following 
culture. 
Larvae were collected from cultures on the day they were required for use 
using a modified Baermann apparatus. This consisted of a funnel with a tap on the 
outflow and containing a 1 mm mesh, lined with "non-fluffy" paper towelling. The 
apparatus was filled with warm water (approximately 30°C) until the paper was 
covered and the larvae from the cultutre plates were gently washed in by filling the 
plates with water and pouring them into the apparatus. Larvae migrated downwards 
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and collected in the outflow of the funnel after approximately 45 mm. Following 
collection larvae were washed 3 times in 10 volumes PBS with penicillin to a final 
concentration of 500 lU/mi and streptomycin to 500 mg/ml. Larvae for mRNA or 
protein extraction were dried by blotting with a corner of paper towel and snap 
frozen in liquid N2 or stored at -80°C respectively. L3 in several aliquots were 
counted under a low power microscope x 5 to give a mean count and number of L3 
per unit volume adjusted to give required doses. 
2.1.3 Recovery of Nippostronqylus brasiliensis adults 
Adult N. brasiliensis were recovered from the small intestine of donor rats at 
7 dpi, around the peak of infection. Rats were euthanised, using CO2. and the small 
intestine removed. The small intestine contents were removed and the small intestine 
slit open and added to the collected contents. 
The collected material was then placed at the centre of a cotton gauze square 
(Millipledge, DG09075). This was suspended by the corners from a cocktail stick 
into a 100 ml beaker of PBS at 37°C. Adult worms migrated from the intestinal 
material through the gauze and were collected in the bottom of the beaker. 
Collected adults were allowed to settle and then washed in a similar manner 
to the L3 described above. Adult worms were snap frozen in liquid N2 for mRNA 
extraction, or stored at —80°C for protein fractionation until required. 
2.1.4 Faecal egg counts 
Faecal egg counts were carried out daily from 5 dpi onwards to the 
termination of infection, as the primary measure of infection. The method used for 
collection and counting was a modified saline floatation method (Jackson, 1974). 
Fresh faecal samples (approximately 1 g) were weighed and broken up in 
water at 10 ml per gram. A 10 ml sample was then removed, strained to remove large 
debris and centrifuged at bOg for 2 mm. The supernatant was removed and the 
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pellet re-suspended in a saturated saline (NaCl) solution. The suspension was 
centrifuged again at bOg for 2 mm. The eggs float to the surface in the saturated 
saline and were removed into a 2 ml cuvette. Eggs were then counted manually under 
a x 40 microscope and results expressed as eggs/g faeces. 
2.1.5 Adult worm counts 
Adult worms were recovered as described above, and counted manually 
under a low power (0) microscope on a watch glass marked with a grid. For 
accurate total worm counts, small intestine contents were collected and the gut slit 
open along its length. This material was then incubated at 37°C in pre-warmed 
(37°C) PBS for 2 h after which the mucosa easily detaches from the inner surface of 
the gut and was stripped and added to the contents. Formalin (Sigma, F1558-7) was 
then added to 2%, to preserve the material and the worms were counted under a low 
power microscope. 
2.2 General molecular biology techniques 
2.2.1 RNA extraction 
Total RNA extraction from adult worms and L3 larvae 
Adult worms stored in liquid N2 (approximately 0.5 - 1 g) were crushed, 
using a sterile mortar and pestle pre-chilled to —70°C, with 5 ml of denaturing buffer 
containing the chaotropic agent guanidine isothiocyanate and the reducing agent 
-mercaptoethanol (Stratagene mRNA Isolation kit, 200347), until finely powdered. 
The mix was then thawed to room temperature, aliquoted into 1.5 ml tubes and the 
proteins extracted with 0.5 ml phenol / chloroform / isoamyl alcohol (Sigma, P-
3803). The aqueous phase was removed to fresh tubes and RNA precipitated using 
0.5 ml isopropanol. Extracted RNA was stored under isopropanol at -20°C or 
reconstituted in RNase free water and used immediately for cDNA synthesis. 
Total RNA was extracted from L3 using the Nucleospin RNA extraction kit 
(Machery-Nagel, 740955.20). The procedure was as described in the kit protocol. 
Briefly, 10 to 30 mg of larvae (snap frozen in liquid N2) were ground in liquid N2 in 
a pre-chilled (-70°C) sterile mortar and pestle with frozen extraction buffer. The 
mixture was thawed and spin filtered in a microfuge to remove protein and debris. 
The lysate was then loaded onto a Nucleospin RNA column. Following a desalting 
wash, DNase was added directly to the column and incubated for 15 min at room 
temperature to remove contaminating DNA. The column was then washed twice with 
ethanol and RNA eluted in 60 Al RNase free water. 
RNA extraction from rat tissues 
mRNA was isolated from rat spleen, mucosa and mesentery samples 
collected at various time points through infection, using the Stratagene mRNA 
Isolation kit (Stratagene, 200347) as per the manufacturers instructions. 
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Approximately 0.5 g of rat tissue, snap frozen and stored in liquid LN2, was 
crushed in 5 ml RNA extraction buffer. Following this, elution buffer (10 ml) was 
added and the mix centrifuged for 30 min at 11,000 g to remove proteins. The 
supernatant was added to 5 ml oligo dT cellulose and the mRNA allowed to bind for 
15 mm. The cellulose was then centrifuged at 700 g for 3 min and the supernatant 
removed. The pellet was re-suspended in 5 ml high salt buffer, re-pelleted and the 
supernatant removed, this wash being repeated twice in high salt buffer and once in 5 
ml low salt buffer. The cellulose was then packed into a push column and the mRNA 
eluted in 3 aliquots of 400 j.tl elution buffer at 65°C. 
2.2.2 Reverse transcription (cDNA synthesis) 
First strand cDNAs were reverse transcribed from total or mRNA using 
cDNA Cycle Kit (Invitrogen, 45-0014) or Superscript First Strand Synthesis System 
(Invitrogen, 12371-019) as described in the manufacturers protocols. Approximately 
0.5 tg RNA was reverse transcribed using the Moloney Monkey Virus or Superscript 
reverse transcriptase. Transcription was primed from oligo-dT primers, which 
hybridise to the poly A tail of the mRNA. Reactions were carried out in kit buffers 
and thermal cycling was performed on a Perkin-Elmer 2400 Geneamp thermal cycler 
using the manufacturers recommended conditions. Following transcription, the first 
strand cDNA was removed from the reaction mixture by addition of an equal volume 
of phenol /chloroform /isoamyl alcohol (Sigma, P-3803) and vortexing briefly. The 
tube was then centrifuged at 11,000 g for 5 min and the aqueous phase containing the 
cDNA removed to a fresh tube and stored at -20°C until further use. 
2.2.3 Amplification of DNA sequences by polymerase chain reaction 
Specific DNA sequences were amplified from cDNA templates by PCR using 
oligonucleotide primers of around 20 to 30 bases designed to bind specifically with 
the target sequence. In general, PCR reactions were carried out using the Expand 
Long Template PCR System (Roche, 1681834). Reactions were performed in 25 p1 
reaction mixtures containing: 
lox buffer (MgCl2  22.5 mM); 0.4 mM dNTPs; 1 jtM Primer 1; 1 pM Primer 2; 1.75 
u Taq polymerase; 50-100 ng of DNA template. 
Thermal cycling was carried out on a Perkin Elmer 2400 Geneamp thermal 
cycler. In general the cycle conditions were 4 min at 95°C to denature the DNA, 
followed by 25 - 40 extension cycles of 10 s at 95°C, 1 min at 50 - 60°C and 2 min at 
68°C. A final extension phase was 7 min at 72°C. 
2.2.4 Separation and visualisation of nucleic acids by agarose gel 
electrophoresis 
Nucleic acids (RNA, cDNA and PCR products) were separated and visualised 
on agarose gels containing ethidium bromide (EtBr). EtBr intercalates into the DNA 
helix and fluoresces under UV light. Gels containing 0.8-2% (w/v) agarose in Tns / 
acetic acid / EDTA buffer (TAE. Appendix 1) and EtBr at 0.1 tg/ml were poured in 
gel trays (Pharmacia Biotech, 18-2400-02) with the required sample well size. 
Samples were loaded into wells on the gel in an equal volume of loading buffer 
(Appendix 1) under TAE buffer. Electrophoresis was then carried out at 80 V for 
approximately 30 min in TAE buffer. Nucleic acids in the gels could then be 
visualised using a UV light box and photographed. 
2.2.5 Determination of nucleic acid concentration using a 
spectrophotometer 
Nucleic acid concentrations were routinely estimated in solution using a 
spectrophotometer (Beckman, DU 650). The optical density (OD) at 260 and 280 nm 
of samples and blanks were measured and nucleic acid concentration and purity with 
regard to contaminating proteins was estimated. OD 260 was used as a measure of 
nucleic acid concentration with a relevant correction factor (RNA = 0.04 14g/Al/OD 
unit, DNA=0.05 ig/tl/OD unit). OD 260/280 was used as a measure of purity with a 
ratio of close to 1.8 being considered to contain relatively few impurities. 
2.2.6 Polymerase  chain reaction product purification 
PCR products were prepared for sequencing by removing PCR reagents and 
contaminants using a Qiaquick PCR prep kit (Qiagen, 28704) as per instructions. 
PCR products were separated on agarose gels and bands excised under UV. The 
excised agarose containing the PCR product was dissolved in sodium iodide (Na!) 
solution at 55°C and the DNA then bound to silica in a spin flow column. This was 
washed with 70% ethanol wash solution and the DNA eluted in sterile distilled 
water. PCR products for cloning into bacterial vectors were cleaned by Geneclean 3 
kit (Bio 101/Q-biogene, 1001-400) following the manufacturers protocol, similar to 
the above. This protocol appeared to preserve the adenine (A) nucleotide overhangs 
at the ends of the PCR products more efficiently than the Qiagen kit. 
2.2.7 Cloning of polymerase chain reaction products in pGEM-T 
bacterial vector 
Prior to sequencing, PCR products were cloned in pGEM-T vector system 1 
(Promega, A3600). This vector is a high copy number, bacterial, plasmid vector. 
PCR products can be cloned directly into the vector for propagation and sequencing 
as it contains thymine (T) overhangs on its free ends. 
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Purified PCR product (approximately 25 ng) was added to pre-cut vector 
(approximately 50 ng) in a 3:1 molar ratio in a ligation reaction comprising; 2x 
buffer, 3 U DNA ligase, made up to 10 JL1 with sterile distilled water. Following 
incubation for 16 h at 4°C, a sample of the ligation solution (5 p1) was then 
transformed into 50 p1 of JM109 competent cells (Stratagene, 200235) by heat shock 
at 42°C for 45 s. Following 1 h outgrowth in 500 j.d Soc medium (Appendix 1), 
200 p1 of transformed cells were plated on Luna I agar (Appendix 1) plates with 
ampicillin at 50 tg/ml and grown overnight at 37°C. colonies were picked into 
10 ml Luria broth with ampicillin at 50 tg/ml and incubated at 37°C overnight. 
2.2.8 Recovery of plasmid DNA 
Plasmid DNA was recovered from 1.5 ml of overnight cultures using a 
Promega Wizard miniprep kit (Promega, A7100) as per instructions. Cells were 
disrupted in kit lysis buffer and the debris and proteins removed by centrifugation at 
11,000 g for 30 mm. DNA was bound to silica in spin columns and washed x2 with 
ethanol based wash buffer. Plasmid DNA was then eluted in 100 Al sterile distilled 
water (dH20). Dilutions of 1 in 100 of the eluted DNA were screened for positive 
inserts by PCR using specific primers. 
2.2.9 Sequencing of polymerase chain reaction products 
PCR products were sequenced in house at Moredun Functional Genomics 
Unit using a PE Biosystems 377 DNA sequencer and Big Dye terminator chemistry 
version 1.1 (Applied Biosystems, 433:7450). This is a chain termination sequencing 
method, and was performed according to manufacturer instructions. 
In brief, cloned PCR products were used as template DNA in PCR reactions, 
primed with vector, or insert, sequence specific oligonucleotide primers. A 
percentage of the nucleotides in the reaction mix were di-deoxy nucleotides (d-
dNTPs). These terminate the polymerisation of the DNA molecule at the point at 
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which they are included by the polymerase. The d-dNTPs were included at a 
concentration such that DNA molecules were produced at lengths differing by one 
nucleotide, with a d-dNTP represented at each position in the DNA sequence. The 
Big Dye system labels each d-dNTP species, adenine, thymidine, guanidine and 
cytidine (A, T, C and G) with a different coloured dye. The reaction products were 
then separated on an acrylamide gel that resolves a one-nucleotide difference. Dyed 
d-dNTPs were scanned as they passed by a laser, allowing the chain terminating 
species to be determined for each length of DNA molecule. The order of passing 
bases corresponds to the sequence of the template DNA. 
Sequencing output and data were analysed using Chromas 1.43 
(Technelysium Pty Ltd.) and DNA Star (DNA Star Inc.) software packages. The 
sequence of the 5' and 3' end of the SOD gene and the full length SOD coding 
sequence produced by primers P1 and P5 were determined in this manner. Further 
analysis of gene and protein sequences was performed using software packages 
available from EBI and NCBI websites. These included homology searches using 
BLAST, alignment with homologous sequences using Clustal-W and protein motif 
searching using Signal-P and Prosite websites. 
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2.3 General protein techniques 
2.3.1 Adult worm somatic extracts 
Somatic extracts (Adult Si) were prepared from adult N. brasiliensis, which 
had been stored at -80°C. Worms were thawed on ice and homogenised in ice cold 
PBS using a 1 ml hand held glass homogeniser (Jencons, England). Homogenates 
were then cleared by centrifugation in a microfuge at 11,000 g for 10 min and stored 
at -80°C until required. 
2.3.2 L3 larvae somatic extracts 
Larval somatic extracts (L3 Si) were prepared from L3 larvae cultured and 
prepared as described earlier and stored at -80°C. Worms were thawed on ice and 
homogenised in ice cold PBS, in a 2 ml vial containing glass beads (Hybaid, 60-
100a-5002), using a ribolyser (Bio 101/Thermo savant, Fastprep FP120). This 
method was used, as larval stages of nematode parasites are small and resistant to 
breakdown in a standard glass homogeniser. L3 were given 6x pulses of 30 s and 
cooled on ice for 30 min between each pulse. When the L3 were judged to be 
sufficiently disrupted, by examination of supernatant under dissecting microscope, 
the resultant homogenate was cleared by centrifugation at 11,000 g for 10 min and 
the supernatant retained. The pellet was re-extracted with a further 2 ml ice cold 
PBS, re-centrifuged and the supernatant added to the previous sample. Homogenates 
were stored at -80°C until required. 
2.3.3 Determination of protein concentration 
Determination of protein concentration using a spectrophotometer 
For general use protein concentration in solution was measured using a 
spectrophotometer (Beckman, DU650). OD at 260 and 280 nm was measured against 
a PBS blank and the protein concentration was estimated from the OD 280 nm - OD 
260 nm with a correction factor applied (1.55xOD 280 - 0.77xOD 260). 
Determination of protein concentration by Pierce assay 
When more accurate protein concentrations were required, protein 
concentration was determined by Pierce BCA protein assay (Pierce, 23225) using the 
kit protocol. This assay is based on the colour change of bicinchonic acid produced 
by the reduction of copper ions. Unknown samples and bovine serum albumin (BSA, 
Sigma, A-7906) standards were incubated in BCA working reagent (containing 
sodium carbonate, sodium bicarbonate, bicinchonic acid and sodium tartrate, 0.1 M 
sodium hydroxide and 0.1 % (w/v) copper sulphate) on a microtitre plate for 30 mm 
at 37°C allowing colour formation. OD at 562 nm was then measured and the 
protein concentration determined by comparison of unknowns against the plotted 
standard curve. 
2.3.4 Separation of proteins by poly acrylamide gel electrophoresis 
Sodium dodecyl sulphate poly-acrylamide gels 
Proteins were routinely fractionated using sodium dodecyl sulphate poly-
acrylamide gel electrophoresis (SDS-PAGE), under either reducing or non-reducing 
conditions. Mini gels of approximately 9 x 6 cm and 1-2 mm thick were poured 
using the Mini Protean gel system (BioRad). These comprised a 10-15% acrylamide 
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resolving gel in separating buffer (Appendix 1), over-laid with a 4% acrylamide 
stacking gel in stacking buffer (Appendix 1). Ammonium persulphate (APS, Sigma, 
A-3678, 0.0005%) and TEMED (Sigma, T-9281; 0.001%) were added to gel mixes 
to facilitate polymerisation. Gels were typically cast with 10 x 30 jil wells. Proteins, 
Si extracts, column or cell fractions, were loaded in either reducing or non-reducing 
loading buffer (Appendix 1). Reducing samples were incubated at >95°C for 5 mm 
and then placed on ice prior to loading. Reducing samples in this manner allows 
accurate sizing of protein bands following fractionation. Protein size markers 
(Invitrogen, LC5677) were also loaded in adjacent lanes to determine the size of 
separated proteins. 
Proteins were fractionated using the Mini Protean gel tanks at 200 V for 
approximately 45 min in Laemmli electrode buffer (Appendix 1). 
Native poly-acrylamide gel electrophoresis 
Protein gels that required fractionated proteins to remain in their native 
unreduced conformation were performed under native PAGE gel conditions. Gels 
were poured with 10-15% acrylamide in Tris / glycine buffer (Appendix 1) as above 
but with no SDS. Loading buffer was Tris / glycerol / bromphenol blue (Appendix 1) 
without SDS or fl-mercaptoethanol and samples were not boiled prior to loading. 
Similarly, the electrode buffer used was Tris / glycine without SDS (Appendix 1) and 
for gels that were to be stained for enzyme activity this was pre-chilled on ice to 4°C 
before use. Fractionation conditions were 200 V for 45 min as before and when gels 
were to be stained for enzyme activity, the apparatus was kept on ice for this period. 
Staining poly-acrylamide gels for protein with Coomassie blue 
Following fractionation gels were removed from the glass plates and stained 
to visualise the proteins. Staining was generally carried out using Coomassie blue 
stain (Appendix 1). Gels were stained in 20 ml stain for 30 min and then washed for 
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3 x 45 min in methanol / acetic acid destain (Appendix 1) to remove the background 
staining. Gels were then photographed or dried onto 3 mm chromatography paper 
(Whatman, 3030917) as a permanent record. 
2.3.5 Detection of proteins by immuno-blot (Western blotting) 
Transfer of proteins to PVDF membranes 
Proteins separated by SDS-PAGE under reducing or non-reducing conditions 
were transferred to PVDF membranes prior to detection of proteins with specific 
antibody. Gels were removed from the glass plates and rinsed in dH20. Transfer was 
carried out using a "semi-dry" electroblot method. Following electrophoretic 
separation the gel was removed from the apparatus and washed briefly in dH20. The 
gel was then placed on the anode of the electroblotter (Milliblot Graphite 
Electroblotter 1, Millipore, MBBDGEOO1), on top of a layer of PVDF membrane 
(Immobilon pTM,  Millipore, IVH0010) that had been activated by immersion in 
methanol and rinsed in dH20. This overlaid two pieces of 3 mm chromatography 
paper, the lower soaked in 0.3 M Tris (Appendix 1) and the other in 0.025 M Tris 
(Appendix 1). The gel was then covered by a third layer of chromatography paper 
soaked in 0.025 mM Tris / glycine (Appendix 1) and the cathode of the blotter. 
Transfer was carried out at 150 mA of current for 45 min following which layers 
were removed and the membrane rinsed in distilled water. 
Visualisation of protein on membranes by reversible staining with Ponceau 
Red 
Proteins were visualised on membrane blots by staining with 0.1% Ponceau S 
solution (Sigma, P-3504) for 5 mm. Separated protein bands stain red allowing lanes 
to be distinguished. At this point lanes could be separated for permanent staining 
with Coomassie or probing with specific antibody. Membranes were then rinsed 
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clear of the stain in Tris buffered saline with Tween-20 (TBST, Appendix 1) for 30 
mm. 
Probing blots with specific antibody 
Detection of individual protein bands on a gel was accomplished by probing 
with specific antibody. Blots to be probed were incubated overnight in 10% dried 
milk powder (Marvel, Premier Brands) in TBST to block non-specific binding. 
Following blocking, membranes were washed for 15 min 0 in TBST. The 
membrane was then incubated in specific anti-sera at the appropriate dilution in 
TBST for 2 h and washed as above. Specific antibody was then detected on the blot 
by incubating with secondary antibody, conjugated to horseradish peroxidase (HRP). 
Blots were incubated with secondary antibody HRP conjugates at appropriate 
dilutions in 10% Marvel / TBST for 2 h. Blots were then visualised by incubating the 
membranes in 3, 3' diaminobenzidine substrate (Sigma Fast DAB, D-4418) and 
washed thoroughly in dH20. 
Visualisation of blots using ECL+Plus 
For more sensitive detection of specific antibody binding the ECL+Plus 
(Amersham Pharmacia Biotech, RPN 2132) was used. This detection system is based 
on the production of chemi-luminescence by a reaction catalysed by the conjugated 
HRP. The luminescence produced is then detected by exposure of autoradiography 
film. ECL was used as per manufacturers protocol. The membrane was covered with 
the ECL+Plus buffer containing Lumigen PS-3 acridan substrate and incubated for 
5 mm. The membrane was then drained and wrapped in clingfilm. Exposure of 
autoradiography film was carried out in X-ray film cassette for the required time 
based on initial results. 
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2.4 Enzyme activity assays 
2.4.1 Superoxide dismutase activity assay 
SOD activity was detected and measured using an assay based on the 
oxidation of iodo-nitro-tetrazolium violet (NT) by the xanthine / xanthine oxidase 
system (Jones and Suttle, 1981). SOD activity in the assay was indicated by the 
inhibition of the purple colour formation, produced as the NT is oxidised. 
Solutions containing, samples of protein (12.5 l) were added to wells of a 96 
well, flat bottomed microtitre plate in 100 Al, 0.25 mM carbonate buffer at pH 10.2 
(Appendix 1) with 0.1 mM xanthine (Sigma, X-0626), 0.025 mM NT (Sigma, I-
8377). The reaction was initiated by the addition of 0.01 U of xanthine oxidase 
(Boehringer Mannheim, 110434) and colour formation allowed to progress for 30 
mm. The OD at 492 nm was then determined using a microplate reader (Bio-tek 
Instruments Inc., ELX808iu). OD is used as a measure of colour and therefore 
substrate formation. SOD activity could be detected by the inhibition of colour 
formation and quantified against a series of SOD standards of known concentration 
(Sigma, S-2515). Activity is defined as 1 U producing 50% inhibition of colour 
formation. 
2.4.2 Acetylcholinesterase activity assay 
AChE activity was determined using an assay adapted from the method of 
EIlman et al (1961), as described in Blackburn and Selkirk (1992). Samples of 
protein in solution (20 Al) were added to wells of a microtitre plate containing 200 Itl 
0.1 M phosphate buffer, pH 7 (Appendix 1) with 0.2 mM 5,5-dithiobis 
(2-nitrobenzoic acid) (DTNB, Sigma, D-8130) and 1.5 mM acetylthiocholine iodide 
(Sigma, A-5751). The colour forming reaction was allowed to progress for 5 mm, 
following which the OD at 414 nm was determined as a measure of substrate 
formation. 
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2.4.3 Staining poly-acrylamide gels for superoxide dismutase activity 
Proteins were fractionated by gel electrophoresis and stained for SOD activity 
(Beauchamp and Fndovich, 1971). Proteins separated on 15% non-reducing SDS-
PAGE, as described above, were removed from the glass plates and washed x4 in 
2 % Triton X-100 (Sigma, X-100) for 15 mm. This wash removes the SDS and 
allows the protein to refold to its original conformation. 
SOD activity was then visualised by incubating gels in a solution containing 
2.45 mM nitro-blue tetrazolium (Sigma, N-6639) in dH20 for 20 mm. This was 
followed by incubation in a solution containing 28 mM TEMED (Sigma, T-9281), 28 
jM riboflavin (Sigma, R-4500) in 0.033 M phosphate buffer pH 7 (Appendix 1) for 
15 mm. Gels were then developed by exposure to light, on a light box, for 5-15 mm. 
This causes superoxide ion (02) production and reduction of the nitro-blue 
tetrazolium with the formation of a blue colour in the gel. SOD activity inhibits this 
reduction and was indicated by clear zones on a blue background. 
2.4.4 Staining native poly-acrylamide gels for acetylcholinesterase 
activity 
AChE activity was visualised on native page gels using the method of 
Karnovsky and Roots (1964). Proteins were separated on 10% PAGE gels as 
described previously, using native conditions and ice-cold buffer, with the 
electrophoresis performed on ice. Following fractionation, the gels were removed 
from the glass plates and incubated in a solution containing 0.1 M phosphate at pH 
6.5 (Appendix 1) with 2.6 mM acetyithiocholine iodide. The following were then 
added to final concentration; 5 mM sodium citrate, 3 mlvi copper sulphate, 0.5 mlvi 
potassium ferricyanide and incubated for >30 mm. AChE activity was visualised as 
brown bands in the gel. Following several rinses in dH20, gels could be 
photographed or dried. 
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2.4.5 Staining native poly-acrylamide gels for esterase activity 
Gels were stained for non-specific esterase activity using the method of 
Grunder et al (1965). Separation of proteins using native PAGE gels was carried out 
as described above using ice cold buffers and with the gel tank cooled in ice during 
electrophoresis. Gels were then removed and stained in 5 mg/ml fast blue RR salt 
(Sigma, F-0500) in PBS with 1/20 volume 2% naphthyl acetate (Sigma, N-8505) in 
acetone. Dark brown bands of colour developed after around 5 min and the 
development was then stopped by several washes in distilled water. Gels could then 
be photographed or dried onto 3 mm chromatography paper. 
2.5 Establishment of the infection model 
2.5.1 Investigation of single challenge and re-infection 
Groups of 3 Wistar rats were infected with 2,000 L3 as described above and 
the infection was allowed to progress through to expulsion of the worms and 
termination of infection. FEC were carried out from day 5 as the primary measure of 
infection and the number of adult worms were also counted around the peak of 
infection. 
Rat tissue samples; spleen, mesentery and intestinal mucosa were collected at 
time points 0, 1, 7, 11 and 14 days during the infection. Tissues from an uninfected 
control group of three rats were taken on day 0. These tissues were snap frozen in 
liquid N2 to preserve the RNA for development of a reverse transcription PCR 
method to monitor host cytokine expression. 
2.5.2 Investigation of varying challenge doses 
Animals used in the investigation of challenge dose were infected, as detailed 
above, with varying numbers of L3 from 25 to 500. Some animals were infected, at 
weekly intervals, with 25 L3 or 3x weekly with 5 U. FEC were performed as the 
primary measure of these infections. 
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2.6 	Molecular cloning and expression of Nippostroncj vi us 
brasiliensis superoxide dismutase 
2.6.1 SMART cDNA synthesis 
Total RNA from N. brasiliensis adults was used to produce cDNA using the 
SMART cDNA Library Construction Kit (Clontech, PT 30011PR92334, K1051-1). 
This was earned out according to the SMART cDNA synthesis by Long Distance 
Polymerase Chain Reaction (LD-PCR) protocol in the user manual. 
In brief, this method is a reverse transcription that produces a first strand 
cDNA, with specific oligonucleotide sequences incorporated at the 5' and 3' end of 
each strand. The cDNA can then be amplified non-specifically by PCR using primers 
directed at these incorporated sequences. The product is a SMART cDNA, with the 
SMART Ill oligonucleotide incorporated at 5' end and the CDS III oligonucleotide at 
the 3' end (Table 2.1). 
2.6.2 Amplification of Nippostrongylus brasiliensis superoxide 
dismutase coding DNA by polymerase chain reaction 
Gene specific primers for SOD (Table 2.1) were designed to regions of the 
gene sequence flanking the SOD active site domains, which is highly conserved 
between nematode species. Some sequence data were also available from previously 
determined partial N. brasiliensis SOD gene sequences (Young, 1996). 
Primer binding sites are outlined in Figure 2. 1, below. The 5' end gene 
product was amplified by priming with the P 1 primer against the antisense P 4 
primer. PCR amplification of the SOD 3' end gene product was accomplished by 
priming with P 2 sense primer towards the 3' poly-A tail and the incorporated CDS 
Ill oligonucleotide in the SMART cDNA template. Internal SOD products were 
amplified as controls using P 2, sense and P 3 and P 4 antisense primers. 
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The products of these reactions were the 5' and 3' halves of the gene sequence 
and internal SOD products respectively. The products were sequenced and the data 
used to design a gene specific primer for the 3' end of the coding sequence, p 5. 
Primer Binding site Sequence 
SMART III 5' end cDNA 
AAG GAG TGG TAT CAA CGC AGA 
GTG GCC AU ATG GCC GGG 
P 1 Fend SOD gene 
ATG AGC AAC CGA GCA GTG GCC 
GTG 
P2 Conserved region 
CTG TAT CTC UG TGG ACC TCA CU 
TAA 
CGA CTC CTC CU CU CTC ACC GAG 
P3 Conserved region TAC 
P4 Conserved region 
GTG AU TCG AAA TGA GCA ACA CCA 
CTG GC 
P5 3' end SOD gene 
TCA CTG GGG AGC AGC GAT GGC 
GAT CAC TCC 
CDS III 3' end of cDNA AlT CTA 
GAG GCC GAG GCG GCC 
GAG ATG-d(T)30N-IN 
Table 2.1. The oligonucleotide primers used in the amplification of SOD gene 
specific products. Primers specific for the conserved region and cDNA ends 
were used to amplify products which were subsequently sequences and 
aligned to provide a contiguous full length gene sequence. P1; start codon 
underlined. CDS Ill; N 1  =A, G or C, N= A, T, G or C. 
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P1 
SMART Ill Oligonucleotide------------------------------ (Sta)------------- .
P P2 	 P3 




---------------------------- (Stop) --------------- AAAAAAAAA-CDS Ill Oligonucleotide 
Figure 2.1. Line diagram showing the outline of the SOD cDNA with primer 
sites, P 1 - P 5, Start and Stop codon, conserved region and the attached 
SMART oligonucleotides. Primers specific for the conserved region and 
cDNA ends were used to amplify products which were subsequently 
sequences and aligned to provide a contiguous full length gene sequence. 
2.6.3 Cloning of superoxide dismutase cDNA into pET22b+ expression 
vector 
A SOD full-length cDNA was amplified by PCR using P1 and P5 primers 
with incorporated BamHl and EcoRl restriction enzyme sites respectively (Table 
2.2). These restriction sites were chosen to allow cloning in frame into pET22b+ 
bacterial expression vector (Novagen, 69744-3). This vector was chosen as it had 
previously been used to express an enzymically active H. contortus SODc (Liddell 
and Knox, 1998). 
P 1 BamHl CGT AGG ATC CGA TGA GCA ACG GAG CAG TG 
P 5 EcoRl GIG TAG4 AAT TCA GTC ACT GGG GAG GAG C 
Table 2.2. The oligonucleotide primers used in the amplification and 
subsequent cloning of the full length SOD gene for in vitro expression in E. 
co/i. (Restriction sites shown in bold). 
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Around 1 g of SOD product and 800 ng of pET22b+ were prepared for 
ligation by restriction digest with BarnHl and EcoRl restriction enzymes (Roche, 
567604 and 200310). Restriction digest reactions (20 p.1), comprising of 2 p.1 lOx 
buffer B; 10 U EcoRl; 10 U BamHl; sterile dH2O to 20 p.1, were incubated at 37°C 
for 3 h. The DNA was then removed from the other reagents using Geneclean 3 kit 
following the protocol described in section 2.2.6. Around 50 ng of prepared SOD 
product was ligated into 50 ng of prepared pET22b+ in lOx ligation buffer with 10 U 
T4 DNA ligase (Roche, 481220) made up to 10 ttl with distilled water and incubated 
at 4°C overnight. 
2.6.4 Transformation into competent Escherichia coil strains 
Escherichia coli JM109 competent cells were used to propagate the 
SOD/pET22b+ construct prior to expression in E. coli BL21 cells, as these are more 
efficient transformants. Transformations were carried out as described previously 
and plasmid DNA recovered by miniprep. Plasmid DNA positive for the SOD insert 
was identified by PCR screening with SOD specific internal primers as described 
above. 
Around 35 ng of positive plasmid were transformed into 50 p.1 BL21 
competent cells (Stratagene, 200133) by heat shock at 42°C for 20 s. The BL21 cell 
type is suitable for expressing recombinant proteins. A control of pET22b+ vector 
containing no insert was also transformed. Following 1 h outgrowth in 500 p.1 SOC 
medium, 200 p.1 of transformed cells were plated on Luria / agar plates with 
ampicillin at 50 p.g/ml and grown overnight at 37°C. 
2.6.5 Induction of expression 
Colonies containing the SOD/pET22b+ construct and pET22b+ alone control 
in BL21 cells were picked into 10 ml Luria broth (Appendix 1) with ampicillin at 50 
p.g/ml and incubated at 37°C overnight. Sub-samples of these cultures (1 ml) were 
then inoculated into 10 ml aliquots of Luria broth containing ampicillin (Stratagene, 
300021-61) at 50 pg/ml. These were incubated with shaking at 37°C for around 3 h 
until the OD at 600 nni reached over 0.6. Isopropylthio-3-D-galactoside (IPTG, 
Bioline, BlO 37036) was then added to one culture of SOD/pET22b+ construct and 
one of pET22b+ alone to a concentration of 1 mM. IPTG induces the cells to express 
proteins by binding to and blocking a transcription repressor site. Cultures were 
incubated for a further 2 h and aliquots removed to examine the expressed proteins. 
2.6.6 Preparation and analysis of protein fractions 
Samples, 1.5 ml, of the induced and non-induced cultures were pelleted at full 
speed in a microcentrifuge for 5 min and the supernatant retained as the media 
fraction. 
Periplasmic, soluble and insoluble cell fractions were prepared to test for 
localisation of the expressed protein. Periplasmic fractions were prepared by 
incubating cells from one 1.5 ml aliquot in chloroform at room temperature for 15 
min then adding 75 jAl of 10 mM Tris / HC1 pH 8. This was then centrifuged at 
11,000 g for is min and the aqueous phase retained as the periplasmic fraction. 
Soluble and insoluble cell fractions were prepared from cells by lysis in 
100 jii of 50 mM Tris pH 8.5 /2 mM EDTA with lysozyme at 100 pg/ml and Triton 
X-100 at 0.1%. MgCl2  was added to 8 mM, DNase 1 (Boehringer, 104159) and 
RNase A (Boehringer, 109169) to 10 pg/m1. The lysate was pelleted at full speed in a 
microcentrifuge for 10 min with the supernatant forming the soluble cell fraction and 
the pellet, re-suspended in 100 tl, 50 mM Tris pH 8.5 / 2 mM EDTA forming the 
insoluble fraction. 
Samples of 10 p.1 of these fractions were separated on 15% SDS PAGE gels, 
and stained using Coomassie blue. 
2.6.7 Purification of recombinant superoxide dismutase protein by ion 
exchange chromatography 
Recombinant SOD was recovered from the culture media or supernatant of 
overnight cultures by ion exchange chromatography in a manner similar to that 
described for H. contortus SOD (Liddell and Knox, 1998). Cell debris was removed 
from 500 ml overnight cultures induced with IPTG by centrifugation at 1700 g for 30 
min at 4°C. The supernatant was decanted into 50 ml aliquots and stored at -20°C 
until required. Aliquots (100 ml) of supernatant were concentrated using centrifugal 
filters (Centricon, Ym-10) to <10 ml prior to ion exchange separation. Media 
proteins were then fractionated on a Mono-Q sepharose ion exchange column using a 
Pharmacia LKB (LCC-500/P5-500) FPLC chromatography system. Salts and other 
media contaminants were first removed from the sample by filtration through a 
Sephadex G25 column (Pharmacia) with the sample proteins being eluted in 10 ml of 
10 mM TrisIHCl pH 7.5 (Appendix 1). Samples were then loaded onto the Mono Q 
column, which bound most proteins in the column matrix. Unbound material was 
eluted with 10 mM TrisfHCl and the bound proteins were eluted using a salt gradient 
of 0-0.3 M NaCl over 30 mm. Eluted proteins were collected in 2 ml fractions which 
were analysed by SDS-PAGE, Western blot and for SOD activity. This showed that a 
fraction enriched for the recombinant SOD and of relatively high purity eluted at 
around 0.07 M NaCI. 
2.7 Detection of immunological markers of infection 
2.7.1 Detection of immune markers by enzyme linked immunosorbent 
assay 
Extraction of soluble antibody from mucosa samples 
Mucosa samples were obtained by scraping the mucosal surface of -10 cm of 
the anterior small intestine with a glass microscope slide. Samples were 
homogenised in 2 ml ice cold PBS, on ice, using a 5 ml, glass homogeniser (Jencons) 
to solublise the antibody in the tissue. Following extraction, samples were centifuged 
at 11,000 g for 10 min to remove cell debris and normalised to 10 mg/ml protein. 
Development of enzyme linked immunosorbent assay to detect antibody 
isotypes from sera and mucosa 
An enzyme linked immunosorbent assay (ELISA) method was developed for 
the detection of the antibody isotypes total IgG, IgG 1, IgG2a, IgA and IgE in sera 
and mucosal tissue from primary challenge infected animals and controls. 
Microlon (high binding) ELISA plates (GreinerlBio-one, 655061) were 
coated with 1 ig/ml of adult N. brasiliensis Si antigen, in 50 l I well bicarbonate 
buffer pH 9.6 (Appendix 1) at 4°C overnight. Plates were then washed 3x with TBST 
(Appendix 1) and incubated overnight at 4°C with 200 jzl / well 10% Marvel / TBST 
to block non-specific binding. Plates were again washed x6 with TBST. 
Sera samples and mucosal homogenates (primary antibody) were used in 
dilution series from 1 in 20 to 1 in 20,480 in PBS and neat to 1 in 1,024 in PBS 
respectively. Primary antibody was added in 50 jsl I well PBS and incubated for 1 h 
at room temperature following which plates were washed x6 as above. 
Individual, isotype-specific secondary antibodies (shown in Table 2.3) were 
then added (one per plate) at a range of dilutions. Secondary antibodies were diluted 
in TBST (50 jsl / well) and incubated on the plates for 1 h at room temperature. 
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Following washing x6 as above, the horse radish peroxidase (HRP) conjugated anti-
IgG secondary antibody could then be detected by the addition of 100 Al / well 
Sigma Fast—OPD (Sigma, P-9187) and the colour allowed to develop for around 15 
min before stopping with 2.5 M H2SO4- 
The other antibody isotypes were detected by incubation with HRP 
conjugated, anti-mouse immunoglobulin antibody (see Table 2.3), for a further 1 h 
before detection with Sigma Fast—OPD in the same manner. Following colour 
development, OD values for each well were read at 450 nm using a plate reader. OD 
values for each dilution of secondary antibody with infected and uninfected control 
samples were then plotted on a graph to determine the most appropriate working 
dilution of each. 
Antibody Type Supplier Cat. No. 
Anti-rat lgG HRP conjugated Sigma R-9037 
Anti-rat IgGi  Serotec MCA194 
Anti-rat lgG2a  Sigma R-0761 
Anti-rat IgA  Sigma R-0636 
Anti-rat IgE  Serotec MCA193 
Anti-mouse Ig HRP conjugated Dako P0260 
Table 2.3. The sources of monoclonal antibodies used in the detection of rat 
immunoglobulin isotypes IgG, IgGi, lgG2a, IgA and IgE by ELISA. All 
antibodies were raised in mice and detected using the Anti-mouse lg HRP 
conjugated antibody, with the exception of the anti-lgG antibody, which was 
HRP conjugated. 
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Detection of antigen specific serum and mucosal antibody using enzyme 
linked immuno sorbent assay 
Antigen specific IgG, IgG 1, IgG2a, IgA and 1gB were detected and quantified 
in sera and mucosal samples from vaccinated animals by ELISA in a manner similar 
to that described above. ELISA plates were coated with 1 jg/m1 of antigen (SOD or 
AChE) in bicarbonate buffer pH 9.6 (Appendix 1) overnight. Plates were then 
washed and blocked overnight with 10 % Marvel / TBST (Appendix 1) and again 
washed x6 with TBST. 
Primary antibody (sera or mucosal homogenates prepared as above) was then 
added in dilution series in PBS and incubated for 1 h following which plates were 
washed x6 as above. Isotype-specific secondary antibody was then added at the 
appropriate dilution and incubated for a further 1 h. Following washing x6 as above 
the HRP conjugated anti-IgG was then detected as above and the other isotypes 
detected with anti-mouse HRP conjugated antibody. Following colour development 
OD values for each well were read at 450 nm using a plate reader. Specific antibody 
levels for vaccinated or infected animals were then calculated as a titre against 
specific antibody levels in dilutions of control sera (1 in 20) or mucosal homogenate 
(10 mg/ml). 
Quantification of rat mast cell protease II levels by enzyme linked immuno 
sorbent assay 
Rat mast cell protease II (RMCP II) levels were detected and quantified from 
sera and mucosal tissues by ELISA in the manner of Miller et al (1983b), using a 
commercially available kit (Moredun Scientific Limited, RMCP II ELISA). Assays 
were carried out according to manufacturer's instructions. ELISA plates were coated 
with 2 tig/ml anti-RMCP II monoclonal antibody in bicarbonate buffer pH 9.6 
(Appendix 1) at 4°C overnight. Following 6x washes with PBS with Tween-20 
(PBST, Appendix 1) plates were blocked at 37°C for 30 min with 4% Bovine serum 
albumin in PBST. Plates were washed again x3 and standards in series from 0.5 - 12 
ng/ml of RMCP II in 4% BSA / PBST were added in triplicate. Unknown samples 
(sera or mucosal homogenates at 10 mg/ml) were then plated in dilution series 1 in 
10 to 1 in 10,000 and incubated at 37°C for 30 mm. Following a further wash x6, 
plates were incubated for 1 h with 50 jLl/well conjugated antibody solution at 37°C. 
Plates were once again washed x6 before addition of 50 td/well substrate. Colour 
formation was allowed to progress for around 15 min before stopping with 0.25 M 
H2SO4- OD values for each well were then read at 450 nm on a microplate reader and 
RMCPII levels calculated by comparison against a plotted standard curve. 
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2.7.2 Detection of rat cytokine expression by reverse transcription - 
polymerase chain reaction 
cDNAs prepared from rat tissues were used as template in a PCR experiment 
to detect cytokine gene mRNA transcription. Oligonucleotide primers (Table 2.4) 
were obtained for a subset of rat Th-1 and Th-2 cytokines to show the relative 
Th-1/Th-2 bias of the immune response during N. brasiliensis infection. Primer 
sequences were obtained from Matsuda et al. (1995). 13-Actin primers were included 
as a constituitively expressed control to allow comparison between experiments. 
Cytokine Primer sequence 
IL-2 F CAT GTA CAG CAT GCA GCT CGC ATC C 
R CCA CCA CAG TTG CTG GCT CAT CAT C 
IL-3 F TGC CU GGA GAT UT GGT GAA GCT CCC 
R CAG GTC CU AAG ATG GAT CAC GTA GA 
IL-10 F TGC CAA GCC UG TCA GAA ATG ATC AAG 
R GTA TCC AGA GGG TCT TCA GCT TCT CTC 
IFN-y F ATG AGT GCT ACA CGC CGC GTC UG G 
R GAG TTCAUGAC AGC TU GTG CTG G 
IL-4 F ACC UG CTG TCA CCC TGT TCT GC 
R GU GTG AGC GTG GAC TCA UC ACG 
IL-5 F TGC UC TGT GCT TGA ACG UC TAA C 
R UC TCT TU TGT CCG TCA ATG TAT UC 
3-Actin F AGA AGA GCT ATG AGC TGC CTG ACG 
R CU CTG CAT CCT GTC AGC GAT GC 
Table 2.4. Oligonucleotide primers specific for rat cytokine and a 
constituitively expressed control (3-Actin) cDNA sequence (Matsuda et al., 
1995). The primers were used in PCR with template cDNA isolated from the 
tissues of Wistar rats infected with 2000 Nippostrongylus brasiliensis L3 
larvae to detect cytokine transcription. 
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2.8 Immunisation of rats with recombinant antigens 
2.8.1 Trial 1 - Subcutaneous immunisation with recombinant superoxide 
dismutase and acetyicholinesterase 
Experimental design 
The immunogenicity and protective capacity of recombinant SOD and AChE 
was initially assessed using a systemic vaccination regime. Previous vaccination 
trials in ruminants have utilised systemic regimes (Smith, 1999), a comparison of 
these antigens with these previous trials was considered a useful starting point. The 
systemic regime chosen was subcutaneous (SC) vaccination. An adjuvant, Quil A, 
considered to boost both Th- 1 and Th-2 systemic immune responses, was used in 
conjunction with the antigens to increase the immune response. Challenge doses for 
the experiment were low level single challenge doses, having been considered the 
most appropriate in previous investigations of challenge dose. 
Immunisation regime 
One group of rats was immunised with 10 jig SOD and one with AChE in 
0.2 ml PBS with 10 Ag of Quil A adjuvant (Superfos Biosector, Batch L77-194). 
Another group of seven, control, rats were not immunised and one further control 
group immunised with 10 jg Quil A alone. All animals were housed in cages of 2 or 
3 animals. The rats were initially immunised on day 0 of the experiment and boosts 
of the same vaccination dose were given at weeks 4 and 8. All immunisations were 
performed subcutaneously above a hind limb while the rats were suitably restrained. 
All groups were challenged at 2 w after the final boost (week 10) with 25 L3 
larvae in 0.2 ml PBS injected subcutaneously above a hind limb as described 




FEC were taken from day 5 - 11 post challenge as the primary measure of 
infection. Samples were collected from each cage and egg counts performed as 
described previously (Section 2.1). Results were expressed as eggs / g faeces for each 
cage giving 3 samples per group or as a mean of each group. Cumulative egg output 
through the course of infection was also calculated and compared between groups 
using analysis of variance (one way ANOVA) as a measure of the statistical 
significance of any differences. 
Blood samples were collected prior to final boost by tail bleed (week 6). Sera 
from these samples was assayed for antigen (SOD / AChIE) specific antibody, to 
confirm that an immune response had been stimulated by the immunising doses prior 
to challenge and to provide pre-challenge antibody levels. Antibody levels were 
assayed by ELISA as described previously (Section 2.7). 
On necropsy, samples were taken for immunological and parasitological 
analyses. Blood (sera) and mucosal scrapings (harvested as described above) were 
collected for analysis of RMCP II and antibody levels by ELISA. The remaining 
small intestine and contents were retained for adult worm counts. 
2.8.2 Trial 2— Intra-peritoneal immunisation with acetyicholinesterase 
Experimental design 
Part 1- Intra-peritoneal immunisation with acetyicholinesterase 
This experiment was carried out to test the immune response and the degree 
of protective immunity stimulated by an immunisation regime designed to produce 
mucosal Th-2 responses. Mucosal and Th-2 responses may be more appropriate than 
systemic response in the immune response to GI nematodes. The preferential 
targeting of such responses might therefore enhance protection. The previous 
systemic immunisation regime was repeated to confirm the results. In addition a 
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further group of seven rats was added. This group was immunised with AChE intra-
peritoneally (IP), a route of immunisation which might enhance mucosal immune 
responses compared to systemic antigen delivery (Murray et al., 1979). In this group 
Aihydrogel (aluminium hydroxide gel, Sigma, A-8222) was chosen as an adjuvant as 
it is considered to enhance Th-2 responses (Nicklas, 1992). 
Part 2 - Immunisation of Sprague Dawley rats with superoxide dismutase 
Based on the results of the previous systemic trial with SOD, this experiment 
was designed to test whether the Wistar strain of rat had failed to recognise the 
foreign SOD protein. Genetic restriction of major histocompatibility complex II 
(MHC II) may occur in rat strains, preventing immune recognition of antigens. The 
previous immunisation schedule was repeated with two groups, one immunised and 
one control, of Sprague-Dawley rats to test whether an immune response was 
invoked in this strain. This strain has been used in previous N. brasiliensis infection 
studies. 
Immunisation regime 
Part 1: A group of seven Wistar rats were immunised with 10 gg AChE with Quil A 
subcutaneously as before. Another group of seven Wistar rats was immunised by the 
IF route, with 10 itg of AChE with Aihydrogel (Sigma, A-8222) in 0.2 ml PBS. Prior 
to immunisation, AChE was absorbed to an equal volume of Alhydrogel for 2 h on 
ice. Absorption was measured at >60% by spectrophotometer. Doses were then 
diluted to the required volume in PBS. One further group of seven, control, Wistar 
rats was not immunised. Immunisations were given on day 0 followed by boosts at 
week 4 and 8 as before. 
Part 2: One group of seven Wistar and one group of seven Sprague-Dawley rats 
were immunised with 10 jig of SOD with 10 pg Quil A in a SC regime as described 
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previously. A group of seven control Sprague-Dawley rats was not immunised. 
Immunisation and boosts were performed to the time schedule outlined above. 
All groups were challenged 2 w after their final boost with 25 L3 larvae 
injected SC as before. The infection was allowed to progress for 11 d and the rats 
then culled for the collection of samples at necropsy. 
Experimental measurements 
Blood (sera) was collected by tail bleed one week prior to infection (week 9) 
for the measurement of pre-challenge specific antibody levels by ELISA. Post 
infection FEC were performed from day 5 as the primary measure of infection. At 
necropsy sera (blood) and mucosal scrapings were collected for measurement of 
immune markers and the small intestine retained for adult worm counts. 
2.8.3 Trial 3— Intra-nasal immunisation with AChE 
Experimental design 
Stimulation of the immune response at a mucosal site in the nasal passage is 
thought to elicit responses at other mucosal surfaces via the common mucosal 
immune system (Davis, 2001). Following the results of the previous experiments, 
this experiment was carried out to further test the specific targeting of immunisation 
to provoke immune responses at the gut mucosal surface. Responses at this site 
might provide a greater degree of protection from mucosally associated nematode 
parasites. Previous experimental groups immunised via the SC and IP routes were 
repeated to give replicate results. A further group was immunised via the intra-nasal 




Groups of seven Wistar rats were immunised SC or IP with AChE as 
described above as well as an infection challenge control group, which was not 
immunised. A further group of seven Wistar rats was immunised with 10 lAg of 
AChE via the nasal passage using 10 jtg of cholera toxin 13-subunit (CTB) as an 
adjuvant. AChE and CTh were administered in 50 itl of PBS to the external nares 
using a micropipette on days 0, 14 and 21 timed to coincide with the final boost of 
the other groups. All groups were challenged 2 w after their final boost with 25 L3 in 
0.2 ml saline as previously described. 
Experimental measurements 
Sera were collected by tail bleed 1 w prior to challenge to monitor pre-
challenge antibody levels by ELISA. FEC were measured from day 5 post infection 
as the primary measure of infection. Egg count data were analysed using a repeated 
measures model described in Section 2.8.4 below. At necropsy sera and mucosal 
scrapes were collected for analysis of immune markers and the small intestine 
retained for adult worm counts. 
2.8.4 Statistical analysis of vaccination trial egg count data 
Where indicated above any differences present in the cumulative egg counts 
between vaccinated and control groups were analysed by analysis of variance (one 
way ANOVA) to measure the statistical significance of the difference. 
Egg count data from the vaccinated and control animals in Trial 3 was 
analysed using a repeated measures model, an advanced statistical test. The counts 
were analysed on a log scale and the repeated measures model was fitted in Genstat 
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7th Edition, using an autoregressive model for the correlation between counts from 
the same animal on successive days. 
As one group of animals in Trial 3, vaccinated with AChE via the SC route, 
was the same as one of the experimental groups in Trial 1, the egg counts of control 
and AChE vaccinated animals from Trial 1 could also be included in the repeated 
measures model. It was valid to include these data as they represented a repeated 
experiment in this test. Inclusion of this data further increased the statistical power of 
the test. 
Chapter 3 - Establishment of the infection model 
3.1 Introduction 
Single challenge infection with several thousand L3 larvae has so far been the 
most studied experimental infection regime using N. brasiliensis in rats (reviewed; 
Rothwell, 1989). In this regime the FEC begins to rise at around 5 DPI and peaks 
around 7 DPI with a corresponding peak in adult worm numbers in the small 
intestine (Ogilvie and Jones, 1971). At this time, moderate pathology and 
inflammation is apparent in the mucosa. Following this, the FEC and number of adult 
worms counted in the small intestine decline with the infection being resolved 
between 10-14 DPI when egg counts and worm numbers approach zero. Some 
authors report a threshold population that survive expulsion and maintain a chronic 
low-level infection after the bulk of the infecting dose has been expelled (Ogilvie and 
Jones, 1971). 
In the present study, a single challenge with 2,000 L3 larvae was performed 
in order to confirm that the dynamics of infection were the same in the strain of rats 
used, namely Wistars. Parasitological and immunological markers of infection were 
measured during this acute single challenge infection. This experiment put future 
experimental challenges into the context of previous work carried out using this 
system (reviewed; Ogilvie and Jones, 1971; Miller, 1984). 
Such a severe, acute infection may not be the most appropriate challenge for 
testing a vaccine. If the infecting dose were too high, the challenge might overwhelm 
any protective effect conferred by vaccination. A high infection dose might also 
stimulate an immediate protective response in primed hosts that would not be 
observed at a lower, more natural, level of infection. 
Prior to vaccination trials therefore, experiments were also carried out to 
establish low level infection regimes, closer to infection levels that may be 
anticipated through natural exposure. These experiments involved infecting groups 
of rats with varying levels of challenge infection. FEC of these groups was 
monitored through the course of infection, as this was to be the main indicator used 
to monitor challenges to vaccinated groups. 
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Single dose challenge infections have to date been the most used regime for 
challenging vaccinated animals in ruminant trials (Knox, 2000; Knox and Smith, 
2001). However, grazing livestock are usually exposed to infection by the continuous 
(trickle) ingestion of infective larvae from pasture over a prolonged period of time 
(Waller and Thomas, 1981; Dobson et al., 1990). A trickle challenge regime with 
N. brasiliensis has previously been shown to yield a long lasting, chronic infection in 
rats. This infection is stable and refractory to the expulsion that has been observed in 
an acute challenge (Jenkins and Phillipson, 1972). This infection regime might be the 
most desirable challenge to vaccinated animals, being the closest to a natural 
acquisition of GI nematode infection. Trickle challenge infection was tested for 
potential use as a challenge infection regime for vaccinated animals in this study. 
3.2 Results 
3.2.1 Faecal egg count during acute single challenge with 2000 L3 
A group of 15 rats was infected with 2,000 L3 per animal in the manner 
described in Chapter 2.1. The infection was allowed to progress for 12 days and FEC 
were performed daily. Egg counts were performed on a pooled sample collected from 
each cage of 3 rats giving a mean from 5 counts for each timepoint. The outcome of 
this analysis is summarised in Figure 3.1. Eggs were detectable in faeces from day 5 
post infection peaking on day 7 at around 2,300 eggs per gram of faeces and then 
dropping rapidly such that eggs were undetectable in faeces by day 10. However, egg 
output was very variable at each time point as judged by the large standard error of 
the mean counts. 
3.2.2 Adult worm count during acute single challenge 
During the course of the infection, groups of 3 animals were culled for adult 
worm counts at regular time-points. The numbers of adult worms in the small 
intestine were counted by the method described in Chapter 2.1.3 and the results are 
shown in Figure 3.2. Worm numbers in the intestine increased from 3 DPI, peaking 
on day 7 and declining thereafter to trace numbers on day 11. At the peak of 
infection around 650 worms were present in the small intestine, around 32% of the 
infecting dose given. The variation in the worm counts was relatively small as shown 
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Figure 3.1. The mean faecal egg output over 10 days from a group of Wistar 
rats given a single challenge infection of 2,000 Nippostrongylus brasiliensis 
L3 larvae. The data represent the mean of egg counts performed on the 
pooled sample collected from each of 5 cages containing 3 rats, +I the 
standard error. Egg count began to rise at 5 days after infection, peaked at 7 
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Figure 3.2. The worm burden over 11 days of a group of Wistar rats given a 
single challenge infection of 2,000 Nippostrongylus bras/liens/s L3 larvae. 
Each point represents the mean of adult worm counts performed from three 
individual rats at each timepoint. 
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3.2.3 Serum immunological marker levels 
Levels of parasite specific antibody and mast cell protease (RMCP II) were 
measured by ELISA in the sera of infected rats, as described in Chapter 2.7. 
Antibody levels were expressed as a titre compared to control serum antibody level 
and the results are displayed in Figure 3.3, panels A to E. 
As shown in Figure 3.3, panel A, IgG titre began to rise around 9 DPI and 
increased until at least 23 DPI. The highest IgG titre, observed on day 23, was 3,000. 
The change in titre of IgG subtypes IgGl and 2a are shown in panels B and C. The 
IgGi titre showed an earlier peak than the IgG2a at 9 DPI, this correlating with the 
rejection of the infection. An increase in IgA and IgE was detectable earlier in 
infection, from day 7. IgA levels (Panel D) began to rise at day 7, peaking at around 
700 on day 11 and were still elevated at day 14. 1gB levels (Panel E) rose from 7 DPI 
and plateaued at around 900 on 11 DPI, this level being maintained until at least 23 
DPI. 
RMCP II levels (Panel F) were initially low, at around 300 ng/ml and showed 
a slight increase as early as the second day of infection. Between 7 and 11 DPI 
RMCP II levels increased, to around 2,500 ng/ml, before dropping again to baseline 
levels by 23 DPI. 
The level of antibody was also measured by ELISA from the serum of a 
group of rats that were re-infected with 2,000 N. brasiliensis on day 23 post primary 
challenge and from a group of repeatedly challenged hyper-immune rats (data not 
shown). During the secondary challenge the antibody level appeared to peak 24 
hours after challenge and the antibody titre was much higher than during primary 
challenge at around 7,000 for IgG, 6,000 for 1gB and 3,000 for IgA. In hyper-
immune animals the titres were also elevated, but not as highly as during the 
secondary challenge. There was also a comparatively lower proportion of IgA, and 
the IgG response appeared to be dominated by the IgGi component. Levels of 
RMCP II were elevated in both cases with a very high level in the serum of the 
hyper-immune rats. 
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Figure 3.3 The parasite specific, serum lgG, IgGi, and lgG2a response of 
Wistar rats over 23 days following infection with 2000 Nippostronglyus 
brasiiensis L3 larvae. The antibody titres were measured by ELISA from a 
pooled serum sample of 3 individual rats at each timepoint and using soluble 
parasite (Si) extract as the capture antigen. 
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Panel F- RMCP II levels during acute single infection 
3000 






1 	2 	3 	7 	9 	11 	14 	23 
Days post infection 
Figure 3.3 (continued) The parasite specific serum IgA and IgE response and 
the Mast Cell Protease (RMCP II) response of Wistar rats over 23 days 
following infection with 2000 Nippostrongylus brasiliensis L3 larvae. The 
antibody titres were measured by ELISA using soluble parasite (Si) extract 
as the capture antigen. The serum for these and the RMCP II ELISA were 
from a pooled sample of 3 individual rats at each timepoint. 
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3.2.4 Mucosal immunological marker levels 
Levels of mucosal immune markers during the acute single infection were 
measured from samples of small intestine mucosa as described in Chapter 2.7. 
N. brasiliensis specific antibodies were detectable, although not at high levels. Titres 
for IgG, IgGi, IgG2a, IgA and IgE isotypes were calculated and are displayed in 
Figure 3.4, Panel A-E. The change in antibody isotype profile conformed to the 
general pattern seen for the serum antibody levels, but antibody was present at 
comparatively lower titres. 
RMCP II levels, shown in Figure 3.4, Panel F, rose from baseline to peak 
levels around day 14 after infection, thereafter declining again to a lower level by 23 
DPI. RIvICP II levels in the mucosa were comparatively higher than those in serum, 
at 5,500 ng/mg soluble protein, on day 14, but again conformed to the general pattern 
seen. 
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Panel F - Mucosal RMCP II 
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Figure 3.4 The parasite specific lgG, IgGi, lgG2a, IgA and lgE response and 
the RMCP II response in the intestinal mucosa of Wistar rats given a single 
challenge infection of 2,000 Nippostrongylus brasiliensis L3 larvae. The 
antibody titres were measured by ELISA using soluble parasite (Si) extract 
as the capture antigen. Antibody titre and RMCP II level were measured from 
a mucosal homogenate sample collected at each timepoint. 
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3.2.5 The effect of different levels of challenge 
Single challenge infection 
FEC results from groups of 6 animals infected with 25 and 50 L3 larvae are 
displayed in Figure 3.5, panels A and B respectively. A similar profile of egg output 
was seen at both infection levels with the egg count peaking at over 300 on 7 DPI 
and then declining gradually to 0 by 13 - 15 DPI. Somewhat surprisingly, the peak 
level of egg output was similar for both infection regimes whilst the FEC from the 25 
L3 group was somewhat less variable than that of the 50 L3 group as demonstrated 
by the lower standard error. 
Trickle challenge infection 
Several trickle challenge regimes were tested to determine how appropriate 
such a regime might be to use as a challenge for vaccinated animals. FEC from 
animals infected with 25, 100 and 200 L3 each week peaked and fell to zero before 
18 DPI in a manner similar to that seen for single challenge infection (data not 
shown). Continued weekly challenge of these animals did not produce a measurable 
egg output. 
FEC results from a group of 6 animals infected with 5 L3 three times a week 
are shown in Figure 3.5, panel C. In this situation the egg count peaked and dipped 
several times before dropping to around zero at 14 DPI. During this phase the 
variability between counts (standard error) was relatively large. With continuing 
challenge, a stable, chronic egg output developed after around 21 DPI and persisted 
until at least day 35. The FEC during this phase was between 20-30 eggs / g faeces 
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Figure 3.5. The mean faecal egg output over 17 days of a group of 6 rats 
infected with a low level single challenge of 25 Nippostrongylus brasiliensis 
L3 (Panel A) and 50 Nippostrongylus brasiliensis L3 (Panel B). Panel C 
indicates the mean faecal egg output over 35 days of a group of 6 rats given 
a trickle challenge infection with 5 Nippostrongylus brasiliensis L3 larvae 
three times a week. 
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3.3 Discussion 
The results of the acute single challenge confirm the pattern of infection seen 
in previous studies (Ogilvie and Jones, 1971). The demonstrated parallel between 
FEC and worm count also confirms the use of FEC as an appropriate primary 
measure of infection. FEC can be taken from live animals and its use as the primary 
measure of infection thus allows smaller groups of animals to be used during 
vaccination trials compared to those required if worm counts were being used. In the 
latter, animals would have to be sacrificed at each time point. 
The increases in levels of parasite-specific antibody during acute single 
challenge infection confirmed the results from previous studies showing an increase 
in specific IgG, IgA, and IgE in the serum (Jarrett and Bazin, 1977). Large increases 
in IgE in particular are associated with N. brasiliensis infection (Jones and Ogilvie, 
1967; Ogilvie and Jones, 1971). Importantly, in this study, IgGi and IgG2a 
correlated closely with the time of expulsion of the parasite. IgGi and IgG2a are 
associated with Th-2 immune responses in rodents (Binder et al., 1995) and IgGi 
was demonstrated as the serum antibody isotype associated with the passive transfer 
of protection in this system (Jones et al., 1970). Levels of parasite-specific antibody 
rose more rapidly and to even higher levels within 24 h in animals re-infected with 
2,000 L3 on day 23 post primary infection and were similarly high in hyper-immune 
animals. The high IgG response of the hyper-immune rats had an increased 
component of IgGi. 
Similar increases in specific antibody levels were detectable in the intestinal 
mucosa, an important site for protection against intestinal parasite infection (Miller, 
1984). Levels of IgG were elevated from day 7 and peaked at day 14. This peak did 
not correspond with the peak in serum antibody titres indicating local production 
rather than leakage of antibody from the serum. Changes in IgA and IgG in the 
intestinal mucosa were similar to those reported previously (Poulain et al., 1976b; 
Sinski and Holmes, 1977; Wedrychowicz et al., 1983). These authors observed a 
peak of specific and total IgA in the intestine 12 DPI and IgG between 18 and 24 
DPI. IgE was also seen to peak at 14 DPI in this study. IgE is not considered a 
secretory antibody isotype and this IgE might represent leakage of antibody from the 
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serum, or immune cell associated IgE both of which would be expected to peak at 
this time-point (Mayrhofer, 1977). 
These data confirm that antibody may be involved in the resolution of 
primary and subsequent challenges with N. brasiliensis. Passive transfer experiments 
have previously implicated antibody in the rejection of Nippostrongylus infection, 
and this was associated with IgGi (Miller, 1984; Jones et al., 1970). A component of 
this IgG 1 response was directed against a functional parasite protein, AChE, and the 
isotype profile of this enzyme changed through the course of infection, perhaps in 
response to this immune pressure (Sanderson and Ogilvie, 1971; Jones and Ogilvie, 
1972). As this protein is thought to play a role in the persistence of the parasite such 
a specific antibody response may play a role in the expulsion of the worm (Jones and 
Ogilvie, 1972; Sanderson et al., 1972). Raising an antibody response against 
functional parasite enzymes might therefore be an appropriate objective of 
vaccination. 
RMCP II was measured from both the serum and mucosa during the acute 
single challenge infection. Higher levels were observed in the mucosa than in the 
serum. This is logical, as the mucosa is the source of circulating enzyme. Levels in 
both compartments showed the same pattern of elevation around the time of peak 
infection in the intestine and decline following expulsion and were similar to levels 
previously reported (Huntley et al., 1993). 
These results confirm that the infection behaved in a similar manner to that 
described in previous studies. This is true of both parasitological and immunological 
markers and allows any results from this study to be compared with those of previous 
work. 
Experiments were also performed to define the most appropriate level of 
infection with which to challenge animals during forthcoming vaccination trials. The 
infection cycle during low-level (25 and 50 L3) single challenge infections was 
slightly more prolonged than the acute (2,000 L3) single challenge and the FEC did 
not drop as sharply. This lower level of infection might be more appropriate than an 
acute infection for vaccination challenge. It was decided to use an infection dose of 
25 L3 during subsequent vaccination trials. Although similar levels of egg output 
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were seen during infections with 25 and 50 L3 the variation in egg counts, the 
standard error, was lowest for 25 L3. 
An initial attempt to establish a cumulative, chronic infection by trickle 
challenge with weekly doses of 25 L3 was unsuccessful. This regime was devised to 
simulate the effect of infecting five times a week with 5 L3 in the manner of Jenkins 
and Philipson (Jenkins and Phillipson, 1972) whilst avoiding excessive trauma to 
animals. In this situation the animals expelled the primary infecting dose and 
remained immune to further challenge in a manner similar to that described 
previously for single challenge and re-infection (Ogilvie and Jones, 1971). Two other 
groups in this experiment, 100 and 200 L3 / week, had been intended to investigate 
any upper threshold level for the establishment of a cumulative, chronic infection. In 
this model such a threshold appears to be less than a single challenge with 25 U. 
In a subsequent experiment animals were infected with 5 L3 three times a 
week. A stable, chronic egg output was eventually established with this regime. This 
infection however produced a low FEC and was not cumulative in the manner of the 
infection produced by Jenkins and Phillipson (1972). It seems likely that the level of 
infection needed to produce such an infection is extremely critical lying between 
multiple doses of 5 and 25 L3. At the lower end of this scale expulsion is not 
provoked, but the number of worms does not accumulate, while at the upper, 
expulsion of the infection is elicited and the host becomes immune to further 
infecting doses. 
Due to the failure of the tested infection regimes to produce the cumulative 
chronic infection demonstrated by Jenkins and Phillipson (1972), it was decided to 
use low-level single infection as a challenge dose in vaccination trials. The results of 
the experiment conducted by challenging with 3 x 5 L3 / week however indicate that 
it may be possible to reproduce such an infection and future work might provide a 
suitable regime for vaccination challenge in this model. 
In summary, the experiments described in this chapter confirm that the 
infection behaves in a manner similar to that previously reported. The changes in egg 
output and worm numbers correlated closely allowing the former to be used as the 
primary indicator of challenge infection. Changes in specific antibody isotype and 
RMCP II levels also conform to the pattern described previously and correlated with 
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worm expulsion, indicating that they may be of importance in the resolution of 
infection. Finally, experiments with differing levels of infection have allowed the 
most appropriate challenge for the proposed vaccination studies to be decided. 
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Chapter 4- Molecular cloning and expression of 
Nippostronqylus brasiliensis Cu I Zn superoxide 
dismutase 
4.1 Introduction 
As stated in the General Introduction (Chapter 1), Cu / Zn SOD is an enzyme 
involved in a pathway that facilitates the reduction of oxygen radicals (Henkle-
Duhrsen and Kampkotter, 2001). These radicals are produced during normal cellular 
oxidative metabolism and cells contain several enzymes, including SOD, catalase 
and peroxidases, which remove them before they can cause damage (Chapter 1, 
Figure 1.4). 
Protective immune responses to intestinal nematode infection are associated 
with eosinophil accumulation in the mucosa (Miller, 1984). These cells are capable 
of an extended respiratory burst resulting in the sustained release of large quantities 
of superoxide anion and other toxic products (Babior et at., 1973). In 
Nippostrongylus brasiliensis infection, maximum eosinophil accumulation occurs at 
the time of, with degranulation occurring prior to, worm expulsion (Kelly and 
Ogilvie, 1972). In vitro studies have shown that eosinophils can accumulate around 
infective L3 larvae (Rainbird et at., 1998; Shin et at., 2001) and have also indicated 
that this cell type could kill the trapped larvae in the gut mucosa (Meeusen and Balic, 
2000). 
SOD is released by many parasitic nematode species (Knox and Jones, 1992) 
and can protect worms from host-mediated free radical release (Rhoads, 1983; Smith 
and Bryant, 1986; Kazura and Meshnick, 1984; Henkle-Duhrsen and Kampkotter, 
2001). As such, it is a rational target for vaccination as an effective immune response 
against the enzyme might remove an important mechanism by which the worms 
protect themselves from damage and expulsion. A previous study on H. contortus 
suggested that Cu / Zn SOD may be effective as a vaccine candidate, giving a 20% 
reduction in worm burden (Liddell and Knox, 1998). One aim of this project was to 
further investigate the potential of this enzyme as a vaccine. 
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To accomplish this it was first necessary to clone and express N. brasiliensis 
Cu I Zn SOD in vitro for use as an antigen in vaccination studies. This was 
accomplished by a Rapid Amplification of cDNA Ends (RACE) PCR method that 
has previously been used to isolate H. contortus SOD (Liddell and Knox, 1998). This 
method selectively amplifies specific sequence using primers directed to highly-
conserved or known regions of the gene sequence. The sequence ends were amplified 
from primers directed towards 5' or 3' conserved sequences, or oligonucleotide 
sequences incorporated into the 5' and 3' ends of the cDNA during synthesis. 
Following amplification and confirmation that the reaction product did 
encode the target SOD by sequencing, gene primers were designed to allow cloning 
of the gene sequence in frame into a bacterial expression vector. Expression of the 
recombinant enzyme was induced and the enzyme subsequently purified from a 
bacterial culture. The purified enzyme was then examined for purity, solubility and 
activity, factors that may affect the efficacy as a vaccine. 
SOD enzyme activity has previously been reported from somatic extracts of 
N. brasiliensis (Knox and Jones, 1992). In this study, expression of the native 
enzyme was examined in both the adult and L3 stages of the worm. The presence of 
the native enzyme in somatic extracts was demonstrated by Western blot. The 
expression of the N. brasiliensis Cu I Zn SOD encoding mRNAs was also examined 
by a semi-quantitative RT PCR to determine any gross differences in expression 
levels between adult and L3 stages. 
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4.2 Results 
4.2.1 Isolation of Nippostrongylus brasiliensis Cu I Zn superoxide 
dismutase - encoding cDNA 
Messenger RNA extraction from Nippostrong v/us brasiliensis adults 
mRNA was extracted from adult N. brasiliensis as described in Chapter 2.2.1. 
The amount of recovered RNA was 130 jig as determined from the ratio of 0D260: 
OD 280  nm. A 10 jil sample of this RNA was separated in 0.8% agarose, visualised 
with EtBr staining and photographed under UV for analysis (Figure 4. 1, panel A). A 
smear of RNA was clearly visible extending over a broad size range, confirming the 
integrity of the mRNA. 
cDNA synthesis from Nippostrong v/us brasiliensis adult RNA 
Around 0.5 jig of total RNA was used to produce SMART cDNA as 
described in Chapter 2.6.1. Following first strand synthesis and amplification by 
Long Distance PCR, 10 Al of cDNA were visualised using 0.8 % agarose gel 
electrophoresis and EtBr staining (Figure 4.1, panel B). The cDNA shows a bright 
smear between 0.1 and 4 kb indicating a high yield of cDNA across the molecular 
weight range. 
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Figure 4.1. Panel A) mRNA extracted from adult Nippostrongylus brasiliensis. 
The smear extending through a broad size range and lack of low molecular 
weight degradation products indicates the integrity of the RNA. Panel B) is 
the corresponding cDNA, reverse-transcribed using a SMART cDNA kit (+ve 
= cDNA synthesis positive control, a prominent band of the expected size is 
visible at 1.6 kb; M= molecular weight marker). 
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4.2.2 SOD PCR products 
SOD gene-specific sequences were amplified from the N. brasiliensis adult 
cDNA as described in Chapter 2.6.2. Primers were designed to a region of the gene 
with high homology between nematode species and against the integrated 
oligonucleotides of the SMART cDNA 5' and 3' ends. The primer sequences are 
shown in Chapter 2.6.2 and the expected product sizes are indicated in Table 4.1. 
The products from PCR amplification after gel electrophoresis in 0.8% agarose gels 
are shown in Figure 4.2. 
Lane Primers Product Expected size (be) 
1 P 2 - P 4 Internal 247 
2 P 2 - P 3 Internal 134 
3 SMART Ill — P 4 5' 500 
4 P2—CDS Ill 3' 500 
5 P1—P4 5' coding sequence 418 
6 P2—P5 31  coding sequence 314 
7 P 1 - P 5 Full coding sequence 485 
Table 4.1. PCR products generated in the amplification of SOD gene 
sequences from Nippostrongylus brasiliensis cDNA. The primer combinations 






Figure 4.2. PCR products amplified during the isolation of the SOD gene 
sequence. The lane numbering indicates the product generated using the 
primer pairs described in Table 4.1 above. PCR amplification generated 
products of the expected sizes although other less prominent bands were 
evident in some reactions. Negative controls with no added cDNA gave no 
products (not shown). M = Molecular weight marker. 
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4.2.3 SOD gene nucleotide sequence 
Sequencing of amplified SOD products was performed as described in 
Chapter 2.2.9. Multiple reads of products cloned in pGEM-T, covering the span of 
the gene sequence, were performed to eliminate sequencing errors. These sequence 
reads were aligned and a full-length contiguous sequence determined. Alignment 
produced a 650 nucleotide, contiguous sequence, shown in Figure 4.3. The sequence 
contained a putative open reading frame (ORF), a polyadenylation signal and a 
polyadenylated tail. A previously determined N. brasiliensis SOD sequence (Young, 













Figure 4.3. The contiguous SOD gene sequence derived from alignment of a 
number of PCR amplified Nippostrongylus brasiliensis SOD sequences. Key: 
underlined bases - putative ORF; E - Start codon; N - Stop codon; R - 
poly-adenylation signal; E - cDNA 3' poly-adenylated tail. 
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4.2.4 Predicted SOD protein sequence 
The ORF encoded a 159 amino acid (aa) protein with a predicted sequence 
shown in Figure 4.4. Analysis of this protein (using Prosite; 
http://ca.expasy.org/prosite/) revealed two regions characterised as Cu / Zn SOD 
signatures. The first of these contains the copper atom, binding site and the second a 
conserved cysteine involved in disulfide bonding. 
Homology analysis, using BLAST search and ClustalW alignment (available 
http://www.ebi.ac.uk/), revealed a high level of homology between this protein and 
other nematode SODs as demonstrated in Figure 4.5. Homology is particularly great 
between this N. brasiliensis sequence and the sequence of the cytoplasmic nematode 
SOD (SODc), with -95% similarity to the H. contortus SODc sequence. As can be 
seen in an alignment with other nematode sequences (Figure 4.5), the protein also 
lacks an N-terminal signal leader sequence, carried by the extra-cellular homologues 
(SODe) in other nematodes. It did not contain any predicted glycosylation sites. 
The single 5' elongated SOD sequence, previously determined (Young, 
1996), had a putative, extended ORF of around 20 aa (data not shown) which may 
have corresponded to the N-terminal leader indicating that this ORF encoded an 
extracellular form of the enzyme. However, analysis did not identify this region as a 
signal peptide. 
MSNRAVAVLRGDAGVTGTVWFSQDKESDPCVIKGEIKGLS - 40 
PGIJH 	 rGCISAGPHFNPFNKTHGGPKDEVR - 80 




Figure 4.4. The predicted Nippostrongylus brasiliensis SOD protein sequence 
translated from the Nippostrongylus brasiliensis SOD gene sequence. 
Key: E - Cu / Zn superoxide dismutase signature 1; • - Cu / Zn 
superoxide dismutase signature 2; underlined residues - amino acids 
conserved with Haemonchus contortus sequence and involved in Cu / Zn ion 
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20 	 40 
Celegans E 	: 	 -MKTRVVLILALS 	-VCIEAASEVIRARAY: 27 
Hcontortus E : ----------------MTMLQQILLISVIIGTVHVHEVDCPNEVLKARAY: 34 
Smansoni C 	: --------------------------------------------MKAVC: 5 
Hcontortus C : -------------------------------------------MSNRAVA: 7 
Nbrasiliensis: -------------------------------------------MSNRAVA: 7 
Celegans C 	: -------------------------------------------MSNPAVA: 7 
Bmalayi E : MNIASFAIFLSHIIFITYATSNQRYFKPNMHNNNTITIRRTITKTATAIA: 50 
Bmalayi C 	: -------------------------------------------MSANRIA: 7 
Smansoni K : ----------------MTVYSYLVILFILLDNYCSAYGYGYSYYHRRHFIJ: 34 
60 	 80 	 100 
Celegans E 	: 	 S S 	-K 	I K: 74 
Hcontortus K : FEAVKGGNPAKT I DLVTGT--L N S S Q - I K: 81 
Smansoni C : NTGTAG----- 	KFTETDNGPI 
	
AEFS I -h 	I 49 
Hcontortus C : LRGDPG-- TWFSDKESDP 	K K T - I : 51 
Nbrasiliensis: LRGIJAG-------TTWFSDKESDP E K S - 	 51 
Celegans C 	:LRGET------- T ITKSENDQ 	E T - 50 
Bmalayi E : LHSDNGN 	T HFQDK--NS K K T - 	93 
Binalayi C 	: LRGDN------4S I RFKEKEGSP 	E T - 50 
Smansoni E PAIASKEP----YI 	QHGDY----S P K I, T 10 : 76 
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Celegans K 	: T GKTFTSSQLPY : 	184 
Hcontortus E : GIL--------: 185 
Smansoni C 	: LAE------: 153 
Hcontortus C : TAPQ-----: 159 
Nbrasiliensis: lA oPQ-----: 
IIS- 
159 
Celegans C 	: LA PQ-----: 158 
Bmalayi E : -------: 199 
Bmalayi C VS1AS-----: 158 
Smansoni E 	: TGFR2P ------ : 	180 
Figure 4.5. The predicted Nippostrongylus bras iliensis SOD protein 
sequence aligned against other known nematode SOD protein sequences 
from: Caenorhabditis elegans; Brugia pahangi; Schistosoma mansoni and 
Haemonchus contortus. The level of amino acid homology is indicated by 
shading: - 100%; 1-80%; -60 %. Suffix C and E refer to cytoplasmic 
and extra-cellular homologues of the enzyme respectively. 
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4.2.5 Phylogenetic analysis 
SOD sequences from nematode and other species were used to construct a 
phylogenetic tree including the putative N. brasiliensis sequence. This was carried 
out using the Phylip program (available online at www.genebee.msu.su). As shown 
in Figure 4.6, the N. brasiliensis SOD groups with other nematodes SODc, and is 
distinct from SOD of other species and nematode SODe. 
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Figure 4.6. A phylogenetic tree constructed from SOD sequences from a 
range of species. Branch length indicates the divergence between 
sequences. The tree illustrates the grouping of the Nippostrongylus 
brasiliensis SOD with the SODc of other nematodes and distinctly from the 
nematodes SODe and the SOD of other phyla. 
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4.2.6 In vitro expression of Nippostrongylus brasiiensis SOD 
Following sequence analysis the SOD coding sequence was cloned in 
pET22b+ expression vector as described in Chapter 2.6.3. Constructs were 
sequenced with vector primers to confirm that inserts had been cloned in frame (data 
not shown). Protein expression was induced in suitable bacterial cultures and cell 
fractions were prepared for analysis of expressed proteins. A protein of 
approximately 21 kDa was abundant in cell fractions from samples of cells 
containing the SOD insert and absent from vector alone controls as shown in Figure 
4.7, panel A, lanes 1 and 2. This size coincided with the predicted size of the 
N. brasiliensis SOD protein based on sequence analysis. Importantly, all of the 
soluble protein fractions (the culture supernatant consisting of the medium with 
secreted proteins, periplasmic and soluble cell fractions) as well as the insoluble 
fraction contained this protein. The recombinant protein was also recognised on a 
Western blot of bacterial cell fractions by serum raised against H. contortus SODc 
and was not present in the vector alone control (Figure 4.7, Panel B, Lanes 1, 2 & 3 
respectively). Gels developed for SOD activity also showed zones of activity 
consistent with this protein band in samples containing SOD insert and was absent 
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Figure 4.7. Panel A, Coomassie blue stained PAGE gel analysis of: 1) 
Soluble bacterial cell fraction and 2) insoluble bacterial cell fraction, from 
cells transformed with the SOD insert, 3) Soluble bacterial cell fraction from 
cells transformed with pET22b+ only (control). Panel B is an immunoblot of a 
similar gel to Panel A probed with rabbit anti-Haemonchus contortus SOD 
antiserum. The brown banding indicates the recognition of recombinant SOD 
from the cell fractions by the serum. 
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4.2.7 Purification of SOD by ion exchange chromatography 
Following detection of the recombinant SOD protein in the soluble fractions 
of the bacterial culture a purification procedure was devised for the SOD protein to 
remove the bulk of the bacterial proteins. Recombinant SOD was purified from 100 
ml of media fraction by low pressure ion exchange column chromatography, as 
described in Chapter 2.6.7. The purification was carried out using a Mono Q 
Sephadex column equilibrated with 10 mM Tris / HC1 pH 7.5. Proteins were eluted 
with a 0 - 30 mM NaC1 gradient and the recombinant SOD eluted in a relatively 
purified and enriched fraction at a concentration of between 5 - 10 mM NaCl as 
shown in Figure 4.8. Following purification the SOD containing fraction was de-







Column TM Start 	Un- 1 5-10 110-151 15-20 120-251 25-30 Un- 	M 
fraction 	material bound mM mM mM mM mM eluted 
Figure 4.8. Coomassie stained PAGE gel, showing fractions eluted from 
Mono 0 Sephadex column at varying NaCl concentrations during the 
purification of recombinant SOD. The recombinant SOD is evident as a 
prominent band at 20kDa in the 5-10 mM NaCI fraction. M = Protein size 
markers. 
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4.2.8 SOD activity 
The activity of the recombinant enzyme was determined by xanthine SOD 
assay in the manner of Jones and Suttle (1981) as described in Chapter 2.4.1. The 
purified recombinant enzyme was active and at a concentration of 200 Wml had an 
activity of 7.6 U/mi. This was approximately three times greater than the media 
fraction from which the recombinant enzyme had been purified and ten times that of 
the equivalent cell fraction of the vector control. 
SOD activity was also visualised on non-reducing PAGE gels by specific 
staining in the manner of Beauchamp and Fridovich (1971) as described in Chapter 
2.4.3. As can be seen in Figure 4.9, a zone of activity was visible at around 20 kDa, 
slightly larger than the size predicted for the recombinant enzyme. This zone of 
activity was inhibited by the addition of 2 mM EDTA, a chelating, metallo-enzyme 
inhibitor. A zone of activity was present higher up the gel and was only partially 
inhibited by the addition of EDTA. This may be a Manganese (Mn) - SOD or another 














SOD +2 mM 
EDTA 
Figure 4.9. A PAGE gel of the Nippostrongylus brasiliensis recombinant SOD 
protein stained for SOD activity. Enzymically active SOD protein is visible as 
white/clear patches against the mauve background. SOD activity at 20 kDa 
was inhibited by the addition of 2 mM EDTA a chelating metalo-enzyme 
inhibitor. 
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4.2.9 Recognition of recombinant SOD by hyper-immune serum 
Recognition of recombinant SOD by serum IgG from hyper-immune rats was 
tested by Western blot, as described in Chapter 2.3.5. Recombinant SOD and a 
control of N. brasiliensis 51 extract, separated by PAGE, were transferred to PVDF 
membrane, which was subsequently probed with serum from one rat repeatedly 
infected with N. brasiliensis U. The blot was then developed for IgG. 
An example blot is displayed in Figure 4.10. The IgG from hyper-immune 
serum recognised the recombinant SOD, present at approximately 21 kDa, and 
weakly recognised several other proteins in the SOD fraction (lane 2). There was no 
staining to indicate that the serum recognised an equivalent sized SOD protein in the 
Si fraction, although several higher molecular weight bands were recognised (lane 
3). These high molecular weight bands corresponded in size to AChE, which are 
known to be immunogenic in this infection (Jones and Ogilvie, 1972). However, the 
immune serum did not recognise recombinant AChE on the same gel (lane 1). In a 
repeat of this experiment, using sera from a different hyper-immune rat, there was no 















Figure 4.10. Recombinant AChE (lane 1), recombinant SOD (lane 2) and 
Nippostrongylus brasiliensis Si fraction (lane 3) blotted on PVDF and probed 
with serum from a hyper-immune rat. The brown banding indictes recognition 
of the recombinant SOD and high molecular weight proteins in the Si fraction 
by lgG in the immune serum. (M= molecular weight markers). 
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4.2.10 Native SOD enzyme expression 
Western blot 
Expression of the native enzyme by adult and L3 stages was studied by 
Western blot. Somatic protein preparations from adult and L3 stages were separated 
by PAGE and blotted as described previously (Chapter 2.3.5). The Western blots 
were then probed with serum raised against the H. contortus SODc enzyme and 
previously shown to recognise N. brasiliensis SOD (data not shown). These were 
then developed with ECL+Plus as described in Chapter 2.3.5. As demonstrated in 
Figure 4.11, panel B, the anti-H. contortus SODc serum recognised two protein 
bands on blots of adult N. brasiliensis somatic proteins. These are visible as a 
doublet with the lower band present in a greater amount than the upper and may 
represent cytosolic and extra-cellular forms. Two bands were recognised also in the 
L3 extract. Again these may be cytosolic and extra-cellular forms with the lower, 
stronger band separating at a similar size to the adult lower band. The upper band 
appears to separate at a slightly different size to that of the adult indicating that this 
may be a third different isoform (Figure 4.11). In the corresponding Coomassie 
stained PAGE gel (panel A), the dark band between 21 and 14 kDa (lane 2, adult 
extract) is probably globin, previously described as the most abundant protein in 










Figure. 4.11. Panel A) a Coomassie stained PAGE gel and B) the 
corresponding Western blot of; 1) L3 and 2) adult Nippostrongylus 
brasiliensis somatic extracts developed with anti-Haemonchus contortus 
SODc serum and ECL+ Plus. The dark bands on the blot indicate the 
presence of SOD isoforms in the somatic extracts. 
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Detection of SOD mRNA by reverse transcription polymerase chain reaction 
Expression of N. brasiliensis SODc coding mRNA was also studied in adult 
and L3 stages by ReverseTranscription (RT) PCR. First strand cDNAs were prepared 
from total RNA extracted from adult and L3 as described in Chapter 2.2.1. 
SOD-specific olignucleotide primers were then used to amplify specific sequences 
from an equal amount (100 ng) of each cDNA. Products were then visualised, or 
detected, by separation on agarose / EtBr gels. As can be seen in Figure 4.12, specific 
SODc products were amplified from both adult and L3 stages as well as the positive 
control (SMART cDNA from adult worms), but not from the negative control, a PCR 
reaction that contained no template DNA. This suggests that, as shown in the 
previous experiment, this SOD was transcribed in both adult and L3 stages. Accurate 
quantification was not possible due to the lack of a constitutively expressed control. 
However, the relative brightness of the product from the L3 was greater than that 
from the adult, for the same amount of template. This might suggest that the level of 
expression was elevated in the U. A truly quantitative RT PCR would be required to 






M +ve Adult L3 -ye M 
Figure 4.12. An agarose / EtBr gel showing SOD specific PCR products 
amplified from adult and L3 cDNA. The same amount of template was added 
to each reaction, therefore the similar brightness of the products indicates the 
amplification of similar amounts of SOD from the cDNA from both L3 and 




SOD specific sequences were amplified by RACE PCR from adult 
N. brasiliensis cDNA, using primers directed towards the conserved active site 
region (Figure 4.2). These sequences were confirmed as encoding a SOD by 
performing homology searches of DNA and protein databases, an analysis which 
revealed a high level of homology between the putative N. brasiliensis SOD 
sequence and SOD sequences of other nematodes (Figures 4.4 and 4.5). The ORF 
encoded a 159 aa protein shown in Figure 4.4. Sequence analysis of this protein 
revealed 2 regions characterised as Cu / Zn superoxide dismutase signatures and 9 aa 
conserved with the H. contortus sequence and involved with metal ion binding and 
catalysis (Liddell and Knox, 1998). The protein was thus confirmed as a 
N. brasiliensis Cu/Zn SOD, a prediction confirmed by the activity detected when the 
protein was expressed in bacteria. 
BLAST searching and Clustal-W alignment also showed a high level of 
homology between this protein and other nematode SODs (Figure 4.5). The high 
homology of the DNA and amino acid sequences to cytoplasmic isoforms (-95% 
similarity to the H. contortus SODc cDNA sequence) strongly suggested that this 
N. brasiliensis sequence encodes a cytoplasmic form of the enzyme. This was 
supported by further analysis of the amino acid sequence, which showed that it did 
not contain an N-terminal leader sequence usually indicative of protein secretion. 
These leader sequences, of around 20 aa, are common to extra-cellular SOD of other 
nematodes and enable the extra-cellular transport of the enzymes (Liddell and Knox, 
1998; Henkle-Duhrsen et al., 1997). A phylogenetic analysis (Figure 4.6) also 
grouped the N. brasiliensis enzyme with other nematodes SODc and distinct from 
extra-cellular SODs. 
One partial single sequence from previously determined SOD sequences had 
a putative extended ORF at the 5' end encoding 20 additional aa, the entire sequence 
of which could correspond to the extracellular form of the enzyme (Young, 1996). 
That an extracellular form may be present was indicated by Western blot analysis of 
L3 and adult parasite extracts (Figure 4.11). Release of SOD by N. brasiliensis 
during in vitro culture has also been described (Batra et al., 1993). 
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In addition, analysis of this partial sequence showed some amino acid 
changes from the derived consensus indicating that it may be a separate gene 
product. The elongated N-terminal sequence was not, however, recognised as a 
signal leader peptide and protein modelling (not shown) suggested that the tertiary 
structure of the two putative proteins would not differ significantly due to the 
sequence differences. It was therefore decided that although this extended sequence 
might be the extra-cellular form of the N. brasiliensis enzyme, the cloned, full length 
SODc would be used for the vaccination trials. 
The sequenced enzyme was expressed as a recombinant protein by cloning in 
pET22b+ expression vector (Figure 4.7), in a manner previously used to express 
SOD from H. contortus (Liddell and Knox, 1998). Soluble, recombinant SOD was 
identified by Western blot and purified from the bacterial culture media by ion 
exchange chromatography. A purified / enriched fraction eluted from the Mono Q 
Sephadex column at around 7 mM NaCl. The recombinant protein was detected in 
this fraction by PAGE gel at 21 kDa with Coomassie staining and confirmed as SOD 
by Western blot (Figure 4.8). 
The enzyme activity of the purified recombinant SOD fraction was measured 
by a xanthine/xanthine oxidase superoxide generator assay and the activity was 7.6 
U/mI, approximately three times that of the source fraction and ten times that of the 
control (pET22b+ alone). Enzyme activity in this assay is determined by measuring 
the inhibition of colour formation which results from the reaction of superoxide, 
generated by xanthine/xanthine oxidase, with a tetrazolium dye (Jones and Suttle, 
1981). Activity was also demonstrated at around 21 kDa on PAGE gels stained for 
activity of the enzyme. The activity was inhibited by EDTA indicating that it is 
dependent on metal ions in the manner of other Cu / Zn SOD (Liddell and Knox, 
1998; Henkle-Duhrsen et al., 1994). 
The recombinant enzyme was recognised by sera from a hyper-immune rat 
(Figure 4.10). This suggests that the native protein is immunogenic and also suggests 
that an antibody response to this protein may be involved in protection, as this animal 
was, following several infections, solidly immune. The recognition of SOD may 
however be incidental, given the range of proteins these animals are exposed to 
during infection. As the recombinant was not recognised by sera from a different 
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hyper-immune rat, it may not be important in the protective immune response. This 
finding also suggests that differences in the immune response occur between 
individual infected rats. 
Expression of the native SOD enzyme was investigated in adult and L3 stages 
of N. brasiliensis. Western blots prepared from adult and L3 somatic extracts were 
probed with serum raised against H. contortus SODc (Liddell and Knox, 1998) and 
previously shown to recognise the N. brasiliensis enzyme (Figure 4.11). These blots 
showed two isoforms were present in both adult and L3 stages, confirming a 
previous study, which indicated the presence of several SOD isofonns in different 
life stages (Knox and Jones, 1992). The lower protein band was the same size in both 
stages and is present in a greater amount in both as judged by the depth of staining. 
The size of the upper band from each stage appeared to differ in size, with the L3 
form being slightly larger than the adult. By analogy to other SODs, the upper band 
in Us and adults is likely to be an extracellular form of the enzyme as these contain 
additional N-terminal leader sequence (Liddell and Knox, 1998; Henkle-Duhrsen et 
al., 1997). However, cDNA sequence analyses failed to conclusively identify a 
sequence encoding this form of the enzyme. The difference in size of this band in L3 
and adults may indicate the presence of distinct isoforms of the enzyme with 
differential expression between life stages, similar to those demonstrated in an earlier 
study (Knox and Jones, 1992). This suggestion would require further analysis, one 
approach being the determination of the N-terminal sequences of the two protein 
bands. 
The expression of mRNA coding for the SODc was also investigated by RT 
PCR. Specific N. brasiliensis SODc products were amplified from both adult and L3 
stages, supporting the previous finding from protein analysis that this form is 
expressed in both stages (Figure 4.12). The PCR was not quantitative due to the lack 
of a constitutively expressed control for normalisation of PCR products on agarose 
gels. However, the band produced from the L3 cDNA appeared brighter on an 
agarose gel than that from the adult cDNA for the same amount of template material. 
This suggests that there was an increased copy number of SOD cDNA in the L3 and 
therefore an increased level of expression of the enzyme in the L3. Increased levels 
136 
of SOD activity were previously demonstrated from L3 larval stages of several 
species of nematode parasite (Knox and Jones, 1992). 
As the mRNA detected in this study is considered to code the cytoplasmic 
form of the protein and the L3 is more active and therefore presumably more 
metabolically active, the findings could be interpreted as increased SOD expression 
in the L3 to counteract metabolic stress. A fully quantitative PCR with a 
constitutively expressed control against which to normalise the amount of PCR 
product would be required to test this result. 
In conclusion, this chapter has described the successful isolation and 
expression of a cDNA encoding a putative cytosolic SOD from adult N. brasiliensis 
that is also present in L3 larvae. The SOD was expressed as an enzymically active 
recombinant protein in bacteria and the following chapters describe its evaluation as 
a vaccine candidate against N. brasiliensis in the rat. 
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Chapter 5- The development of assays to monitor 
the immune responses of the rat 
5.1 Introduction 
Previous studies have characterised the immune responses of the host rat 
during infection with the parasitic nematode N. brasiliensis as described in Chapters 
1 and 3 (reviewed; Rothwell, 1989). The response in general can be characterised as 
a Th-2 immune response based on the pattern of cytokine and cellular responses 
seen. Th-2 hypersensitivity responses are a common feature of helminth infections 
and are characterised by antigen-specific IgG, 1gB and IgA with eosinophils and mast 
cells infiltrating the site of infection (Rothwell, 1989). Cytokines, especially LL-4 
and —5, are often implicated in the development of protective immune responses 
(Urban et al., 1992; Finkelman et al., 1997). 
Cellular responses during GI nematode infection include the accumulation 
and activation of mast cells, basophils, eosinophils, goblet cells and lymphocytes 
(Miller, 1984). While some or all of these cell types might have a function in the 
expulsion of the infection, accumulation of others may be incidental. Any of the cell 
types commonly accumulating during a challenge infection may, however, be used as 
a marker of infection indicating the stimulation by the parasite of a cellular response 
in the intestinal tissue. 
Prior to the vaccination trials described later (Chapter 6, 7 and 8), assays for 
the measurement of immune markers of infection were devised and optimised. These 
tests were to allow the level of antibody, cellular and cytokine response in vaccinated 
animals to be compared to controls and to provide data for comparison of immune 
responsiveness between trials. 
Changes in antibody levels during infection are well documented with 
increases in IgG, IgA and 1gB being associated with expulsion in this system (Jarrett 
and Haig, 1976; Jarrett and Bazin, 1977). These associations are discussed in Chapter 
1 and 3 and it is clear that the stimulation of antibody responses might be an 
objective of vaccination. An appropriate method for the measurement of host 
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antibody responses in sera and tissue is enzyme linked immunosorbent assay 
(ELISA; Wedrychowicz et al., 1983). Secondary antibodies for a panel of rat 
antibody isotypes were obtained and ELISAs developed and optimised for the 
measurement of parasite, or immunising antigen-specific antibody levels during this 
study. 
As noted above, mast cells accumulate in large numbers in the intestinal 
mucosa of the rodent host during infection with N. brasiliensis (Miller, 1984). When 
activated, they release their granule contents including a protease (RMCP II; Miller 
et al., 1983b). Mast cell protease levels rise both systemically and in mucosal tissue 
during both rodent and sheep nematode infections, this rise correlating with worm 
expulsion (Miller et al., 1983b; Huntley et al., 1993; Douch et al., 1996). RMCP IT 
measurement is therefore a useful marker of mast cell activation during nematode 
infection. Mast cell proteases have been ascribed a variety of functions, one of which 
is to act on epithelial cell tight junctions to increase the epithelial permeability to 
enable the passage of macromolecules such as immunoglobulin into the intestinal 
lumen (McDermott et al., 2003). 
RMCP II levels can be measured in serum and tissues by ELISA and a 
commercially produced kit is available for this purpose. This kit was tested for the 
measurement of RMCP II levels in the sera and small intestine tissue of infected 
animals. 
The expression of cytokine mRNA in rats during infection with 
N. brasiliensis has been studied previously by RT PCR (Matsuda et al., 1995; 1999). 
These experiments confirmed the increased expression of Th-2 cytokines during 
infection, in particular expression of IL -3, -4 and -5 increases correlating with 
expulsion, while Th-1 cytokine expression is depressed. The utility of RT PCR to 
investigate cytokine expression levels during vaccination trials was assessed in a 
series of experiments. 
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5.2 Results 
5.2.1 Optimisation of serum antibody ELISA 
The serum antibody ELISA was optimised using hyper-immune and control 
rat sera, as these were likely to show large differences in specific antibody level. 
Initially, several dilutions of coating antigen and a dilution series of primary serum 
from 1 in 20 to 1 in 20480 were tested. These dilutions of primary serum have 
previously been used in measurement of sheep antibody levels by a similar ELISA 
method. Secondary antibodies specific for; total IgG, IgG 1, IgG2a, IgA and IgE, 
were then tested at a range of dilutions (based on the manufacturers 
recommendation) to determine the most appropriate dilution. 
Coating antigen concentration was not found to effect the signal level in the 
ELISA, at all the dilutions tested (data not shown). Accordingly, it was subsequently 
used at the highest dilution tested, 1 JLg/ml. The dilution series of primary serum 
chosen also gave an appropriate reduction in signal level through the dilution range 
required to allow accurate quantification of antibody level (data not shown). 
The OD from a series of ELISAs with hyper-immune and control sera, using 
a dilution series of secondary antibody are shown in Figure 5. 1, panel A - E. As 
shown in all of the graphs, large differences in antibody level existed between sera 
from the negative control and hyper-immune rats. This is shown by the higher OD of 
the immune samples at equivalent dilutions to control samples. 
The results indicated that the secondary antibodies were effective through all 
of the dilution range used for each, as shown by the tight matching of the curves 
from either control or immune sera. One exception was the IgG secondary antibody, 
which showed some decrease in the signal seen with an increase in dilution (Panel 
A). 
Antibody titre during this study was determined by comparison of the 
antibody level of a test sample, against the level in the negative control sample. This 
was the dilution of the test sample that had the equivalent antibody level of a 1 in 20 
dilution of the negative control. In the results summarised in Figure 5. 1, this is 
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equivalent to the point on the graphs where the immune OD crosses the control 1 in 
20 dilution OD level. 
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Figure 5.1 Panel A-C. The effect of secondary antibody dilution on ELISA 
(IgG, IgGi and lgG2a) optical density. The curves represent the OD of ELISA 
performed using dilution series of pooled immune or control sera and 
differing dilutions of secondary antibody. The dilution of secondary antibody 
did not appear to affect the performance of the ELISA in the range tested for 
IgGi and lgG2a detection antibodies. For total IgG the OD reduced with 
secondary antibody dilution and this antibody was accordingly subsequently 
used at the highest dilution tested. 
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Figure 5.1 Panel D and E. The effect of secondary antibody dilution on ELISA 
(IgA and IgE) optical density. The curves represent the OD of ELISA 
performed using dilution series of pooled immune or control sera and 
differing dilutions of secondary antibody. The dilution of secondary antibody 
did not appear to affect the performance of the ELISA in the range tested for 
IgA and IgE detection antibodies. 
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5.2.2 Optimisation of mucosal antibody ELISA 
The ELISA for the detection of antibody in mucosal homogenates was 
initially tested under the same range of primary antibody dilutions as the sera, using 
the optimised secondary antibody levels. Mucosal homogenates were prepared from 
animals at 7, 14 and 23 DPI with 2,000 L3 and control animals, as described in 
Chapter 2.7. 
The ELISA results for the mucosal homogenates are shown in Figure 5.2. 
Differences in mucosal antibody level between infected and control animals were 
detected by this ELISA method for IgG, IgG1, IgG2a and IgE. Slight differences 
were also apparent in the IgA results although these were somewhat masked by the 
high background OD at higher dilutions. These data indicated that levels of antibody 
were much lower in the mucosa than in sera and that a lower range of primary 
antibody dilutions would be more suitable. A doubling dilution series of the mucosal 
homogenates in a range from neat (10 mg/ml) to 1 in 1,024 was therefore used in 
subsequent assays. 
Titres could be calculated for these results in the same manner as for the sera 
results, by comparison to 1 in 20 of the neat (10 g/ml) control (data not shown). 
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Figure 5.2. The effect of primary antibody (mucosal homogenate) dilution on 
ELISA (lgG, IgGland IgG2a) optical density, with samples from four 
timepoints during infection. The data represent the OD of ELISA performed 
on a dilution of mucosal homogenate from an individual animal at each 
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Figure 5.2 (continued). The effect of mucosal homogenate dilution on ELISA 
(IgA and IgE) optical density, with samples from four timepoints during 
infection. The data represent the OD of ELISA performed on a dilution of 
mucosal homogenate from an individual animal at each timepoint. 
Differences in the antibody level were observed between the different 
timepoints. 
5.2.3 Measurement of rat cytokine expression by RT PCR 
RNA extraction 
Total RNA was extracted from rat spleen, intestinal mucosa and mesentery 
collected at regular time-points during infection with 2,000 L3 as described in 
Chapter 2.7.2. These samples were chosen for their relevance at the site of infection 
(mucosa), draining lymph nodes (mesentery), or their role in systemic immune 
response (spleen). Prior to cDNA synthesis, samples of RNA were separated on 
agarose / EtBr gels for analysis. One such gel is shown in Figure 5.3, panel A. A 
smear of mRNA was evident to above 3 kb with no evidence of degradation. This 
sample is typical of the quality of RNA seen during the tissue extraction from spleen, 
mucosa and mesentery. 
cDNA synthesis 
Samples of RNA (as shown in Figure 5.3, Panel A) from different tissues and 
at different time-points were used in the synthesis of cDNA in the first step of the RT 
PCR, in the manner described in Chapter 2.7.2. Following first strand synthesis, a 
sample of cDNA was analysed on agarose / EtBr to check the quality and yield. One 
sample is shown in Figure 5.3, panel B. The cDNA was visible as a smear to over 
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Figure 5.3. A typical agarose / EtBr gel of A.) RNA and B.) the corresponding 
cDNA from rat mucosa at 1.) 14 days post infection and 2.) 0 days (Control). 
The smear extending through the size range and the lack of low molecular 
weight degradation products indicates the integrity of the RNA. (M = 
molecular weight marker). 
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The detection of cvtokine expression in rat tissues using RT PCR 
Amplification of cytokine specific sequences by PCR was performed using 
positive control or test rat tissue cDNA with the primers shown Chapter 2.7.2. 
Typical results, obtained with rat spleen mRNA, are shown in Figure 5.4. Only the 
amplification with 13-actin primers, a constititively expressed mRNA species, 
produced a product, confirming the viability of the cDNA template. 
Also shown (Figure 5.5) are the products of PCR with primers for IL-4 and 
IL-5 and a dilution series of a positive control cDNA template. These reactions 
produced products of the expected size with visible bands produced even at low 
levels of template cDNA. The positive result from the IL-4 and IL-5 primers with a 
positive control template suggests that the PCR reaction works well with the addition 
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Figure 5.4. A typical agarose / EtBr gel of PCR products amplified using a 
panel of rat cytokine primers and N. brasiiensis infected rat spleen cDNA 
template. Only primers specific for -Actin (a constituitively expressed 
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Figure 5.5. Agarose / EtBr gels of PCR products specific for A.) IL-4 and 
B.) IL-5 produced using a positive control template at a range of dilutions. 
Lanes 1-5 contain the products from reactions performed using doubling 
dilutions from 1 in 2 to 1 in 32 of a lOx positive control from the Maxim 
Biotech MPCR kit. Products were amplified to a high dilution of template 
DNA. 
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The detection of cytokine expression in the intestinal mucosa using a 
Multiplex PCR 
The detection of rat cytokine expression in tissue samples was also attempted 
using a commercial multiplex PCR kit as described in Chapter 2.7.2. This kit 
contained positive control template for optimising the PCR with GAPDH as an 
internal control in the primer mix. Some results are shown in Figure 5.6. Products of 
the expected size were produced for all cytokine primer sets in the panel with the 
addition of the positive control template. The internal control, GAPDH, gave a 
product of the expected size in all of the samples tested confirming the quality of the 
cDNA. In the infected tissue samples, bands were evident that were approximately 
the same size as those of the cytokines in the positive control and some variation was 
seen in the appearance and intensity of these bands between samples at different 
time-points. However, replicate PCR often failed to reproduce these results and when 
some of these bands were cloned and they were not found to match the expected 
cytokine sequences (data not shown). 
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Figure 5.6. Agarose EtBr gel showing PCR products produced in a multiplex 
PCR with cDNA template from rat small intestinal mucosa at; 1.) 0 DPI; 2.) 7 
DPI; 3.) 9 DPI; 4.) 11 DPI and 5.) 14 DPI. Some products appeared to 
correspond in size to cytokine specific products, labelled above in a positive 
control PCR (+ve). However, more accurate sizing indicated that these 
products were not the same. (M = kilobase marker). 
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5.3 Discussion 
This chapter describes the development and optimisation of assays for the 
measurement of immune markers of infection and immunisation. Assays for the 
measurement of specific antibody and RMCP II by ELISA and cytokine production 
by RT PCR were developed. These were used to measure specific antibody and 
cellular responses in the vaccination trials described in later chapters. 
The data from the optimisation of the antibody ELISA indicated that, as 
expected, large differences existed in the antibody level present in the sera of control 
and hyper-immune rats. These large differences allowed the optimisation of the 
ELISA with regard to coating antigen, primary and secondary antibody dilution. 
Standard operating concentrations of coating antigen and the primary antibody 
dilution were thereby set. 
The OD from ELISA with a series of dilutions (Figure 5.1) showed that, with 
the exception of the total IgG secondary antibody, the secondary antibodies were 
effective through all of the dilution ranges used for each. Accordingly, the secondary 
antibodies were used in subsequent ELISAs at the highest dilution in the tested 
range. The total IgG secondary antibody was used at the lowest dilution tested as this 
gave the strongest signal. 
The levels of antibody present in hyper-immune serum samples could also be 
calculated as a titre whereby the level was expressed as the dilution necessary to 
reduce the OD to the level of a 1 in 20 dilution of the control sera. This was to be the 
standard method for expressing all subsequent antibody ELISA data. These titres 
(data not shown) indicated that the profile of antibody production in hyper-immune 
animals was similar to that described previously (Jarrett and Haig, 1976; Jarrett and 
Bazin, 1977), as discussed in Chapter 3. The highest response was in total IgG with 
this dominated by the IgGi component. IgGi was the antibody isotype associated 
with protection from infection in this system (Jones et al., 1970). High 1gB titres 
were also stimulated but the IgA response was less. 
Differences were also evident in the levels of the different antibody isotypes 
present in the small intestine mucosa during the course of an acute single infection 
(Figure 5.2). These differences were not so large as those seen between immune and 
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naïve sera, but were measurable. The use of samples taken at various time-points 
through a challenge with 2,000 N. brasiliensis L3 allowed the optimisation of the 
ELISA with regard to the dilution of primary antibody, in this instance the soluble 
tissue homogenate. 
As well as allowing optimisation of the mucosal ELISA, this test gave 
mucosal antibody titres from several time-points through a primary infection as 
described previously in Chapter 3. These changes in mucosal antibody matched the 
changes seen in the sera through the course of the infection, in a manner similar to 
those previously observed in this system (Poulain et al., 1976a; Sinski and Holmes, 
1977; Wedrychowicz etal., 1983). The highest responses were in IgG and IgE with a 
reduced but still visible response from IgA. Both IgE and IgA isotypes peaked earlier 
(14 DPI) in infection compared to IgG which remained elevated during the period of 
sampling. 
Despite repeated attempts, no products were produced from test rat cDNAs 
when PCR were performed using cytokine primers. Positive control PCR with the 
IL-4 and IL-5 primer pairs gave good signals from low levels of template indicating 
that the deficiency was not in the PCR (Figure 5.5). The visualisation of RNA and 
cDNA prior to detection of cytokine species also indicated good quality template 
production from all samples and at all time-points, as judged by their separation on 
agarose / EtBr (Figure 5.3). Further evidence of the quality of the template was 
provided by the positive control PCR, which amplified -actin products from all of 
the tested samples (Figure 5.4). These data suggest that cytokine transcripts were not 
present in sufficient quantity to be detected by this method. 
A commercial multiplex PCR kit was also tested for its ability to detect 
cytokine mRNA. Once again the internal control, in this case GAPDH, was amplified 
from samples at all time-points indicating the viability of the template cDNA and the 
appropriateness of the PCR conditions (Figure 5.6). Several other bands were also 
amplified of several sizes, some of which were similar to the sizes of specific 
cytokine bands produced in the positive control reaction. Differences were also 
apparent between samples of the same tissues collected at different time-points. 
Accurate sizing of these bands however showed that many of them were not 
of sizes matching those expected for the cytokine bands, suggesting non-specific 
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amplification at the high template and low stringency conditions used. Several of the 
bands were cloned and sequenced and the results indicated that these sequences were 
not the expected cytokines. 
It must therefore be concluded that RT PCR failed to accurately, or 
repeatedly, detect cytokine mRNA from the test samples as described previously 
(Matsuda et al., 1995). This may have been due to the absence of cytokine mRNA or 
extremely low levels of such mRNA in the tissues tested. Some variation in the 
amount of cytokine mRNA expressed does exist between rat strains and it may be 
that the strain used in these experiments expresses only low levels of these species 
(Uchikawa et al., 1996). The RNA extraction was also performed on whole tissues 
rather than on dissected lymph nodes or purified cells, which may be more 
appropriate sources of material for the detection of cytokine expression by RT PCR 
(Matsuda et al., 1995; Matsuda et al., 1999). As the assay was intended for use as a 
marker of Th-2 responses in the vaccine trials described below, it was decided to use 
the RMCP II ELISA as an indicator of this response. 
To overcome these problems, dissection of specific lymph node tissue, or 
isolation and purification of lymph node cells might be required. These cell 
populations will contain most lymphocytes, a major cytokine producing cell 
population. In vitro stimulation of these cell populations with worm antigens might 
also be required for the production of sufficient transcripts for detection (Matsuda et 
al., 1999). Improved detection systems such as fluorescent labelled probes could also 
be employed for low amounts of PCR product as well as more accurate 
quantification by densitometry. 
In summary, the work described in this chapter set out to establish routine 
and discriminatory methods to monitor the immune response in the vaccination trials 
described below. ELISAs were established to measure the major antibody isotypes in 
sera and in intestinal mucosa samples taken at the site of infection. Despite 
considerable effort, a reproducible PCR-based assay for cytokine expression could 
not be established. Possible reasons for this and future directions to overcome the 
problem were addressed briefly in this discussion. 
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Chapter 6 - The effect of subcutaneous vaccination 
with recombinant Nippostrongylus brasiliensis 
acetyicholinesterase and superoxide dismutase on 
the outcome of infection in the rat 
6.1 Introduction 
As stated in Chapter 1, previous attempts at vaccination against several 
species of nematode have been made using worm AChE. In a Guinea pig / 
T. colubrformis model, no significant level of protection was achieved (Rothwell 
and Merritt, 1975). However, in this experiment the antigen was given as a single 
dose sub-cutaneously without an adjuvant, prior to parasite challenge. Guinea pigs 
were partially protected against D. viviparus challenge following subcutaneous 
immunisation with AChE partially purified from adult ES, the antigen being 
delivered subcutaneously with Freund's adjuvants (McKeand et al., 1995a; McKeand 
et al., 1995b). No protection was observed in a subsequent trial in calves but, on this 
occasion, the AChE was a recombinant of a single isoform of the enzyme (Matthews 
et al., 2001). In a mixed nematode infection in sheep of T. colubriformis, 
H. contortus and C. oncophora, vaccination with T. colubriformis AChE led to a 
31% reduction in the total worm burden (Griffiths and Pritchard, 1994). 
These studies indicate that AChE may be a useful target antigen for 
vaccination. However, none have systematically examined the effect of route of 
AChE delivery on the outcome of a subsequent challenge infection. This is one of the 
aims of the work described in this and following Chapters. 
As described in Chapter 1, SOD may play a critical role in parasite survival in 
the intestinal tract. To date, the protective efficacy of this protein has only been 
tested using a combined recombinant vaccine comprising the cytosolic and 
extracellular forms of the protein from H. contortus (Liddell and Knox, 1998). A 
20% reduction in final worm burdens was noted when vaccinated animals were 
compared to controls. The vaccinated animals had an elevated faecal egg output, an 
observation that may indicate that the parasites were exposed to increased 
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immunological stress. Again, in this trial, antigens were given SC with Quil A as 
adjuvant. 
Most previous experimental vaccinations against GI nematodes have been 
performed via a systemic route of vaccination (Knox, 2000). The immune response 
to systemic vaccination is characterised by increases in serum immunoglobulin levels 
and specifically in IgG (Harlow and Lane, 1988). However, it is likely that the 
immune responses generated in this way are not the most appropriate in protection 
against GI nematode infection, which may be modulated by local humoral and 
cellular responses (Emery et al., 1993). In a previous vaccination experiment using 
N. brasiliensis protection was achieved using somatic antigens immunised sub-
cutaneously, but a higher degree of protection was afforded by IP vaccination, a 
regime that stimulates mucosal as well as systemic responses (Murray et al., 1979). 
Therefore, the choice of vaccination route can affect the outcome of vaccination 
against mucosally associated parasites such as T.colubriformis or N. brasiliensis. 
Antibody responses may be characterised as Type (Th)- 1 or -2 by the IgG 
isotype produced. In rats, Th-2 responses are associated with IgG2a and IgGi and 
Th-2 responses (Binder et al, 1995) with the IgG2b and IgG2c isotypes (Gracie and 
Bradley, 1996). The choice of adjuvant and inoculation site may affect the Th-1 / -2 
balance of the immune response. As protection against nematode infections is 
considered to be due to Th-2 polarised effects, this too might affect whether an 
immune response was protective. 
In most previous trials of helminth vaccines an adjuvant has been 
administered in combination with the immunising antigen to boost the immune 
response. Freund's adjuvant has been used extensively because it stimulates both 
humoral and cellular immune responses, but is now considered unsuitable due to its 
potentially harmful side effects and could not be used for commercial vaccine 
production purposes (Cox and Coulter, 1997). An acceptable adjuvant is Quit A, 
which has been used with success in developing anti-helminth vaccines (Knox and 
Smith 2001). Quit A is a saponin derived adjuvant that boosts immune responses in a 
non-specific manner but which is considered to primarily induce a high antibody titre 
(Estrada et al., 2000). 
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The first vaccination experiment in rats using recombinant AChE and SOD, 
described in this chapter, was designed to follow a similar regime of systemic 
vaccination to that commonly used in sheep. In rodents, systemic vaccination may be 
performed by SC immunisation. This trial was considered to be a test of the 
immunogenicity of the two candidates as well as determining any protective effect 
conferred by an immune response. Subsequent trials consequently investigated the 
effect of immunisation by other routes (Chapters 7 and 8). In this trial a group of 
animals was immunised with the bacterially expressed recombinant SOD (Chapter 4) 
in combination with Quil A and another with a Pichia-expressed recombinant AChE 
in combination with Quil A. Both recombinant proteins were enzymically active. 
Control groups consisted of a group immunised with Quil A adjuvant alone and a 
non-immunised group. These groups were designated SOD, AChE, Adjuvant and 




In general, the vaccination regime was well tolerated with no obvious side 
effects. In the group immunised with SOD and Quil A however, serious effects did 
occur in two animals. In both cases this consisted of bleeding from the nose, with one 
animal more affected than the other. This implied a respiratory system haemorrhage. 
The more heavily affected animal was extremely distressed and was euthanised, the 
other subsequently recovered with no further effects. 
6.2.2 Pre-challenge IciG level 
The level of antigen-specific antibody in the serum of SOD and AChE 
vaccinated animals was measured by ELISA 7 days prior to challenge infection, by 
the method described in Chapter 2.7. The titres of SOD- and AChE-specific antibody 
compared with control rat serum are displayed in Figure 6.1. The titre of SOD- and 
AChE-specific antibody was measured also in the Quil A immunised (Adjuvant) 
animals as a measure of non-specific antibody binding or background titre conferred 
by the Quil A component of the immunisation alone. 
As shown in Figure 6. 1, panel A, the SOD immunised animals did not show a 
SOD-specific IgG response significantly greater than that of the Adjuvant control. 
The AChE immunised animals showed a statistically significant increase in the level 
of AChE-specific IgG over the Adjuvant control (P=0.007, Figure 6. 1, panel B). 
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Figure 6.1 Panel A.) the SOD specific and B.) the AChE specific lgG levels in 
serum from Quil A (Adjuvant), SOD and AChE immunised rats 7 days prior to 
challenge. The data represent the mean total lgG titre of the 7 animals in 
each vaccination group measured by ELISA (+1- the standard error). 
6.2.3 Faecal egg counts 
FEC from control and vaccinated groups are displayed in Figure 6.2, panel 
A - C. The FEC from the control group was similar to that demonstrated previously 
for a challenge infection of 25 L3 (Chapter 4). Animals vaccinated with the adjuvant 
alone showed a similar egg output to the controls (Figure 6.2, panel A). 
The results from the group of animals vaccinated with SOD are shown in 
Figure 6.2, panel B. The FEC from these animals was slightly elevated compared 
with those of the controls but this was not statistically significant, when tested by 
analysis of variance (one way ANOVA). 
The FEC from the AChE vaccinated group was markedly reduced through the 
course of the infection. The largest difference occurred around days 6 - 8 post 
infection, around the peak of infection. This difference in egg output corresponded to 
a decrease of 48% in the total egg output through the course of infection. The peak in 
egg output in this group was also later, occurring 8 DPI rather than 7 DPI for the 
other groups. The reduction in egg counts in this group, however, did not prove to be 
statistically significant, when tested by one way ANOVA. 
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Figure 6.2. The faecal egg count from Control (unvaccinated) and Adjuvant, 
SOD and AChE vaccinated animals over 11 days following challenge 
infection with 25 Nippostrongylus brasiiensis L3 larvae. The data represent 
the mean of faecal egg counts performed on three pooled samples from each 
group at each timepoint (+1- the standard error). Vaccination with AChE 
reduced the egg output compared with the controls. 
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6.2.4 Adult worm counts 
At the time of sampling, 11 DPI, no adults were detected in the small 
intestine of any of the animals. 
6.2.5 Serum antibody levels 
Antigen (SOD or AChE)-specific antibody levels were measured in the serum 
of the vaccinated animals and controls at the time of necropsy, as described in 
Chapter 2.7. Results, expressed as titres over the uninfected control, are shown in 
Figures 6.3, panels A and B. 
The levels of specific antibody isotypes in the serum of animals in the 
Adjuvant alone immunised group was not significantly different from the Control 
group for either antigen (Figure 6.3, panels A and B). The results from ELISA 
measuring SOD-specific antibody indicated that low titres of each of the antibody 
isotypes (IgG, IgGi, IgG2a, IgA and IgE) were present in the sera from the SOD, 
Adjuvant and Control groups (Figure 6.3, panel A). The SOD vaccinated group did 
not show significantly higher levels of specific antibody than those seen in the 
Control and Adjuvant groups. 
The antigen specific antibody levels from the serum of AChE vaccinated 
animals are displayed in (Figure 6.3, panel B). This group had a significantly 
elevated AChE specific IgG titres compared to the Control and Adjuvant groups 
(P=0.002). Significantly increased serum titres of both AChE-specific IgGi and 
IgG2a were detected compared with these controls (P<0.02). A significantly 
increased mean level of IgA and IgE was also observed in serum from this group 
compared with the control groups (P<z0.02). 
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Figure 6.3. Panel A.) The SOD and B.) AChE specific serum antibody 
response of SOD and AChE vaccinated animals, Adjuvant alone vaccinated 
and Control (unvaccinated) animals at 11 days following challenge with 25 
Nippostrongylus brasiliensis L3. The data represent the mean antibody titre 
of the 7 animals in each vaccination group measured by ELISA (+1- the 
standard error). A marked difference in the magnitude of the serum antibody 
response was observed between the groups. 
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6.2.6 Confirmation of antibody specificity by Western Blot analysis 
The specificity of antibody from immunised animals for the immunising 
antigens was confirmed by Western blot. Blots were performed as described in 
Chapter 2.3.5 with the antigens, SOD and AChE being transferred to PVDF 
membrane and probed with primary serum from SOD, AChE or Adjuvant animals. 
These were then developed for total IgG. 
Blots are displayed in Figure 6.4, and as demonstrated in lanes 1 and 2, SOD 
on the membrane was not recognised by IgG in sera from SOD vaccinated or 
Adjuvant control animals. SOD was recognised weakly by serum from 2 individual 
animals on subsequent blots performed in the same manner (data not shown). AChE 
was recognised by sera from AChE vaccinated animals, reflecting the increased IgG 
titre (Figure 6.4, lane 3). AChE was not recognised by sera from Quil A (Adjuvant) 
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Figure 6.4. A Western blot of recombinant SOD (lanes 1 and 2) and 
recombinant AChE (lanes 3 and 4) probed with serum IgG from; SOD 
vaccinated (lane 1), AChE vaccinated (lane 3) or Adjuvant vaccinated 
animals (lanes 2 and 4). Recombinant AChE was recognised by serum 
from AChE vaccinated but not from Adjuvant vaccinated rats. SOD was not 
recognised on the blot. (M denotes molecular weight markers). 
6.2.6 Mucosal antibody 
Using a mucosal antibody ELISA, as described in Chapter 2.7.1, no specific 
antibody was detected in the mucosa of vaccinated and control animals at necropsy 
11 DPI. 
6.2.7 Serum and mucosal mast cell protease levels 
Mast cell protease (RMCPII) levels were measured in the serum and mucosa 
of vaccinated animals and the results are displayed in Figure 6.5. RMCP II levels in 
serum from Control, Adjuvant alone and SOD vaccinated animals was higher than 
those previously seen in uninfected controls (Chapter 3), ranging from 800-1,000 
ng/ml. The level of RMCP II in serum from the AChE vaccinated group was 
significantly lower than these groups at around 400 nglml (P=0.001). 
Levels of RMCP II in the mucosa were around 50 - 100 ng/mg soluble 
protein in the Control and SOD vaccinated groups. The level in the AChE group was 
significantly elevated above these at around 400 ng/mg soluble protein (P=0.002). 
The levels in the Adjuvant alone group were also elevated above the Control and 
SOD at around 700 ng/mg soluble protein, however the variation in this group was 
also high as indicated by the large standard error and the difference was not 
significant. 
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Figure 6.5. The levels of mucosal and serum RMCP II from Control 
(unvaccinated) and Adjuvant SOD and AChE vaccinated animals at 11 days 
following challenge infection with 25 Nippostrongylus brasiliensis L3. The 
data represent the mean RMCP II level of the 7 animals in each vaccination 
group measured by ELISA (+/- the standard error). Some differences in the 
levels of RMCP II in each compartment were observed between the groups. 
6.2.8 The effect of antibody on acetyicholinesterase activity 
The effect of serum from vaccinated animals on the activity of recombinant 
AChE was investigated by incubating AChE with sera from individual animals, then 
separating the proteins on a native PAGE gel and staining for esterase activity. 
Several zones of activity were visible when recombinant AChE was 
incubated with serum from control animals, Figure 6.6, panel A. The prominent 
upper band could be attributed to endogenous esterase activity in the serum (serum 
lane) with the lower band being due to the recombinant AChE (AChE lane). When 
the recombinant AChE was incubated with sera from animals vaccinated with 
recombinant AChE, the pattern changed (Figure 6.6, panel B). In this case the 
activity in the recombinant AChE band, for several individuals (lanes 10 and 12), 
was decreased and in all animals, a zone of activity high on the gel appeared 
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Figure 6.6. The effect of serum antibody on acetylcholinesterase activity. 
Serum from individual A.) Control (unvaccinated) and B.) AChE vaccinated 
animals was incubated with recombinant AChE, separated on Native PAGE 
gels and stained for cholinesterase activity. The activity associated with the 
recombinant AChE was reduced following incubation with serum from some 
AChE vaccinated rats (lanes 10 and 12) and there was an increase in activity 
high on the gel indicating a slowly or non-migrating product. 
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6.3 Discussion 
This chapter described the first in a series of trials that tested the efficacy of 
recombinant AChE and SOD of N. brasiliensis as protective antigens in the rat 
challenge model. In this trial, the immunogenicity of the recombinant proteins and 
the protection conferred by systemic (SC) immunisation were tested. Protection was 
measured by comparing the cumulative faecal egg outputs from the vaccinated 
groups with groups of non-immunised animals (Control), or animals given adjuvant 
alone (Adjuvant). The immunogenicity was assessed by measure of the antibody and 
mast cell protease response of the animals. 
The FEC of the AChE vaccinated group was markedly reduced through the 
course of the infection compared with the control, indicating that a protective effect 
had been conferred. The FEC of the SOD vaccinated group showed no such 
reduction and was slightly elevated compared with the control. These apparent 
differences in egg output were matched by differences in the specific antibody 
response generated against the immunising antigen between the groups. The AChE 
group showed significant increases in specific antibody isotypes over the controls 
while the SOD specific antibody levels were not significantly different from the 
control. The AChE vaccinated group also differed in the mast cell protease (RMCP 
II) response it expressed. Antibody from the serum of AChE vaccinated animals was 
shown to inhibit the migration of recombinant AChE through a native PAGE gel. 
The cumulative FEC from the AChE vaccinated group was reduced by 48% 
compared with the control, indicating that a level of protection had been conferred. 
This finding agrees with the results from previous vaccination experiments in which 
immunisation with AChE enriched fractions provoked protective immune responses 
against D. viviparus (McKeand et at., 1995a) and a mixed nematode infection 
including T. colubriformis (Griffiths and Pritchard, 1994). The apparent level of 
protection is similar to that seen in these earlier experiments, with approximately 
50% protection conferred against D. viviparus infection in Guinea pigs (McKeand et 
at., 1995a) and 30% protection against a mixed nematode infection (Griffiths and 
Pritchard, 1994). 
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The level of protection demonstrated was lower than that observed in a 
previous SC vaccination trial against N. brasiliensis in rats using an adult somatic 
extract as antigen (Murray et al., 1979). In this trial the number of adult worms was 
reduced by 77% with a corresponding reduction in egg output. However, the trial 
was performed using large amounts (up to 10 mg) of a crude native antigen 
preparation containing a complex mixture of proteins and therefore might not be 
comparable to the trial described here. 
The present data did not indicate that the differences in FEC from the control 
were statistically significant. This is most likely due to the high variability, a 
common problem with FEC data (Mes, 2003). Although there was likely to be a real 
effect, an increase in statistical power would be needed to resolve it to statistical 
significance (J. Sales, BioSS, pers. comm.). This could be achieved by an increase in 
the sample number. During this trial it was only possible to sample each cage rather 
than each individual animal (due to constraints of housing and welfare defined by the 
local Home Office Inspector). The sample size was therefore reduced from 7 to 3, 
reducing the power of the analysis. This trial was repeated in work described in 
Chapter 8 with the same result. As detailed in Chapter 8, combining the data from 
both trials allowed more powerful statistical analysis and showed that the effect was 
significant. 
AChE-specific IgG titres were significantly increased in the serum of the 
AChE vaccinated group compared with the Control and Adjuvant groups. Both 
IgG2a and IgGi were elevated by similar amounts indicative of a Th2 response to 
vaccination (Binder et at., 1995). An increase in IgG, without necessarily a particular 
IgG2a or IgGi (Th-1 / -2) bias was expected with this vaccination regime (Harlow 
and Lane, 1988; Cox and Coulter, 1997). That a particular IgG isotype is the effector 
of protection cannot be excluded because antibodies can have differing avidity for an 
antigen and this can be associated with whether or not a protective response is 
observed (Mulcahy et al., 1998). 
AChE vaccination also resulted in an increased serum IgA titre. IgA is a 
secretory antibody isotype that is active at mucosal sites (Miller, 1984), however no 
antibody was detected in the mucosa of any of the animals during this trial. As the 
major source of secretory IgA is the serum (Jackson et al., 1978), the absence of 
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antibody in the mucosa indicates that no secretory / mucosal IgA response was 
generated in this instance. The lack of detectable antibody in the mucosa might also 
reflect a reduction in worm-mediated damage such that antibody was not transported 
across the mucosa from the circulation. 
The titre of AChE-specific IgE in the AChE and Adjuvant groups was also 
significantly increased compared with the control. This antibody isotype is involved 
in hypersensitivity and inflammatory type responses indicating that such a response 
might be provoked in these animals. That AChE is antigenic for specific IgE during 
N. brasiliensis infection has previously been demonstrated (Nakazawa et al., 1995). 
Elevated IgE levels support the view that the vaccination regime stimulated a Th-2 
biased response. 
The change in the activity profile of AChE when incubated with vaccinated 
serum does suggest a role of antibody in protection (Figure 6.6). The decrease in 
activity associated with the recombinant AChE isoform and the increase in activity 
higher in the gel compared with the control can be explained by antibody binding the 
AChE and forming a complex, which retains enzyme activity and migrates only 
slowly into the gel. This effect has previously been demonstrated in serum from T. 
colubrfonnis infected sheep and D. viviparous infections of guinea pigs, when the 
antibody isotype was identified as IgG (Rothwell et al., 1976; McKeand et al., 
1995a). Such a mechanism in vivo, while not inhibiting the activity of AChE, might 
prevent its diffusion / dissemination and thus prevent its biological function in 
protecting the worm. 
The level of RMCP II in the serum of the AChE vaccinated group was 
significantly lower than the control whilst that in the mucosa was significantly 
higher. These differences may indicate reduced mast cell activation and resultant 
RMCP II release. This scenario would cause the lower serum level with the increased 
mucosal level indicating the retention of RMCP II by mucosal mast cells. Another 
possibility is that worm damage to the mucosa was reduced in the AChE vaccinated 
group with the result that RMCP II did not leak into the systemic circulation to the 
same degree as in the controls. The FEC of the SOD vaccinated group showed no 
significant reduction and, indeed, was slightly elevated compared with the control, 
indicating that no protective effect had been conferred. SOD-specific antibody titres 
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were low with no significant differences between, SOD vaccinated, Control and 
Adjuvant groups. This indicates that the SOD may be only weakly immunogenic and 
therefore does not provoke a strong immune response. Strategies to overcome this 
might be to couple the recombinant SOD to a strong immunogen, denature the 
protein or to add groups such as dinitrophenol or arsenate to the protein (Harlow and 
Lane, 1988). 
Another reason for the lack of response might be that the SOD protein was 
not recognised by the major histocompatibility complex (MHC) class 2 proteins 
expressed by this strain of rat. Genetic restriction of the MHC class 2 receptors 
expressed would lead to the lack of response by preventing antigen presentation to 
T-cells by antigen presenting cells (Harlow and Lane, 1988). MHC restriction of 
antigen recognition during rodent infection with helminth parasites is well known 
(Kennedy et al., 1991; McKeand et al., 1994a) and restricted recognition of ES 
antigens during N. brasiliensis infection has also been reported (Kennedy et al., 
1990). In this latter report the authors suggested that, 
"Immune selection might have resulted in the evolution of biochemically active 
exoantigens [ES enzymes] which are of poor immunogenicity or only subject 
to immune recognition in certain members of the definitive host species," 
(Kennedy et al., 1990). 
The hypothesis that MHC - class 2 protein restriction of the recognition of the 
recombinant SOD is responsible for the lack of immune response observed could be 
tested by immunising a different strain of rat in the same manner to see whether this 
increased response. 
The level of RMCP II in either compartment of the SOD vaccinated animals 
also did not significantly vary from the level seen in the control. RMCP II levels in 
the serum and mucosa of Control animals were somewhat lower than the levels seen 
during the acute challenge infection at this time-point (Chapter 3). However, the 
lower level of infection used probably accounts for this difference. Protease levels 
were similar in the Adjuvant group in the serum but in the mucosa were elevated 
above the Control. A very large standard error in the mucosa results may account for 
this result and the Adjuvant group might, therefore, conform more closely to the 
pattern of high serum and lower mucosal levels seen in the control. 
171 
Pathogenic effects occurred in two individuals in the SOD immunised group 
during the course of vaccination. While these effects may have been due to some 
other cause than the vaccinating doses, the adjuvant Quil A is known to have some 
toxic side effects such as haemolysis due to its detergent properties (Estrada et al., 
2000). This may have been the cause of the side effects in rats although the absence 
of effects in both adjuvant control and AChE vaccinated groups, both receiving the 
same dose of Quil A, would appear to contradict this or suggest that only certain 
individuals might be affected. The SOD itself may have produced the effects seen, 
however the symptoms were not those of anaphylaxis and the low response to SOD 
seen in antibody levels would indicate only weak immunogenicity. This would 
appear to rule out an auto-immune or hypersensitivity reaction and another 
mechanism of pathology would be needed before a SOD-based explanation of the 
effects could be confirmed. 
In conclusion, the results of this trial indicate that protection against 
N. brasiliensis infection may be conferred by vaccination with recombinant worm 
AChE, but no protective effect was seen with SOD vaccination. The protection in the 
AChE vaccinated group was associated with an increase in AChE-specific total IgG 
compared with the controls. Elevated levels of IgG2a and IgGi isotype, in 
association with marked increases in serum IgE are indicative of a Th-2 response in 
vaccinated rats. No significant increase and no significant difference were seen in the 
SOD-specific antibody levels between control and SOD vaccinated animals. 
Differences in RMCP II level between the AChE group and the SOD and control 
groups might indicate reduced mast cell activation. 
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Chapter 7- The effect of immunisation using 
Ni  ppostronqylus brasiliensis recombinant 
acetyicholinesterase via the intra-peritoneal route in 
Wistar rats and recombinant superoxide dismutase 
via the sub-cutaneous route in Sprague—Dawley rats 
71 Introduction 
Chapter 6 described a protection trial in which rats immunised with a single 
recombinant form of a Nippostrongylus brasiliensis AChE were partially protected 
against challenge infection, as judged by a reduction in faecal egg output compared 
with the control. In that trial the antigen was administered systemically with Quil A 
as adjuvant. The immune response to vaccination was characterised by increases in 
IgG 1, IgG2a and IgE isotypes indicative of a Th-2 response. 
Sera (presumably serum antibody), from vaccinated rats, was also 
demonstrated to inhibit the migration of the recombinant enzyme on a PAGE gel 
stained for enzyme activity. Such an effect has been noted previously with sheep, 
which had been infected with T. colubrformis, producing antibodies that bind to the 
worm AChE (Rothwell and Merritt, 1974). Guinea pigs vaccinated with an 
AChE-enriched fraction from adult D. viviparus were partially protected against 
subsequent challenge infection, and IgG from their serum inhibited AChE activity 
(McKeand et al., 1995b). In the study described in Chapter 6, there was, however, no 
detectable local antibody response in the mucosa. It is possible that a vaccination 
regime which is designed to stimulate local mucosal immune responses may enhance 
the level of protection observed in the previous experiment (Emery et al., 1993). 
As discussed in Chapter 1, worm expulsion from the GI tract has been 
associated with both systemic and local antibody and immune cell responses in the 
mucosa, with mast cell activation being identified as a key event (Balic et al., 2000). 
In the case of N. brasiliensis, antibody responses have previously been described 
during infection (Ogilvie and Jones, 1971) and infection is known to induce large 
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specific and non-specific IgE responses (Jarrett and Haig, 1976; Yamada et al., 
1991). Mastocytosis in the intestinal mucosa with subsequent mast cell degranulation 
and release of mast cell proteases are observed (Huntley et al., 1993). Goblet cell 
hyperplasia also occurs and both the amount of mucus increases and glycosylation of 
mucus secreted changes during expulsion (Karlsson et al., 2000). Worms can 
become trapped in mucus and the latter contains local antibodies including IgG and 
IgA (Wedrychowicz et al., 1983), which have been ascribed roles in worm expulsion 
(Balic et al, 2000). This highlights the possibility that successful vaccination might 
require similar effector immune responses. 
Use of different adjuvants administered with vaccines may influence the T-
cell (Th-1 / -2) bias of the primed immune response (Cox and Coulter, 1997). The Th 
balance of the immune response may influence the outcome of infection, as 
protective responses against nematodes are associated with Th-2 responses (Urban et 
al., 1992). Different adjuvants administered with vaccine antigens have previously 
been shown to influence the protection conferred by vaccination against nematodes 
(Jacobs et al., 1999). 
In the previous vaccination experiment, recombinant SOD and AChE 
antigens were administered systemically with Quil A, an adjuvant considered to 
promote a high circulating antibody titre and Th- 1 and -2 responses (Cox and 
Coulter, 1997). The outcome of the experiment indicated that AChE might provoke a 
protective immune response as indicated by a marked reduction in FEC in vaccinates 
compared to controls. The antibody response was a systemic event with no detectable 
antibody in the small intestine mucosa. 
The experiment described in this chapter was therefore designed to target the 
antigen to provoke a mucosal immune response. One way to achieve this is to present 
the antigen by the IP route. The peritoneum or gut cavity contains many mucosal 
surfaces and administration by this route is considered to enhance presentation of the 
antigen to the mucosa as well as boosting a large systemic immune response in 
rodents (Harlow and Lane, 1988). By immunising in this way it was hoped to 
provoke a local, mucosal response against the parasite. Antigen was presented in 
combination with aluminium hydroxide (alum) adjuvant. This adjuvant boosts 
immune responses with a bias towards Th-2 response (Cox and Coulter, 1997). As 
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the previous vaccination experiment provoked an antibody response that showed no 
clear Th polarisation it was considered worthwhile to evaluate if this adjuvant might 
improve the level of protection observed by stimulating a mucosal response with a 
Th-2 bias. 
In the previous experiment immunisation with SOD did not lead to a high 
SOD specific antibody titre in the vaccinated animals possibly because the protein is 
not particularly immunogenic. The lack of antibody response may also have been 
due to immune restriction. Mammals, including rodents, are able to express only a 
finite number of major MHC receptors, which allow them to recognise foreign 
antigens. MHC-restricted antibody recognition to helminth parasites has been 
previously reported (Kennedy etal., 1991; McKeand etal., 1994a). 
To test the hypothesis that the poor antibody response was due to the genetic 
background of the Wistar rats, a separate strain of rat, Sprague—Dawley, was 
inoculated in the same manner as before. This experiment was designed to determine 
whether the strain of rat could influence the outcome of immunisation and generate 
an increased antibody response. The Sprague—Dawley strain has previously been 
used in N. brasiliensis challenge experiments. The infection cycle has been well 
characterised in this strain and conforms to the pattern seen previously in the Wistar 




In general the immunisations were well tolerated with no adverse reaction. 
However, a single animal in the group immunised SC with AChE in combination 
with Quil A had to be put down after developing nasal bleeding following the second 
immunisation. A subsequent post-mortem was unable to give a definitive cause of 
pathology other than to confirm that there was bleeding from the respiratory system. 
7.2.2 Pre-challenge serum antibody level 
One week prior to challenge serum was collected by tail bleed and the total 
IgG titre specific for AChE or SOD was measured by ELISA as described in Chapter 
2.7. 
The antigen specific IgG titre of the group of animals immunised with AChE 
/ SC was significantly increased compared with the control, with a titre of 490 
(P=0.006). Delivery of AChE via the IP route give a much higher mean IgG titre of 
36,000 which was, again, significantly higher than the controls (P=0.0015). 
The group of Wistar rats immunised SC with SOD indicated a specific IgG 
titre of 127. This titre did not, however, represent a significant increase compared 
with the Wistar controls. The SOD specific antibody titre of the Sprague-Dawley rats 
also did not differ significantly from that of the Sprague-Dawley controls. 
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7.2.3 Faecal egg counts 
Faeces were sampled from 5 DPI and FEC performed as described in Chapter 
2.1. Results of these FEC are displayed in Figure 7. 1, panels A - D. 
Results from all the groups, including the control, were lower than had been 
seen in earlier experiments (Chapter 3 and 6). The Wistar control group peaked at 
less than 50 eggs / g faeces on day 7 after infection with the Sprague-Dawley control 
peaking at less than 100. The AChE / SC peaked at less than 100 and AChE / IP at 
less than 25. Both SOD vaccinated groups peaked between 50 and 100 eggs /g 
faeces. In addition there was high variability in the FEC from the different samples 
within each group. In some samples there was a minimal (or zero) egg output 
indicating that a patent infection had not been established while other cages in the 
same group had a higher egg output. 
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Figure 7.1. The faecal egg count from Control (unvaccinated), SOD and 
AChE vaccinated Sprague-Dawley and Wistar rats for 11 days following 
challenge infection with 25 Nippostrongylus brasiliensis L3 larvae. The data 
represent the mean of faecal egg counts performed on three pooled samples 
from each group at each timepoint (+1- the standard error). The faecal egg 
outputs varied dramatically from those previously observed. 
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7.2.4 Post challenge serum antibody levels 
Serum antibody levels were measured by ELISA following necropsy at day 
11 post infection, as described in Chapter 2.7 and the results of these assays are 
demonstrated in Figure 7.2, panel A and B. 
The total IgG titre, as well as both IgGi and IgG2a subtypes, from the AChE 
/ SC vaccinated animals were significantly elevated compared with the control group 
(Pcz0.003). The IgG2a component appeared more prominent at 4,600 compared with 
an IgGi titre of 1,100 (Figure 7.2, panel A). IgE and IgA isotype titres displayed no 
significant differences from the control in this group. 
Serum antibody levels from the AChE / IP vaccinated group are displayed in 
Figure 7.2, panel B. In general AChE specific antibody responses in this group were 
much larger than those seen previously. The total IgG titre showed the largest 
increases at over 40,000. Of this total the specific IgG 1 titre was 16,000 and the 
specific IgG2a titre, 26,000. Increased titres of AChE specific IgE (20,000) and IgA 
(15,000) were also observed. The increases in AChE specific antibody titre in the 
serum of the AChE / IP vaccinated group when compared with the control group 
were all statistically significant (P:!A02). 
The SOD-specific antibody titre of all antibody isotypes measured in the 
serum from SOD immunised Wistar and Sprague-Dawley rats was not increased or 
significantly different from the respective controls (data not shown). 
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Figure 7.2. The AChE specific serum antibody response of Wistar rats 
vaccinated with; A.) AChE / SC and B.) AChE / IP compared with Control 
(unvaccinated) animals at 11 days following challenge with 25 
Nippostrongy/us brasiliensis L3. The data represent the mean antibody titre 
of the 7 animals in each vaccination group measured by ELISA (+1- the 
standard error). Some differences in the levels of specific antibody were 
observed between the groups. 
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7.2.5 Mucosal antibody levels 
Mucosal antibody levels were detectable in AChE vaccinated animals and 
were measured by ELISA, as described in Chapter 2.7. Antibody isotype titres from 
the Wistar control group and the AChE vaccinated groups are displayed in Figure 
7.3, panel A and B. 
As demonstrated in Figure 7.3, panel A, the titres of AChE-specific antibody 
isotypes IgG 1, IgA and 1gB measured from the mucosa of the AChE / SC vaccinated 
animals did not differ significantly from the controls. Small but statistically 
significant increases in total IgG and IgG2a over the controls were observed 
(P!~0.01). 
The results from the group vaccinated with AChE / IP are displayed in Figure 
7.3, panel B. AChE-specific antibody titres were increased in this group compared 
with the control. The largest increase was seen in the titre of IgG, which had a titre of 
750. Titres of IgGi and IgG2a were both elevated, with IgGi titres of 105 and IgG2a 
titres of 210. Specific IgA and IgE titre were also both increased over control levels 
with titres of 175. These increases in the specific antibody titre were statistically 
significant when compared with the titre of specific antibody from Wistar controls 
(P!~0.03). 
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Figure 7.3. The AChE specific mucosal antibody response of Wistar rats 
vaccinated with; A.) AChE / SC and B.) AChE I IP compared with control 
(unvaccinated) animals at 11 days following challenge with 25 
Nippostrongylus brasiliensis L3. The data represent the mean antibody titre 
of the 7 animals in each vaccination group measured by ELISA (+1- the 
standard error). Some differences in the levels of specific antibody were 
observed between the groups. 
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7.2.6 Serum and mucosa mast cell protease levels 
RMCP II levels were measured from the serum and mucosa of the Wistar 
control and the AChE vaccinated groups by ELISA following necropsy at day 11 
post infection, as described in Chapter 2.7. The results of these ELISAs are displayed 
in Figure 7.4. 
The serum levels of RMCP II were low in each of the vaccinated groups and 
in the control group, ranging between 150 and 300 ng/ml. No statistically significant 
differences were demonstrated between levels of RMCP II in the serum of the 
vaccinated and control animals. The serum levels of RMCP II, demonstrated in these 
three groups of animals, were similar to those demonstrated previously in uninfected 
control animals (Chapter 3). 
The mean RMCP II level in the mucosa of the control group animals was 
elevated compared with normal uninfected rats, at 684 ng/ml. The level of RMCP II 
in the mucosa of the AChE I SC vaccinated animals was significantly less than that 
demonstrated in the infection control, at 200 ng/ml (P=0.05). The AChE / IP 
vaccinated groups had a mean mucosal RMCP II level of 300 ng/ml, which was not 
significantly different from that of the infection control group. 
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Figure 7.4. The mast cell protease response in the mucosa and serum of 
Wistar rats vaccinated with AChE, and unvaccinated Controls, at 11 days 
following challenge with 25 Nippostrongylus brasiliensis L3. The data 
represent the mean protease level of the 7 animals in each vaccination group 
measured by ELISA (+1- the standard error). Some differences in the levels 
of RMCP II were observed between the groups. 
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7.2.7 The effect of antibody on acetyicholinesterase activity 
The effect of antibody on the activity of recombinant AChE was investigated 
by incubating recombinant AChE with serum from control and vaccinated animals as 
described in Chapter 2.5.5. Following this incubation the samples were separated on 
native PAGE gels and stained for esterase activity. Gels containing recombinant 
AChE incubated with serum from control and AChE I IP vaccinated animals are 
displayed in Figure 7.5, panel A and B. 
The pattern, observed previously with control serum, of two major bands of 
activity corresponding to endogenous activity and recombinant AChE activity, is 
shown in Figure 7.5, panel A. The AChE / IP vaccinated serum (Figure 7.5, panel B) 
indicated bands of activity corresponding to recombinant AChE that were much 
weaker than the control (lanes 8, 9 and 13), and in some cases absent completely 
(lanes 10, 11, 12 and 14). There were also no bands of activity higher up on the gel, 
previously observed when recombinant AChE was incubated with serum from AChE 
/ SC vaccinated animals and indicative of very slowly migrating products (Chapter 
6.2.8). 
An attempt was made to replicate this experiment with soluble homogenate 
containing antibody from the mucosa of the AChE / IP vaccinated animals. This 
however proved impractical due to the presence in the mucosal homogenates of 
several bands of endogenous cholinesterase activity that made it impossible to 





MW AM 0#0 	 4W OW - 	 cholinesterase 
activity 
	
Mi •' • 	iii N N _AChE activity 
AChE Serum 1 
	
2 	3 	4 	5 	6 	7 




' 	OW . 	, AM qW wow 440 L—cholinesterase 
- 	activity 
_AChE activity 
AChE Serum 8 	9 	10 	11 	12 	13 	14 
AChE pre-incubated with sera from 
AChE / IP vaccinated animals 
Figure 7.5. The effect of serum antibody on the activity of recombinant 
acetyl chol i neste rase. Serum from individual A.) Control (unvaccinated) and 
B.) AChE / IP vaccinated Wistar rats was incubated with recombinant AChE, 
separated on Native PAGE gels and stained for cholinesterase activity. The 
activity of the recombinant AChE was dramatically reduced by the addition of 
the AChE / IP serum (lanes 8 - 14). 
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7.3 Discussion 
The experiment outlined in this chapter had three aims. First to confirm the 
outcome of the trial described in Chapter 6. Second, to investigate whether IP antigen 
delivery would result in a detectable humoral immune response in the intestinal 
mucosa and enhanced protection. Third, to investigate if the poor immunogenicity of 
SOD in Wistar rats, noted in Chapter 6, could be circumvented by using a different 
rat strain. 
The results of the challenge infection from the control groups indicated that 
the establishment of infection was poor when compared to previous experiments 
(Chapters 3 and 6). In previous experiments, faecal egg output peaked at 
approximately 200 eggs per gram faeces but here, peak output was consistently less 
than 100 eggs per gram faeces and the data were more variable (Figure 7.1). In fact, 
faecal egg output from the controls was often lower than that from vaccinates. 
Consequently it was impossible to ascertain the level of protection, if any, that was 
conferred by vaccination with any of the antigens. Despite this problem, it was 
notable that the lowest egg output was recorded from the AChE / IP group with this 
tending to be lower than any other group in the experiment. In a previous vaccination 
experiment performed in this system IP vaccination produced the highest level of 
protection using a somatic extract antigen when compared with SC and oral 
immunisations (Murray et al., 1979). 
The reason for this failure to produce a viable infection is thought to be the 
age of the faecal cultures from which the infection doses were harvested (D Knox, 
pers. comm.). As these cultures were several months old the viability of the larvae 
may have been reduced to a level such that their infective capacity was impaired. 
Measures to prevent a repeat of this possible failure in future infection were 
implemented. These included the preparation of fresh larval cultures and the use of 
tracer animals prior to challenge of vaccinated groups to check the infective capacity 
of the larvae. These measures are discussed in greater detail in Chapter 8. 
Strong immune responses, as judged by increases in specific antibody titres, 
were again generated by vaccination with the recombinant AChE. SC immunisation 
resulted in higher total serum IgG titres than those observed in the previous trial 
(2,500 vs. 400) with IgE and IgA titres being lower. Vaccination via the IP route 
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produced the highest serum antibody titres with all isotypes having titres higher than 
10,000. In addition, increased levels of all specific antibody isotypes were detected in 
the mucosa of IP vaccinated rats, while smaller increases in only two mucosal 
antibody isotypes were seen in the SC vaccinated animals. These data confirm that IP 
immunisation does stimulate a higher systemic and mucosal response in comparison 
to SC delivery as expected (Harlow and Lane, 1988). Unfortunately, due to the 
problems with the infectivity of the challenge dose of Nippostrongylus larvae it 
proved impossible to determine any increased level of protection afforded by this 
increased immune response or if the mucosal response would enhance protection. 
The observed differences in the antibody response of the SC groups between 
trial results might be due to the failure of the infecting dose of worms to establish a 
similar level of infection in each of the trials. If this were the case then the previously 
observed IgE and IgA responses would have been a result of N. brasiliensis infection 
and not a result of the vaccination alone (Chapter 6). This further suggests that the 
primary immune response generated by the vaccination alone might be an IgG 
response particularly of the IgG2a isotype. Native AChE has been demonstrated 
previously to be immunogenic for the stimulation of 1gB during N. brasiliensis 
infection (Nakazawa et al., 1995). N. brasiliensis infections are also well known to 
stimulate IgGi, IgA and especially 1gB responses (Jones et al., 1970; Jarrett and 
Haig, 1976; Jarrett and Bazin, 1977). Nippostrongylus antigens have also been 
demonstrated to possess an adjuvant effect for Th-2 responses, including 1gB and 
IgGi production driven by IL-4 (Holland et al., 2000) 
The effect of antibody binding on AChE activity was determined using sera 
from the AChE / IP vaccinated animals. Sera from all immunised rats inhibited 
recombinant AChE activity (Figure 7.5), an effect which may be due to antibody-
mediated inhibition of enzyme activity by the antibody (Rothwell et al., 1976; 
McKeand et al., 1995a). Alternatively it might indicate a binding effect, such as that 
observed in the previous experiment (Chapter 6.2.8), but of increased efficacy. This 
effect may possibly prevent AChE from entering the gel, and enzyme activity is 
therefore not seen. An attempt to further characterise this effect by titrating the serum 
concentration to see if the profile changed to one similar to that of the AChE / SC 
vaccinated sera unfortunately did not produce a result due to the confounding effect 
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of endogenous esterases in the serum (data not shown). Either an inhibitory or 
increased binding effect might be due to the increased titres of antibody present in 
the serum of AChE / IP animals when compared with the AChE / SC vaccinated 
animals. The inhibitory effect of the serum on the AChE activity might also have 
been due to an increase in either the predominant IgG isotype, or of one of the other 
antibody isotypes (1gB or IgA). Purifying antibody subclasses for examining this 
effect could be achieved by column chromatography, but was beyond the scope of 
this project. Previous work on D. viviparus AChE indicated that a similar inhibitory 
effect of antibody was due mainly to the IgG isotype (McKeand et al., 1995b). 
An element of this experiment was designed to test the hypothesis that the 
lack of response of rats to vaccination with recombinant worm SOD may be due to 
genetic restriction of antigen recognition dictated by the strain of rat used in the 
previous trial (Chapter 6). Genetic restriction of MHC-antigen recognition during 
infection with helminth parasites is well known (Kennedy et al., 1991; McKeand et 
al., 1994a). Immunisation of a second strain of rat with recombinant SOD in 
combination with Quil A, using the same route of delivery (SC) did not result in an 
increased immune response to the antigen. Low responses were again observed in the 
Wistar strain indicating that the lack of effect might be due to low immunogenicity 
of the SOD protein rather than immune restriction. However, it is notable that sheep 
vaccinated with SOD from H. contortus did mount a vigorous antibody response and 
were partially protected against challenge infection (Liddell and Knox, 1998). These 
data suggest that SOD is immunogenic and that the problem here is likely to be due 
to restricted recognition dictated by the strain of rat used. This suggestion is further 
supported by the earlier observation that hyper-immune sera from different rats 
varied in their recognition of the recombinant SOD (Chapter 4). 
The levels of RMCP II in the serum and mucosa of the vaccinated and control 
animals at the end of this trial differed from those observed previously (Chapter 3 
and 6). Whereas in the previous trial elevated mucosal and serum levels were seen in 
the control, in this trial elevated mucosal levels were observed but serum levels were 
similar to those observed in uninfected rats. As mast cell accumulation and 
degranulation is strongly provoked during N. brasiliensis infection (Miller et al., 
1983b), this may be an indication of the reduced stimulation of mast cell aggregation 
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and degranulation induced by the lowered level of infection seen during this 
challenge. Indeed levels of RMCP II in the sera of both the control and vaccinated 
groups did not appear to differ from the level demonstrated previously in uninfected 
control animals (Chapter 3). This suggests that there was no detectable activation of 
mast cells at this time-point of the trial. 
The amount of RMCP II in the mucosa of the AChE I SC and AChE I IP 
groups differed from the control group, with lower levels observed. The levels of 
both mucosal and serum RMCP II in these groups were similar to those seen in the 
AChE / SC group in the previous trial (Chapter 6). Once again the differences 
between control and vaccinated groups may have been conferred by the treatment, 
but with the differing results of the control groups between the two trials caused by 
the effect of the reduced infection level. The observed levels again suggest that 
vaccination with AChE had a significant effect, reducing recruitment and activation 
of mast cells during this infection. However, due to the differences in the infection 
level between the experiments, interpretation of such an effect during this second 
trial may be harder to explain. Any conclusions based on this trial may be flawed due 
to the confounding effects of the reduced infection level on mast cell protease levels. 
In summary, it was concluded that vaccination with AChE and alum via the 
IP route did increase antibody titres in both the serum and the small intestinal 
mucosa compared with AChE and Quil A via the SC route. There was a 
corresponding increase in the inhibitory effect on the activity of the AChE enzyme 
linked to this increase in specific antibody titre. It was not possible to determine any 
effect that this improved antibody response might have on protection however. 
It was also concluded that the low response of animals to SOD was due to the 
low immunogenicity of the protein and not immune restriction. As attempts to 
improve immunogenicity might be time consuming and unsuccessful, SOD was 
therefore not included in further vaccination trials but it was decided to concentrate 
effort on the more effective AChE antigen. 
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Chapter 8— The effect of vaccination with 
recombinant Nippostrongylus brasiliensis 
acetyicholinesterase by the intra-nasal route 
81 Introduction 
In previous nematode vaccination trials in sheep, animals have generally been 
immunised systemically, producing a circulating antibody response (Emery et al., 
1993). Immunisation via the SC route produces a systemic antibody response in 
rodents (Harlow and Lane, 1988). A previous trial with recombinant N. brasiliensis 
AChE delivered via this route produced a significant AChE-specific antibody 
response in the serum and a 48% level of protection. This result however was not 
statistically significant due to experimental constraints (Chapter 6 and 7). 
Immunisation via the IP route produces high circulating antibody titres in rats 
(Harlow and Lane, 1988) and also stimulates a mucosal immune response. 
Immunisation via this route was more effective in producing protection against 
Nippostrongylus infection than SC immunisation, using adult somatic extract antigen 
(Murray et al., 1979). 
The use of aluminium adjuvants also boosts antibody responses and may 
polarise the antibody response towards a Th-2 response (Nicklas, 1992; Cox and 
Coulter, 1997), of the kind thought to act against nematode parasites (Urban et al., 
1992; Finkelman et al., 1997). In a previous experiment, immunisation via the IP 
route using alum adjuvant produced a higher antibody titre in the serum (Chapter 7). 
Using this regime, specific antibody was also detected in the intestinal mucosa, an 
important site in the protection against GI nematodes (Miller, 1984). Unfortunately, 
any protection conferred by these heightened antibody responses could not be 
assessed due to experimental difficulties (Chapter 7). 
Stimulation of Th-2 immune responses (Akhiani, 1997) and protection 
against gut dwelling nematodes (Tsuji et at., 2001; McGuire et al., 2002) have been 
demonstrated by immunising via the intra-nasal (IN) route using cholera toxin (CT), 
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or its component 3-subunit (CTB), as an adjuvant. CT and CTB are powerful 
mucosal adjuvants, which promote local as well as systemic immune responses 
(Elson and Ealding, 1984; Tochikubo et al., 1998). Type 2 responses may also be 
preferentially stimulated by CT adjuvant (Akhiani, 1997). This route and choice of 
adjuvant may be useful for stimulating immunity in the intestinal mucosa as priming 
at one mucosal surface may stimulate a response at another via the common mucosal 
immune system. This site is important in the defence against GI nematodes and 
therefore stimulating responses in this tissue might be appropriate to elicit protective 
immunity (Miller, 1984). 
The third vaccination trial was therefore designed to address these issues. 
Firstly to repeat the protection trial with SC and IP vaccination with AChE and 
secondly to measure the immune responses and assess the protective capacity of IN 
vaccination with the same antigen. 
In order to overcome the problems faced in the previous vaccination trial, 
several measures were taken to ensure the viability of the infection doses prior to the 
challenge to the vaccinated animals. Fresh faecal cultures were prepared and timed to 
produce fresh, mature L3 larvae during the period when challenge would take place. 
The infective capacity of these larvae was also tested on several tracer animals one 
week prior to challenge of the vaccinated animals. FEC were measured to confirm 
that these infections produced similar levels to those demonstrated previously 
(Chapter 3). 
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82.1 Observations 
During this experiment there were no problems related to the immunisation 
such as were observed during the first two vaccination trials. Animals immunised 
with AChE / Quil A were closely monitored for associated pathology but none was 
detected. 
With regard to the nasal immunisation regime, it was observed that the 
animals often exhaled (or sneezed out) a significant quantity of the immunising dose, 
either immediately on it being applied to the nares or after being inhaled for one 
breath. This tended to occur despite the mild anaesthesia under which the 
immunisations were applied to the animals. This observation led to a concern that 
animals may not have received a sufficient dose of the immunising antigen or that 
the response of individuals would vary markedly. 
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8.2.2 Pre-challenge serum antibody levels 
Prior to challenge the vaccinated animals were bled and the serum levels of 
total IgG were measured by ELISA to assess the response to vaccination, as 
described previously (Chapter 2.8.2). 
While each vaccinated group demonstrated an IgG response, the level of this 
response varied between each group (data not shown). The highest IgG titres were 
generated with IF delivery with alum (AChE / IP). Elevated titres, albeit of a lower 
magnitude, were observed following SC delivery with Quil A (AChE / SC) and, 
encouragingly, IN delivery with CT (AChE I IN). 
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8.2.3 Faecal egg counts 
Faecal egg counts - Trial 3 
FEC were performed on samples from tracer and vaccinated animals as 
described in Chapter 2.1.4 (Figure 8.1, panel A - Q. The results from the tracer 
animals indicated that in this experiment the infective capacity of the L3 larvae, as 
judged by FEC produced, was similar to previous experiments (data not shown). This 
was confirmed by the FEC from the vaccination control group, which conformed 
closely to the levels of egg output seen in earlier successful infection experiments 
(Chapters 3 and 6). 
Both the SC and IN vaccinated groups (Figure 8.1, Panels A and C) 
demonstrated reduced FEC compared to the controls. These corresponded to a 23% 
and a 38% reduction in the cumulative egg output respectively. In the SC group, the 
effect was particularly evident during the earlier stages of infection. These reductions 
were not statistically significant. 
Although early egg output was reduced in the IP group, this was due to a lag 
in egg output that was offset by a longer plateau of peak output compared to the 
controls. This resulted in the IP group producing a similar cumulative egg output to 
the controls (Figure 8. 1, Panel B). 
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Figure 8.1. The faecal egg output from AChE vaccinated and unvaccinated 
Control Wistar rats over 11 days following challenge infection with 25 
Nippostrongylus brasiliensis L3 larvae. Data represent the mean of counts 
performed on three pooled samples collected from each group of animals (+1-
the standard error). Vaccination with AChE / SC and AChE / IN reduced egg 
counts compared with the control. 
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Statistical analysis of combined Trial 1 and 3 faecal egg count data 
In order to increase the statistical power applied to the data from this trial an 
advanced statistical test, a repeated measures model, was performed using the FEC 
results. The details of this test are described in Chapter 2.8.4. When applied to the 
results of this trial alone, this test provided a statistical indication (P~0.09) that there 
was a real difference in the egg output when the SC and IN groups were compared to 
the non-vaccinated controls. 
Because the control and SC groups were exact repeats of equivalent groups in 
Trial 1 (Chapter 6), it was considered valid to include the Trial 1 data in the analysis, 
this constituting a repeated experiment and increasing the statistical power of the 
analysis. This analysis identified a statistically significant difference in egg output 
between the SC and IN vaccinated groups and the controls (P:50.019). There was no 
evidence of a difference between the control and IP vaccinated animals and the 
analysis also indicated that there was no difference between the Trial 1 and Trial 3 
results. 
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8.2.4 Post challenge serum antibody levels 
Serum was collected at post mortem 11 days after infection and antibody 
isotype levels were measured by ELISA (Figure 8.2, panels A and B). The titre of all 
antibody isotypes detected in the serum of AChE vaccinated animals was 
significantly elevated above those of the control (P<0.001). The response was 
particularly marked with IP delivery being at least 10 fold higher than that with SC 
or IN delivery (Figure 8.2, panel B). Both IP and SC delivery produced antibody 
titres that were higher than had been observed during previous experiments (Chapter 
6 and 7), but were in a comparable range (Figure 8.2, panels A and B). 
IN delivery of AChE resulted in elevated serum titres of each antibody 
isotype. With the exception of IgA these were higher than those produced by SC 
immunisation (Figure 8.2, panel A). With all modes of delivery the antibody 
response was highest in IgG with an increase in IgGi and IgG2a. 
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Panel A - Serum antibody levels from animals vaccinated via 
the sub-cutaneous and intra-nasal routes 
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Figure 8.2. The AChE specific serum antibody response of Wistar rats 
vaccinated with; A.) AChE / SC or AChE I IN and B.) AChE / IP compared 
with Control (unvaccinated) animals at 11 days following challenge with 25 
Nippostrongylus brasiliensis L3. The data represent the mean antibody titre 
of the 7 animals in each vaccination group measured by ELISA (+1- the 
standard error). Some differences in the levels of specific antibody were 
observed between the groups. 
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8.2.5 Mucosal antibody levels 
Antibody isotype levels were measured in the mucosa of control and 
vaccinated animals by ELISA as described in Chapter 2.7.1. Antibody responses 
were detectable from the mucosa of all of the AChE vaccinated groups, illustrated in 
Figure 8.3, panel A and B, and these were significantly elevated over the control 
group titres (P<0.001). The highest titres were again produced by IP vaccination, 
with the titres of mucosal antibody similar to those produced previously (Figure 8.3, 
panel B, Chapter 7). 
Mucosal antibody Litres were of a slightly higher level in the IN compared 
with the SC group for all isotypes except IgG2a (Figure 8.3, panel A). The IgGi and 
IgG2a ratio in the IP and SC groups was similar, indicating increases in both 
subtypes. In contrast to the SC and IP groups and the response observed in the serum, 
the mucosal IgG response of the IN vaccinated group was dominated by IgGi, 
approximately 5 times that of the IgG2a titre. 
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Figure 8.3. The AChE specific mucosal antibody response of Wistar rats 
vaccinated with; A.) AChE / SC or AChE / IN and B.) AChE I IP compared 
with Control (unvaccinated) animals at 11 days following challenge with 25 
Nippostrongylus brasiiensis L3. The data represent the mean antibody titre 
of the 7 animals in each vaccination group measured by ELISA (+1- the 
standard error). Some differences in the levels of specific antibody were 









8.2.6 Mucosa and serum Mast Cell Protease levels 
Levels of RMCP II were measured from the mucosa and the serum of control 
and AChE vaccinated animals by ELISA (Figure 8.4). 
The amount of RMCP II in the mucosa and in the serum of the unvaccinated 
control animals was elevated compared with the level previously observed in 
uninfected animals (Chapter 3) and of a comparable level to those measured from the 
control animals in the first vaccination experiment (Chapter 6). Serum levels in the 
SC group and the mucosal levels in all of the vaccinated groups were higher than 
those observed in the unvaccinated controls however these increases were not 
statistically significant. 
Figure 8.4. The mast cell protease response in the mucosa and serum of 
Wistar rats vaccinated with AChE and unvaccinated Controls at 11 days 
following challenge infection with 25 Nippostrongylus brasiliensis L3. The 
data represent the mean protease level of the 7 animals in each vaccination 
group measured by ELISA (+1- the standard error). No significant differences 
in RMCP II levels were observed. 
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8.2.7 Inhibition of acetyicholinesterase activity by antibody 
The effect of serum antibody on the activity of AChE was investigated as 
described previously (Chapter 2.5.5). Native PAGE gels of recombinant AChE and 
N. brasiliensis soluble extract (Si) pre-incubated with sera and stained for esterase 
activity are displayed in Figure 8.5, panel A - C. 
Control serum (Figure 8.5, panel A) showed no effect on the activity of the 
recombinant AChE as observed previously (Chapter 6 and 7). By contrast, AChE 
activity was almost completely abolished in the presence of sera from rats 
immunised with recombinant AChE IN (Figure 8.5, panel B). The effect was similar 
to those observed when sera from SC and IP immunised animals were tested 
previously (Chapter 6 and 7). 
The effect of serum antibody on the activity of native N. brasiliensis enzyme 
was investigated in the same manner. In this experiment N. brasiliensis Si was 
separated on the gel either alone or following incubation with serum. Serum from 
control and AChE vaccinated (SC, IP or IN) was incubated with the Si for 2 h prior 
to separation as described previously (Chapter 2.5.5). The Native PAGE gel stained 
for esterase activity is displayed in Figure 8.5, panel C. 
Three bands of activity were visible from the Si fraction, the lower two of 
these probably correspond to isoforms of AChE previously identified in 
N. brasiliensis with the upper band representing an endogenous esterase (Edwards et 
al., 1971). The activity of these bands was unaffected by incubation with the control 
serum. Incubation with serum from animals immunised SC, IP or IN with AChE 
however reduced the activity from the lower two bands corresponding to the AChE 
isotypes termed AChE b and AChE c. 
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Figure 8.5. The effect of serum antibody on recombinant and native 
acetyicholinesterase activity. Serum from individual A.) Control (non-
vaccinated) and B.) AChE / IN vaccinated Wistar rats was incubated with 
recombinant AChE, separated on native PAGE gels and stained for esterase 
activity. The activity of recombinant AChE was reduced by incubation with 
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Figure 8.5 (Continued). Panel C.) illustrates the effect of incubation with 
serum from Control (non-vaccinated) and AChE / SC, AChE / IP or AChE / IN 
vaccinated Wistar rats on the activity of native acetylcholinesterases (AChE b 
and c) from a soluble fraction of Nippostrongylus brasiliensis extract (Si). 
The activity of the native AChE was reduced by incubation with serum from 
AChE vaccinated rats. 
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8.3 Discussion 
The vaccination experiment described in this chapter was established to 
confirm the protection against N. brasiliensis infection in the rat immunised SC with 
recombinant AChE as described in Chapter 6. Further, this experiment evaluated the 
immune response and level of protection conferred by the IP and IN routes of antigen 
delivery. Immunisation via the IP route produces high circulating antibody titres in 
rats (Harlow and Lane, 1988) and also stimulates a mucosal immune response. IN 
delivery of antigen in association with CT stimulates Th-2 immune responses 
(Akhiani, 1997) and has been demonstrated to produce protection against gut 
dwelling nematodes (Tsuji et al., 2001; McGuire et al., 2002). 
In this experiment vaccination with recombinant AChE produced reductions 
in FEC of between 0 - 38% compared with the unvaccinated control animals. The 
analysis of these results in combination with results from an earlier trial (Chapter 6) 
indicated that there was a statistically significant reduction in the EEC of animals 
vaccinated with AChE via the SC and IN routes. The level of protection produced, as 
judged by a reduction in FEC, also varied with the different immunisation regimes 
applied to the three vaccinated groups. These differences in the level of protection 
were mirrored by differences in the level of specific antibody measured in the serum 
and the mucosa of the different trial group animals. Antibodies from the serum of the 
vaccinated groups inhibited the activity of the recombinant enzyme and, importantly, 
also inhibited the activity of two forms of the native enzyme present in adult worm 
somatic extracts. 
The cumulative FEC from the SC and IN vaccinated groups showed a 
reduction when compared with the control group (Figure 8.1). This indicated that a 
degree of protection was conferred by these vaccinations. There was no reduction in 
the cumulative egg output of the IP vaccinated group. When these data were 
subjected to an advanced statistical test, the repeated measures test, there was 
evidence that the reductions in egg output compared to the controls obtained after SC 
or IN delivery of antigen was likely to be significant. The power of this analysis was 
enhanced further by combining the data described in this chapter with those from the 
previous successful vaccination trial (Chapter 6), a valid approach as the groups 
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represented a repeated experiment under this model. The output of the model showed 
that a statistically significant reduction in egg output was conferred by immunisation 
with recombinant AChE using SC or IN delivery. 
These results confirm that protection against N. brasiliensis infection may be 
conferred by vaccination with recombinant AChE via the SC route as demonstrated 
in an experiment described previously in Chapter 6. This is the first report of 
protective immunity being conferred against nematode infection with AChE alone. 
In several earlier trials using this antigen equivocal protection results were observed. 
In a Guinea pig model of T. colubriformis infection no significant level of protection 
was achieved following IP immunisation with an AChE enriched fraction prepared 
from worm homogenates (Rothwell and Merritt, 1975). Protection of around 50% 
was achieved in a Guinea pig model of D. viviparus infection (McKeand et al., 
1995a). This trial used protein extracts enriched for AChE, but also containing other 
proteins (D.P. Knox, pers. comm.). Protection against D. viviparus did not extend to 
challenged calves when immunised using a recombinant AChE (Matthews et al., 
2001). In a mixed gastro-intestinal nematode infection of T. colubriformis, 
H. contortus and C. oncophora in sheep, vaccination with partially purified 
T. colubriformis AChE led to a 31% reduction in total worm burden (Griffiths and 
Pritchard, 1994). Again, the antigen used was not solely AChE. 
The results reported in this chapter also indicated that differing degrees of 
protection were associated with the different vaccination regimes. The least protected 
group was the IP vaccinated, which showed no overall reduction in egg output. The 
level of protection conferred by SC immunisation was 23%, compared with 48% in a 
previous trial (Chapter 6) and the IN vaccinated group gave a reduction in FEC of 
38%. Different routes of immunisation have previously been shown to stimulate 
differing degrees of protection in this system using adult somatic extract as an 
antigen (Murray et al., 1979). In contrast to the presented results the greatest degree 
of protection, over 90% as judged by a decrease in the mean number of worms, was 
afforded by IP immunisation. 
Vaccination via the IN route was the most effective mode of immunisation 
during this trial (Figure 8.1). This confirms previous observations that IN vaccination 
can provoke protective responses against gut dwelling nematodes (Tsuji et al., 2001, 
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McGuire et al., 2002). The data presented here, suggest that more effective 
protection may be achieved with IN delivery than SC and support the hypothesis that 
locally produced immune responses may be more appropriate for protection against 
these pathogens. However, IN delivery did also provoke a marked systemic antibody 
response that may have been active in the protective response demonstrated. 
Interestingly, the pattern of faecal egg output differed when each group was 
compared to the controls. SC immunisation resulted in a delayed peak in egg output 
compared to the controls (9 days and 7 days respectively) with egg output being 
lower in the early phase (5 to 8 days) of infection. A similar effect was observed in 
the IP group but here egg output persisted at a higher level than the controls in the 
later stages (9 to 11 days) of infection. Following IN delivery, egg output was 
reduced compared to the controls at all time points throughout infection and showed 
a similar temporal profile to the controls. 
A delay in the onset of peak faecal egg output such as that demonstrated by 
the SC and IP groups indicates that vaccination with AChE affected the host / 
parasite interaction, through the immune response or via direct effects on the worm. 
It might also suggest that the establishment of infection was delayed. As stated in the 
Chapter 1, AChE has several postulated in vivo effects that might aid worm survival. 
These include acting as a biochemical holdfast by reducing acetylcholine stimulated 
muscle contraction (Foster et al., 1994) or by modulating immune response 
mechanisms mediated by acetylcholine such as the induction of rapid mucus 
secretion from goblet cells (Specian, 1980) and the induction of cellular immune 
responses (Strom etal., 1974). 
Differing serum antibody responses were produced by the different modes of 
vaccination. The serum IgG response of the IN vaccinated animals was marginally 
higher than that observed in the SC group and both demonstrated a similar ratio of 
IgG2a to IgGi. In addition, IgE was higher and IgA lower in the IN compared to the 
SC group. Systemic antibody responses generated to an IN immunisation, adjuvanted 
with CT have been previously described (Wu and Russell, 1993, McGuire et al., 
2002), but such a response generated by this mode of vaccination may not be the 
most appropriate for protection against GI nematodes (Emery et al., 1993). IP 
delivery resulted in the highest titres of each isotype tested, which again were around 
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ten fold higher than those observed in the other groups (Chapter 7). However, no 
protection was demonstrated using this route of immunisation. 
Measurement of mucosal antibody responses (Figure 8.3) showed that, in 
contrast to previous results (Chapter 6), all delivery regimes resulted in detectable 
mucosal antibody. Intriguingly, IN delivery induced a predominant IgGi response in 
the IgG isotype and in addition the relative proportion of IgE and IgA was increased 
in the mucosa. An Th-2 polarised response is considered to be of importance in the 
expulsion of GI nematodes (Miller, 1984; Finkelman et at., 1997). Increases in 
specific IgG and IgA in the intestinal mucosa during N. brasiliensis infection have 
been previously documented and correlate with expulsion (Wedrychowicz et at., 
1983). Increases in intestinal IgA following IN immunisation are also associated with 
protection against A. suum and T. spiralis (Tsuji et al., 2001; McGuire et al., 2002). 
It is interesting to speculate that the observed alterations in the antibody isotype ratio 
at the site of parasite infection contributed to the slightly higher level of protection 
observed in the IN immunised group during this trial. 
The relative proportions of antibody isotypes observed when serum and 
mucosal responses were compared, in particular the observed shift in the IN group to 
an IgGi dominated response, suggest that some of the mucosal antibody was 
produced locally as a result of this mode of antigen delivery. The relative proportions 
of antibody in the serum and mucosa were the same for both the SC and IP groups. 
This indicates that the antibody present in the mucosa of these groups was likely to 
be derived from systemic leakage into the mucosa as a result of worm damage or the 
resultant immune response (McDermott et at., 2003). This hypothesis is further 
supported by the mucosal antibody of the SC group correlating with the increased 
serum antibody response in this trial. 
The apparent differences in the class and / or origin of the mucosal antibody 
response in the IN group might suggest that there are important differences in the 
ability of this antibody to carry out it's protective function. These might include 
increased avidity such as has been demonstrated in the vaccination against 
F. hepatica using Cathepsin-L protease (Mulcahy et at., 1998). If so then this would 
indicate that the amount (relative titre) of antibody is less important than the quality 
of this antibody. This might also explain why, though the IP vaccinated group clearly 
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shows a high response to vaccination and changes the profile of egg output, it does 
not confer an overall protective effect i.e. in this case the response is not appropriate. 
It may also be that with the IN vaccinated group that the antibody per se is not the 
effector of protection. The differences in antibody in the mucosa might merely reflect 
that there is a difference in the response of this group and that some other component 
of this different response confers increased protection. 
Serum antibody from IN vaccinated animals inhibited the activity of AChE 
(Figure 8.5). Similar inhibition was observed by antibodies in the sera of guinea pigs 
immunised against D. viviparus (McKeand et al., 1995b) and has been demonstrated 
by the sera of sheep infected with a variety of nematode species (Rothwell et al., 
1976). There was a suggestion that serum from IN vaccinated rats inhibited AChE 
activity to a greater extent than serum from those vaccinated by SC (Chapter 6) but 
less so than serum from IP vaccinated animals (Chapter 7). These differences 
probably reflected differences in the serum antibody titre between the samples. 
However, an experiment intended to confirm this did not resolve the cause due to the 
confounding effects of endogenous serum esterase activity, which masked the effects 
of the titration. The observed differences in antibody inhibition of the AChE activity 
might again be due to class differences in the antibody response stimulated by the 
different vaccination regimes. Factors such as increased avidity of the IN serum 
antibody might produce the observed differences in inhibitory effect. Measurement 
of the avidity of antibody can be performed by thiocyanate elution as described by 
Mulcahy et al. (1998). 
Importantly, the serum antibody from all three modes of vaccination inhibited 
the activity observed from two forms of AChE present in a somatic extract of adult 
N. brasiliensis worms. This indicates that the antibody produced by these 
immunisations inhibits the native AChE enzyme as well as the recombinant form. 
During infection native AChE enzyme illicits an IgE and IgG 1 antibody response in 
the host (Nakazawa et al., 1995). This response has been shown to affect the profile 
of enzyme isoform expressed by the worm with associated effects on the viability of 
the worms (Jones and Ogilvie, 1972; Sanderson et al., 1972). The finding that 
antibody from vaccinated animals has an effect on native enzyme activity therefore 
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supports a role for the antibody response produced by vaccination with AChE in the 
protective response observed. 
No significant differences in the level of RIvICP II between the control and 
vaccinated groups were observed during this experiment. This contrasts with the 
previous successful vaccination trial (Chapter 6) in which serum levels of the 
protease in vaccinated animals were reduced compared to the controls. As a higher 
level of protection was observed in the previous trial as judged by egg output, the 
reduced serum RMCP II level in that trial might have been indicative of a reduced 
worm burden and therefore reduced stimulation of mast cell response. 
The results obtained in this trial confirmed that a reduction in egg output and 
therefore a protective effect was conferred by immunisation with recombinant AChE. 
The results further indicated that different modes of immunisation might confer 
varying levels of protection and that these might be associated with changes in the 
serum and mucosal antibody level. Further, the serum antibody was shown to inhibit 
the activity of the recombinant enzyme and subtypes of AChE in the somatic extract 
of N. brasiliensis. This work therefore confirms that AChE might be a useful antigen 
in the production of a recombinant vaccine against GI nematode infection. The mode 
of application of anti-nematode vaccines was also shown to be important in the 
candidate antigens ability to generate protective immune responses. Nasal 
vaccination produced the highest degree of protection and appeared to stimulate a 
local immune response. These findings support further investigation of this route of 
immunisation for delivery of anti-nematode vaccines. 
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Chapter 9— General Discussion 
GI nematode infections in farm animals are a cause of substantial production 
and economic loss both in the UK and world-wide. Control is currently undertaken 
using prophylactic dosing regimes using three classes of anthelmintic drugs. 
Spreading parasite resistance to all three classes of these anthelmintic drugs along 
with consumer concerns over chemical residues in food has driven interest in the 
production of vaccines as an alternative means of controlling these infections. The 
use of recombinant proteins as a potential source of antigen might yield a relatively 
cheap means of production of successful vaccine candidates (Knox, 2000; Knox et 
al., 2001). 
In the UK two species of nematode are of particular importance in sheep, the 
abomasal dwelling species T. circumcincta and the small intestinal species T. vitrinus 
(Reid and Armour, 1975; Bartley et al., 2003). The related rat intestinal nematode 
N. brasiliensis shares many similarities with species of the genus Trichostrongylus, 
including the niche it occupies in its host and, importantly, in the functional antigens 
that it excretes or secretes. Several of these antigens, including the enzymes AChE 
and SOD, have been identified as potential vaccine candidates against different 
species of GI nematode and have been tested in vaccination trials in sheep (e.g. 
Griffiths and Pritchard, 1994; Liddell and Knox, 1998). 
Vaccination trials in sheep are expensive and this therefore limits the 
parameters, such as different antigens or modes of delivery that can be tested. The 
aim of this project was therefore to evaluate N. brasiliensis infection of the rat as a 
suitable model to test recombinant protein vaccines, primarily against 
Trichostrongylus sp. This system might offer the advantages of being cheap and easy 
to manipulate as well as allowing extended trials, such as the investigation of 
different modes of antigen delivery. Immunological markers in the rat are also well 
defined and easily measured. 
Experimental challenges with N. brasiliensis, described in Chapter 3, initially 
confirmed that the proposed model infection behaved as had previously been 
described (Ogilvie and Jones, 1971). Parasitological measures, the faecal egg output 
and the number of adult worms established in the intestine, peaked at 7 days after 
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which both declined as expulsion progressed. The pattern was the same irrespective 
of the level of infection employed. Egg output could be accurately determined and 
showed low variability at low infection doses. The FEC was subsequently chosen as 
the primary measure of vaccination challenge infections. This measure can also be 
performed without the need to sacrifice animals at each time-point, an important 
practical consideration given the cost of animal purchase and upkeep and reduction 
in animal numbers for welfare considerations. 
Challenge experiments with varying numbers of L3 larvae in several regimes 
of low-level infection allowed the most appropriate dose of larvae with which to 
challenge vaccinated animals to be decided (Chapter 3). Doses of around 2,000 L3 
have previously been used in laboratory infections (Ogilvie and Jones, 1971) but 
such a large challenge might overwhelm any protective responses conferred by 
immunisation. An infection using 25 L3 larvae, yielding a consistent egg output that 
lasted for over 12 days was subsequently chosen as an appropriate challenge dose. 
Trickle infection regimes with small numbers of larvae have previously been 
shown to lead to a cumulative and prolonged infection (Jenkins and Phillipson, 1971; 
1972). This situation has clear similarities to infection establishment and 
maintenance in the ruminant where animals are continuously exposed to infection 
from pasture. In the present study, despite using several variations of this regime, it 
proved to be impossible to provoke a cumulative, chronic infection. 
It has been suggested that the accumulating worm burden achieved in these 
previous studies may have been an artefact caused by the young age of the 
challenged animals (Miller, 1984). Prior to 11 weeks of age, rat pups do not expel 
secondary infections of N. brasiliensis as efficiently as older animals (Jenkins, 1974). 
In these experiments, however, all animals were pre-immunised with a 
N. brasiliensis infection of 1,000 L3 larvae prior to the challenge infections 
described (Jenkins, 1974). In the trickle challenge experiments of (Jenkins and 
Phillipson, 1971; 1972) there was no immunising infection and trickle challenges 
produced cumulative worm burdens and egg counts in naïve animals. 
The data presented in this study suggest that it may be possible to provoke a 
chronic N. brasiliensis infection, as a low egg count was maintained through the 
course of an infection regime in which animals were infected with 5 L3, three times a 
214 
week. Sterile immunity was not provoked, however a cumulative infection such as 
that previously described (Jenkins and Phillipson, 1971; 1972) was not achieved. The 
reason for this appeared to lie in the extremely critical level of infection needed to 
produce a cumulative worm burden without stimulating an expulsive immune 
response (Chapter 3). 
Apart from measuring the effect of vaccination on infection outcome using 
parasitological measures, there was a need to develop assays to monitor the humoral 
and cellular immune responses in the challenge experiments. If protection were 
noted, it might correlate to a particular immune parameter. This information might 
suggest a mechanism of protection and indicate an antigen delivery method for future 
experiments, further enhancing the protective response. 
Methods to measure some appropriate immunological markers, selected on 
the basis of work published previously, were developed (Chapters 3 and 5). These 
included several subtypes of parasite-specific antibody and a mast cell protease 
(RMCP II). Analyses were conducted on samples of serum and small intestinal 
mucosa, the former to provide an indication of the systemic, the latter the local, small 
intestine mucosa immune response. In Chapter 3, some of these assays were used to 
analyse the responses of rats to challenge infection. These experiments demonstrated 
increases in serum antibody responses and RMCP II levels during the course of 
infection similar to those described previously (Ogilvie and Jones, 1971; Miller, 
1984). Importantly, a rise in IgGi titre correlated closely with the time of expulsion 
of the worms. This isotype has previously been linked with protection (Jones et al., 
1970) and is indicative of a Type 2 immune response (Chapter 3). 
Increases in the level of RMCP II in the serum and in the intestinal mucosa 
also correlated with expulsion of the worms. RMCP II is released by activated mast 
cells and may be involved in the increase in epithelial permeability of the intestine 
observed (McDermott et al., 2003). It has been suggested that this facilitates the 
expulsion of GI nematode infection by allowing the transport of serum components 
(such as antibody) and fluid into the intestinal mucosa and degrading the 
environment of the worm. RMCP II release is strongly stimulated during 
N. brasiliensis infection and is indicative of a Type 2 response (Miller et al., 1983b); 
(Huntley et al., 1993). 
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Cytokine production can provide information on the Th balance of an 
immune response. Th-2 cytokines are considered to be produced during and 
influence the immune response and outcome of nematode infection (Urban et al., 
1992). Th-2 cytokine production has previously been observed during N. brasiliensis 
infection (Matsuda et al., 1995; 1999). Despite extensive effort, a RT PCR method 
for detection of cytokines from infected rat tissues (Matsuda et al., 1995) did not 
prove be a consistent or repeatable method for measurement of this immune marker 
set during the present study (Chapter 5). An alternative approach would be to 
measure the levels of cytokine protein in the mucosal extracts using commercially 
available anti-cytokine antibodies and ELISA based assays. 
Reactive oxygen intermediates (ROl) such as 02 and OH are thought to play 
a role in the host immune response, and their production by a number of cells, 
including macrophages and eosinophils, has been detected (reviewed; Rothwell, 
1989). ROl have been implicated in worm expulsion through mechanisms that may 
either alter the intestinal environment by damaging intestinal cells and rendering it 
unsuitable for parasite maintenance or by damaging the worms directly. Damage to 
worms could be effected by RO! reducing levels of protective enzymes and 
inhibiting lipoprotein synthesis (Smith and Bryant, 1989b) or causing DNA damage 
and lipid peroxidation in membranes (Nussler and Thomson, 1992). 
The susceptibility of different nematode life cycle stages to in vitro killing by 
granulocytes and oxidant mediated killing appears to be dependent on the levels of 
SOD and other antioxidant enzymes in the ES (Lightowlers and Rickard, 1988). 
Comparison of rodent infections with N. dubius (formerly H. polygyrus) and N. 
brasiliensis has implied a role for antioxidant enzymes including SOD in the 
longevity of infections (Smith and Bryant, 1986). Higher levels of antioxidant 
enzymes were detected in N. dubius compared to N. brasiliensis, indicating a 
possible reason for the persistence of N. dubius infections while N. brasiliensis 
infections were expelled (Smith and Bryant, 1986; 1989a; 1989b). In S. mansoni 
infections parasite antioxidant levels increase as the parasite matures and adults 
appear less susceptible to oxidative damage (Nare et al., 1990). 
Generation of ROT by activated phagocytes has been demonstrated to occur in 
N. brasiliensis infections and is observed earlier and at greater levels during heavy 
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compared with lighter infections (Smith and Bryant, 1989a). In N. brasiliensis 
infections SOD levels have been demonstrated to decrease while infection progresses 
and rising oxidant levels were detected in the host intestine, these changes being 
implicated in worm expulsion (Batra et al., 1993). The SOD isoform profile also 
varies with age and with host immune status as activity and isoform polymorphism 
increased in primed compared with naïve host (Knox and Jones, 1992). 
The evidence therefore appears to suggest that antioxidant enzyme levels play 
a role in preventing worm expulsion in a number of species. In addition lambs 
immunised with enzymically active recombinant SOD protein from H. contortus 
were partially protected against challenge infection (Liddell and Knox, 1998). For 
these reasons, SOD was selected as one of the main antigens of interest for use in the 
vaccination studies described here. 
The cloning and expression of a putative SOD gene from N. brasiliensis 
cDNA for use a recombinant vaccine was described in Chapter 4. Homology analysis 
showed that the gene was a cytoplasmic form of the enzyme (SODc), through its 
close homology to other nematodes SODc and its lack of a 5' transmembrane leader 
sequence, carried by extra-cellular isoforms (Liddell and Knox, 1998; Henkle-
Duhrsen et al., 1997). The expressed bacterial recombinant was soluble and 
enzymically active, both of which features might be important in its effectiveness as 
a vaccine candidate. The predicted protein sequence showed high homology with a 
putative extra-cellular isoform for which a partial sequence was obtained. It was 
therefore considered suitable to proceed with vaccinations using this cytoplasmic 
form of the enzyme, in the absence of a cloned extra-cellular isoform. Antibodies 
rasied against the H. contortus SODc cross-reacted with the extra-cellular form from 
the same parasite (Liddell and Knox, 1998). It was therefore considered likely that 
the two N. brasiliensis forms would be antigenically similar, due to their high 
homology, with the result that a vaccine induced immune response would be 
effective against both forms. 
Acetylcholine acts as a neurotransmitter in the central and peripheral nervous 
systems in humans and animals. Recent experiments have demonstrated a 
widespread expression of the cholinergic system in non-neuronal cells in humans 
(Wessler et al., 1998). Choline acetyltransferase, the synthesising enzyme, 
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acetylcholine, and acetylcholine receptors are expressed in a variety of cells and non-
neuronal acetylcholine appears to be involved in the regulation of many important 
cellular functions. Importantly it also has barrier and immune functions. 
Esterases hydrolyse uncharged substrates such as lipids or acetylcholine and 
are located throughout the tissues. Esterases have been detected in nematodes 
including T. colubriformis (Rothwell et al., 1976), N. brasiliensis (Edwards et al., 
1971) and D. viviparus (McKeand, 1992). The cholinesterases hydrolyse esters of 
choline and carboxylic acids and are separated into two groups, the true 
cholinesterases and pseudo-cholinesterases. AChE is a true cholinesterase and 
hydrolyses acetylcholine as a substrate. AChE in nematodes has a 'house keeping' 
role in modulating acetylcholine levels at neuronal and neuromuscular junctions. 
Secreted AChE may have a number of further possible functions. These include 
modulating mucus secretion, inhibiting some anti-parasite immune responses and 
functioning as a 'biochemical holdfast' by inhibiting local gut peristalsis (reviewed 
Pritchard, 1993). 
AChE release during in vitro maintenance has been recorded from a number 
of 01 nematodes including N. brasiliensis, T. circumcincta, H. contortus, and 
T. colubrformis (Ogilvie et al., 1973). Evidence of AChE release by D. viviparus 
and T. vitrinus has also been provided (McKeand et al., 1994b; Jones and Knox, 
1990; MacLennan, 1995). Immunolocalisation studies have demonstrated that AChE 
in N. brasiliensis is concentrated in the sub-ventral glands, which insinuates active 
secretion of the enzyme (Nakazawa et al., 1995). In vivo release of AChE is implied 
also by the observation of parasite AChE-specific antibodies in immune animals 
(Jones and Ogilvie, 1972; Rothwell et al., 1976; McKeand et al., 1994b). 
McKeand et al. (1994a) noted that isoenzymes of AChE in D. viviparus 
showed antigenic differences and suggested that this may allow parasite AChE to 
remain active in the face of antigenically specific immune responses which could 
effect parasite survival. Differential expression of secreted AChE isoforms has also 
been observed during N. brasiliensis infection (Edwards et al., 1971; Blackburn and 
Selkirk, 1992). The isoform profile was observed to alter during the course of an 
infection and this correlated with the expulsion of the worms and the host immune 
status (Edwards et al., 1971; Sanderson et al., 1972). Residual "adapted" worms that 
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are able to overcome the immune response had an increased and altered AChE 
expression profile from normal worms 
Elevated levels of non-specific esterases, with a relatively broad substrate 
specificity, have been detected in H. contortus, T. circumcincta and T. colubrfonnis 
strains resistant to benzimidazoles (BZ) compared to parasites which were 
susceptible to the drug (Sutherland and Lee, 1993). Why esterase levels are increased 
is unknown, but it has been suggested that the enzyme is involved in the 
detoxification of BZ or alternatively that BZ binding to tubulin may interfere with 
microtubule formation which may impair enzyme secretion (Lacey, 1988). 
Resistance to levamisole-morantel anthelmintics has also been associated with raised 
levels of AChE in the parasite (Sutherland and Lee, 1993) further indicating the 
potential importance of AChE for parasite survival. 
These observations give an indication that the secretion of AChE is important 
in the in vivo maintenance of GI nematodes. As a result, AChE has been proposed as 
a potential immunogen, for use in sero-diagnosis or vaccination (Jones and Knox, 
1990; Knox, 1994). For these reasons, AChE was selected as a second antigen on 
which the present studies would be based 
The enzyme used in the work described here was a kind gift from Prof. 
Murray Selkirk, Imperial College, London. High level expression was obtained via 
secretion from Pichia pastoris (Hussein et al., 1999). The purified enzyme (isoform 
B) behaved as a monomeric hydrophilic species. The recombinant enzyme efficiently 
hydrolysed acetylthiocholine but showed minimal activity against the alternative 
substrate butyrylthiocholine. It also displayed excess substrate inhibition with 
acetyithiocholine at concentrations over 2.5 mM and was highly sensitive to both 
active site and "peripheral" site inhibitors (Hussein et al., 1999). 
Vaccination trials using the recombinant SOD and the recombinant AChE are 
described in Chapters 6, 7 and 8. In repeated trials (Chapter 6 and 8) vaccination with 
AChE reduced cumulative egg counts by 48% and 23% respectively. Although 
individually results were not significantly lower than the control, statistical analysis 
of combined egg count data from SC and IN immunisations indicated that a 
significantly reduced egg output was conferred by these treatments. These reductions 
in faecal egg output indicated a protective effect and confirmed the utility of AChE 
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as a vaccine. This follows previous successful trials with AChE-enriched fractions 
against D. viviparus in Guinea pigs (McKeand et al., 1995a) and mixed infections 
containing T. colubrformis in sheep (Griffiths and Pritchard, 1994). However, 
importantly this is the first demonstrable protection conferred solely by a 
recombinant AChE antigen, suggesting that a recombinant AChE may be efficacious 
against ruminant infections. 
The single trial with IN immunisation of the AChE reduced egg output by 
38%, while the observed data indicated that no significant reduction in the egg output 
was conferred by IP immunisation (Chapter 8). These regimes tested the hypothesis 
that targeting immunisation to mucosal surfaces might promote more appropriate 
immune responses to GI nematodes (Emery et al., 1993). The data confirm that IN 
delivery of protein vaccines can elicit protection in rodent nematode infections (Tsuji 
et al., 2001; McGuire et al., 2002). The level of protection was higher than the SC 
group produced in this experiment (38% compared to 23%), therefore IN 
immunisation might offer improved levels of protection when compared directly 
with SC immunisation (Chapter 8). 
SC and IN immunisation induced elevated titres of specific antibodies in the 
serum (Chapter 6, 7 and 8). Specific antibody in the mucosa of SC vaccinated 
animals was also detected in the final trial (Chapter 8). In this latter instance it was 
possible that the antibody was a result of crossover from the serum and not local 
antibody production because the relative ratio of the isotypes was similar in both 
compartments with IgG2a predominating (Chapter 8, Figure 8.3 and 8.4). By 
contrast, while IgG2a predominated in the systemic response to IN delivery, the 
mucosal response showed predominant IgGi and elevations in IgE and IgA, 
indicative of a local mucosal Th-2 type antibody response. Because the protection 
observed in the IN vaccinates was higher that that in the SC, it is possible that the 
IgGi isotype is the principal effector antibody in the context of a pronounced Th-2 
background. 
IP immunisation induced a relatively very large rise in specific antibody 
isotypes in the serum that was mirrored by an increased mucosal antibody level 
(Chapter 7 and 8). Once again it was possible that the mucosal antibody was a result 
of crossover from the serum. The lack of protection observed suggested that this 
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extremely strong serum antibody response to immunisation was not appropriate to 
elicit protection. 
As noted above, in contrast to the other modes of immunisation the antibody 
response in the mucosa of IN immunised animals was differentiated to an IgGi 
response, with an increased IgE and IgA component. This suggested a local antibody 
response with a bias towards Th-2 response. Such a response has been previously 
demonstrated using this adjuvant (Cholera toxin) via this route of immunisation and 
might be more appropriate in stimulating responses against GI nematodes (Tsuji et 
al., 2001; McGuire et al., 2002). It might be that the elevated level of protection 
compared with IP and SC vaccination (38% compared with 0 and 23% respectively) 
was conferred by these local changes in antibody profile or that these were indicative 
of an improved protective response. The IN group did also however express a serum 
response that was slightly elevated compared with the SC. 
The involvement of a local mucosal immune response in protection could be 
confirmed by defining local antibody production from antibody secreting cells 
harvested from the draining (mesenteric) lymph nodes (Bowles et al., 1995). In 
addition, cytokine expression in these nodes could be monitored using a RT PCR 
assay, as attempted in Chapter 5. Indeed, using dissected out lymph nodes would 
provide a richer source of cytokine mRNA than the whole mesentery tested in 
Chapter 5 and may overcome the difficulties of specificity and sensitivity indicated 
by that work. 
In this study, measurement of the levels of RMCP II in the sera and intestinal 
mucosa of rats in each of the vaccination trials was used as a marker of cell-mediated 
immunity. Elevations in the levels of this enzyme have previously been shown to 
coincide with worm rejection (Miller, 1984; Balic et al., 2000). In the present study, 
RMCP II proved to be an inconsistent marker during the vaccination trials. For 
example, although serum levels were depressed in the AChE immunised group in the 
first trial (Chapter 6, Figure 6.5) compared to control rats and indicated a significant 
alteration in the activation of mast cells, in a later trial serum RMCP II levels were 
elevated (Chapter 8, Figure 8.4). Similar contrasting results arose from the 
measurement of mucosal levels of the enzyme. It is likely that these data fall within 
the normal range of variation associated with RMCP II levels in the rat, a suggestion 
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supported by the range of levels observed in the control groups in the three 
vaccination experiments conducted. The titres of RMCP II observed in each of the 
trials was much lower than those observed at the 11 DPI peak noted in Chapter 3, 
although this is probably explained by the much lower challenge infection. 
From the observed changes in antibody isotype levels and the lack of an 
observed cellular response, it is possible to draw the tentative conclusion that the 
effectors of protection observed was an antibody response to the parasite enzyme 
inhibiting its action. That antibody against AChE is involved in protective immunity 
has been indicated previously in N. brasiliensis and other parasites known to secrete 
AChE (Jones and Ogilvie, 1972; Rothwell et al., 1976; McKeand et al., 1994b). 
Evidence that this was a possibility was sought by employing a gel based 
enzyme activity assay. With the gels run under non-reducing, non-dissociating 
(Native) conditions, enzyme-inhibitor (antibody) complexes should not be disrupted 
with the result that migration of the enzyme in the gel would be much slower than 
the native enzyme, or the activity may impaired. In this study, enzyme migration was 
retarded by pre-incubation with sera from animals vaccinated with recombinant 
AChE (Figure 6.6). An additional slow-migrating zone of activity was apparent at 
the top of these gels compared to controls, indicating that the enzyme was complexed 
to a factor in the serum, an interaction that did not inhibit activity. Activity was 
inhibited by pre-incubation with sera from animals vaccinated with recombinant 
AChE via the IP and IN routes (Figure 7.5 and Figure 8.5), possibly due to the higher 
antibody titre of these sera or some qualitative difference in the antibody (Chapter 7 
and 8). Importantly, this inhibition was also apparent when native AChE in parasite 
extracts was incubated with vaccinate sera (Figure 8.5, panel Q. 
Whether or not the factor responsible for this retarded migration and 
inhibition was antibody could be confirmed by purifying antibody from the sera 
using Protein G. Similar inhibition of D. viviparus AChE by sera from vaccinated 
Guinea pigs was attributed to IgG by such a method (McKeand, 1992). 
Repeated trials indicated that the recombinant SOD did not induce a strong 
immune response as judged by the antibody response to systemic (SC) immunisation. 
Further to this, the immunisation produced no reduction in egg output and the 
cellular response (as judged by RMCP II level in serum and mucosa) did not differ 
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significantly from the control. One possible reason for this lack of response is genetic 
restriction of antigen recognition in the strain of rat being used. This hypothesis 
being supported by an earlier finding that different, hyper-immune animals varied in 
their recognition of the expressed SOD enzyme (Chapter 4). 
That genetic restriction might be responsible for the lack of response to 
immunisation with the recombinant SOD was examined by immunisation and 
challenge of a second strain of rat (Sprague-Dawely). Again, the IgG responses were 
not significantly increased compared to the control or responses in the original rat 
strain (Wistar). Therefore, it is likely that the SOD protein is simply weakly 
immunogenic in its present form. Methods by which the immunogenicity of this 
protein could be improved were described in Chapter 7.3. 
The results obtained in this series of experiments suggest that the 
N. brasiliensis / rat infection system might be a useful model of vaccination against 
intestinal nematodes. The antibody response comprised of increases in specific IgG, 
IgE and IgA, with increases in IgG 1 and IgG2a correlating with expulsion (Chapter 
3). Mast cell activation with release of protease also correlated with expulsion 
indicating a cellular component to the response (Miller et al., 1983b). Antibody and 
mast cell responses in the rat during this infection were therefore confirmed as being 
similar to those produced during ruminant nematode infections (reviewed; Miller, 
1996; Balic et al., 2000). 
Immunisation with the recombinant AChE produced an immune response that 
conferred a protective effect (Chapter 6 and 8). As discussed previously AChE may 
have several in vivo functions in the maintenance of the parasite within its host and is 
excreted or secreted in relatively large amounts by both N. brasiliensis and 
Trichostrongylus sp., an indicator of its functional importance (Ogilvie et al., 1973). 
The observed protection when either host is immunised with this protein strongly 
suggests that the enzyme is of importance in the maintenance of infections with both 
species and is suitable as a vaccine candidate. These observed similarities support the 
utility of the N. brasiliensis / rat model system outlined in this thesis for the 
investigation of vaccines against Trichostrongylus sp. 
The lack of response demonstrated following vaccination with SOD is in 
contrast to a previous trial using H. contortus SOD (Liddell and Knox, 1998) and the 
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suggested role of SOD in the maintenance of this infection (Henkle-Duhrsen and 
Kampkotter, 2001; Smith and Bryant, 1986). These data indicate that isolation of a 
recombinant secreted isoform or improvement of the immunogenicity of the protein 
may need to be carried out to truly assess the utility of this vaccine candidate. 
It is the similarity between the two intestinal species that is of primary 
consideration in assessing the potential of N. brasiliensis as a model for 
Trichostrongylus sp. Ultimately it is by comparison with vaccination trials against 
Trichostrongylus in sheep that this system must be judged as a useful vaccination 
model of intestinal nematodiasis. The level of protection conferred by immunisation 
with AChE during this trial and in the previous studies using this antigen may be 
comparable (approximately 30-50%; Griffiths and Pritchard, 1994; McKeand et al., 
1995a). However in these previous trials protection was measured as a reduction in 
worm burden rather than egg output. A further extended study to measure any 
reduction in worm burden conferred by vaccination with N. brasiliensis AChE would 
therefore be required to allow a direct comparison of these experiments. This could 
be achieved by expanding the current trial design to include killing rats at 7 days post 
infection to harvest and count the worms present in the small intestine. 
Immunising animals via different routes may influence the expressed immune 
response, with consequent effects on the protection achieved (Murray et al., 1979; 
Tsuji et al., 2001). As mucosal responses may be more important in protection than a 
systemic response, rejection of potentially useful antigens based on lack of protection 
conferred when tested using a systemic immunisation regime is a danger. As 
equivocal results using the same antigens with different adjuvant may be obtained, 
this system might be of use in screening the most appropriate adjuvant (Jacobs et al., 
1999; Vervelde et al., 2003). Investigation of different modes of immunisation 
indicated that different degrees of protection are conferred using different routes of 
immunisation and different adjuvants in the N. brasiliensis system (Chapter 7 and 8). 
Once again, this supports the utility of this model system in the investigation of 
different modes of delivery and adjuvant formulation for ruminant vaccine 
candidates. 
Further uses of this system might include the investigation of the effects of 
parturition on the outcome of vaccination (Houdijk et al., 2003). The outcome of 
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vaccination in neonatal rats, which are unable to expel infections (Love and Ogilvie, 
1974) in a similar manner to young lambs (Gibson and Parfitt, 1972), could also be 
investigated. As discussed in Chapter 1 these are epidemiologically important 
phenomena in ruminant infections. 
Screening other candidate antigens with homologues in Nippostrongylus 
could also be carried out. These include the Ancylostoma secreted protein (ASP) 
homologues, which are ES proteins of interest in vaccination studies against the 
human hookworm Ancylostoma duodenale (Hawdon et al., 1996), and the ruminant 
GI nematode H. contortus (Schallig et al., 1997). Further, as a rodent hookworm, the 
N. brasiliensis infection model might also have relevance to studies of hookworm 
vaccines, due to the similarities in life cycle and gene expression. ASP homologues 
are 	present 	in 	the 	N. 	brasiliensis 	EST 	data 	set 
(www.nema.cap.ed.ac.uk.org.nematodeESTs.nembase.html), but the outcome of 
trials with these or other candidates might depend on the relevance of the antigen in 
the life cycle of the worm. 
While these findings may be useful there are a number of problems that exist 
with the model and that would need to be addressed to allow full assessment of its 
potential. The primary concern identified by these experiments was that the variation 
in egg counts from vaccinated groups of animals at each timepoint was so large that 
it was difficult to identify meaningful statistical differences between treatments. 
While this problem was overcome by combining trial results in analysis, the effect 
was primarily due to the large variability of the data, and the low number of samples 
that could be collected. Increasing the number of samples from each group would be 
necessary to address this problem (Jill Sales, BioSS, pers. comm.). A sample size of 
seventeen per group has been estimated to be necessary to resolve statistically 
significant differences between two groups of animals based on the data from these 
trials. This sample number decreases as more groups are included in each trial, with 
fifty animals in total estimated for four trial groups (Jill Sales, BioSS, pers. comm.). 
Although during these trials seven animals were included in each group, 
restrictions on housing due to welfare and Home Office licensing restrictions meant 
that they were caged in pairs or threes. This limited the sample number to three 
samples per group, thereby limiting the statistical power that could be applied to the 
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data. One way in which this problem could be removed is by housing animals 
individually during the course of challenge infection or, at least, during faecal 
sampling periods. Individual sampling would allow an increased number of samples 
per group, compared with the three possible during these trials. Correlation of high 
and low egg output to the response of immune markers in individuals could also be 
detected, allowing more insight into the possible mechanisms of protection. With the 
trials performed in this study as a pilot experiment, this housing scheme could be 
justified in future experiments. 
The restriction on using sawdust floors instead of wire mesh also may have 
limited the quality of the faecal samples due to drying and meant more regular and 
time consuming sampling techniques had to be used. The use of wire mesh floors 
over damp towelling would allow less frequent and higher quality samples to be 
collected making the experiments easier to perform and possibly increasing the 
quality of the data (reducing variability). Housing animals on wire mesh floors in this 
manner would also allow a larger sample to be collected per animal, as coprophagy 
would be eliminated. This would also eliminate any possible auto-reinfection caused 
by worm eggs in the faeces. Once again, with the trials performed in this study as a 
pilot experiment, housing on mesh floors, at least during the sampling period, could 
justify these changes in future experiments. 
Other changes to the sampling regime might also be useful. The FEC data 
presented here indicated that a major difference between vaccinates and controls 
occurred at 7 DPI (Chapter 6 and Chapter 8). In future trials, antigens could be 
screened initially for protective efficacy by measuring faecal egg output in faeces 
harvested directly from the colon of individual animals in each group. This would 
increase the number of observations per group and, therefore, increase the statistical 
power available. An alternative approach would be to increase the level of parasite 
infection although this would require careful titration to ensure that the infection 
does not overwhelm any protective immune response. Increasing the parasite dose 
should allow meaningful worm counts to be undertaken with the possibility of 
determining whether any reductions in faecal egg output resulted from reductions in 
parasite establishment or in fecundity effects. 
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A further consideration is the tissue migratory phase of the life cycle of 
N. brasiliensis. It is possible that the mechanism of protection conferred by 
immunisation might act during this phase of the life cycle and not during the 
intestinal phase. Vaccination with AChE is unlikely to be protective during this 
phase, as native AChE is expressed strongly in the L4 and adult stages of the worm 
present in the gut of the rat but not in the migratory L3 stage (Sanderson and Ogilvie, 
1971). However, it would be important to confirm this before conducting any more 
advanced experiments. Additionally, the stage specificity of expression of any other 
antigen found to be protective in this system might be relevant to the stage of the life 
cycle in which the protection was expressed. 
The effect of vaccination on different N. brasiliensis life cycle stages could 
be tested by recovering larvae from different time-points through the course of 
infection (Sanderson and Ogilvie, 1971). A larger challenge dose of L3 than was 
used in these experiments and a cull of animals through an infection would be 
required to perform the experiment. Any antigens found to be protective during the 
larval migratory phase might in any case have relevance to studies into vaccination 
hookworms or D. viviparus with which the earlier tissue migratory stages of 
N. brasiliensis bears similarities. 
To summarise, this study has indicated that the N. brasiliensis / rat model is a 
useful tool for the evaluation of antigens and delivery systems in the development of 
recombinant vaccines against ruminant nematodes. The protection trial data suggest 
that recombinant worm AChE might be a useful component of a vaccine against 
intestinal nematodes, confirming previous work on this enzyme. The data further 
suggest that the mode of delivery and antigen used in trials of recombinant antigens 
may be important in the ability to provoke a protective immune response against GI 
nematodes. This finding might have important implications for the testing of 
recombinant vaccine candidates. Finally it is possible to speculate that this and future 
work in this system may play an important part in the development of recombinant 
vaccines against intestinal nematodes of ruminants. 
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Appendix 1- Working Buffers and Solutions 
Tris / Acetic acid / EDTA (TAE) buffer: 40mM Tris / acetic acid, 2mM EDTA (pH 8) 
in H20. 
PAGE Separating gel buffer: 1.5 M Tris, 1.5 mM SDS in H20. 
PAGE Stacking gel buffer: 0.25 M Tris, 1.5 mMSDS in H20. 
PAGE Electrode buffer: 25 mM Tris, 0.2 M glycine, 3.5 mM SDS in H20. 
PAGE Sample buffer: 0.125 M Tris pH 6.8, 20% glycerol (v/v), 1.5 M SDS, 10% B- 
mercaptoethanol (v/v), 0.025% bromophenol blue. 
PAGE Non-reducing sample buffer: 0.125 M Tris pH 6.8, 20% glycerol (v/v), 1.5 M 
SDS, 0.025% bromophenol blue. 
Blotting anode buffer 1: 0.3 M Tris in H20. 
Blotting anode buffer 2: 0.025 M Tris in H20. 
Blotting Cathode buffer: 0.025 M Tris / glycine pH 8 in H20. 
Tris / HCI buffer: 10mM Tris adjusted to desired pH with HC1 in H20. 
Tris buffered saline (TBS): 50 mM Tris / HC1 pH 8, 150 mM NaCl in H20. 
Tris buffered saline with Tween-20 (TBST): TBS with 0.05% Tween-20 (v/v). 
Carbonate/bicarbonate buffer: 0.25 mM Na2CO3 adjusted to desired pH with 0.25 mM 
NaHCO3 in H20. 
Phosphate buffer: 0.1 M K2HP03 adjusted to the desired pH with 0.1 M KH2PO4 in 
H20. 
Phosphate buffered saline (PBS): 0.1M phosphate buffer pH 7.4, 0.9% NaCl (w/v) in 
H20. 
Phosphate buffered saline with Tween-20: PBS with 0.05% Tween-20 (v/v) in H20. 
Coomassie blue stain: 0.25% Coomassie brilliant blue, 40% methanol (v/v), 10% 
acetic acid (v/v) in H20. 
Destain: 30% methanol, 10% acetic acid in H20. 
Agarose loading buffer: 40% sucrose, 0.25% bromophenol blue in H20. 
SOC media: 2% Trypton, 0.5% yeast extract, 0.05% NaCl, 0.1 M Mg SO4, in H20. 
Luria broth (LB): 1% Trypton, 0.5% yeast extract, 1% NaCl. 
LB Agar: 1% Trypton, 0.5% yeast extract, 1% NaCl, 1.5% Agar. 
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